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Structural Analyses of Two Inositol Metabolizing Enzymes 
By Rebecca Goldstein, Advisor: Prof. Mary Roberts 
 
Myo-inositol and its phosphorylated derivatives are found across all 
domains of life, and these molecules play crucial roles in a wide variety of cellular 
processes. While the biosynthesis of inositol is an evolutionarily conserved 
pathway, there are a wide variety of enzymes that use inositol and its derivatives 
as substrates. This thesis explores two such enzymes; a phosphatidylinositol-
specific phospholipase C (PI-PLC) produced by Staphylococcus aureus, and 
AF2372, a dual action inositol monophosphatase/ fructose bisphosphatase 
produced by the Archaeoglobus fulgidus. At the outset of this work, the structure 
of the S. aureus PI-PLC was unknown, but some interesting biochemical 
properties about the enzyme had been observed.  The structure of AF2372 had 
been reported, but a structure had not yet been solved in the presence of 
osmolytes known to thermoprotect the enzyme. Both the S. aureus PI-PLC and 
AF2372 catalyze the cleavage of phosphorylated inositol compounds, but share 
no mechanistic, structural, or taxonomical similarities. Protein crystallography is a 
powerful tool, and with it I have been able to study these two enzymes at a 
molecular level, providing insight into complex biological questions about each 
enzyme.  
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1.1 Inositol 
 myo-inositol (cis-1,2,3,5-trans-4,6-cyclohexanehexol) (see Figure 1-1)  is 
the most prominent naturally occurring  stereoisomer of inositol. This crucial 
cyclic polyol is found in eukaryotes, bacteria and archaea. Myo-inositol is an 
essential nutrient and its phosphorylated derivatives are used in eukaryotic signal 
transduction pathways. Phosphoinositides, phospholipids with a phosphorylated 
inositol headgroup, are involved in several types of cellular events; they facilitate 
membrane trafficking, ion channel modulation, maintenance of the actin 
cytoskeleton, regulation of cell death and survival, and act as anchors for plasma 
membrane proteins (GPI-anchored proteins) (Lu et al., 2012; Michell, 2011; 
Fischer et al., 2002). The phosphoinositide signaling cascade processes 
chemotaxic stimuli such as cAMP and folate (Fischbach et al., 2006). 
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Inositol is biosynthesized in an evolutionarily conserved pathway: the 
enzyme MIPS (myo-inositol-3-phosphate synthase) catalyzes the intramolecular 
oxidoreduction and aldol cyclization of glucose-6-phosphate, using NAD+ as a 
cofactor to generate the cyclitol (Fischbach et al., 2006). Inositol is so crucial, 
that experiments depriving an inositol auxotroph mutant of the cellular slime mold 
Dictyostelium discoideum of inositol prevented this organism from phagocytosis 
of bacteria, its exclusive nutrient source. Cultures of auxotrophic D. discoideum 
deprived of inositol lost viability within one day (Fischbach et al., 2006).  
 In bacteria and archaea, inositol has many uses. It is involved in 
physiological processes including growth regulation and membrane biogenesis, 
and appears as an osmolyte in hyperthermophiles (Roberts, 2005; Fischbach et 
al., 2006). Inositol is crucial for synthesizing phosphatidylinositol (PI), an 
essential phospholipid for all eukaryotes as well as some mycobacteria 
(Reynolds, 2009). In bacteria, the majority of inositol is used to generate PI. In 
eukaryotes, these membrane lipids can also be derivatized to attach complex 
carbohydrates or proteins to the cell surface. While most Gram-negative bacteria 
do not contain much PI in their membranes, PI does appear in the Actinomyces; 
(Mycobacteria sp., Corynebacterianm nocardia, Micromonospora sp., 
Streptomyces sp., and Propionobacterium sp.) especially in the mycobacteria 
where it is critical for the synthesis of cell wall lipoglycans of M. tuberculosis 
(Roberts, 2005).  PI lipids are much more common in archaea than they are in 
bacteria, and they constitute one of the major archaeal phospholipids (Sato and 
Atomi, 2011). Additionally, the use of myo-inositol is widespread in archaea, 
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where it is used to make various compatible or protective solutes: di-inositol-1,3’-
phosphate (DIP), mono and di-mannosides of DIP and glycerophosphoinositol 
(GPI). These solutes work to both physically stabilize components of the cell, and 
to provide an osmotic drive to rehydrate the cell when water is limited (Michell, 
2011).  
Though biosynthesis of myo-inositol is evolutionarily conserved, it can also 
be generated by the hydrolysis of a number of inositol monophosphate isomers. 
This catalysis is undertaken by a class of enzymes known as inositol 
monophosphatases (IMPases). These enzymes, in eukaryotes, bacteria, and 
archaea, all share a general αβαβα arrangement of α-helices and β-sheets. Most 
IMPases are homodimeric enzymes that are metal dependent, strongly favoring 
Mg+2. They are also inhibited by Li+. They remove equatorially positioned 
phosphates from inositol monophosphates to yield myo-inositol (Stieglitz et al., 
2002; Atack et al., 1995; York et al., 1995). The archaeal IMPases are of 
particular interest. Though structurally quite similar, unlike the bacterial and 
mammalian IMPases, they can hydrolyze fructose 1,6-bisphosphate (FBP) as 
well as inositol-1-phosphate (I-1-P) (Stec et al., 2000). Furthermore, these 
archaeal IMPases are active a high temperatures and usually quite thermostable. 
For example, the Archaeoglobus fulgidus IMPase is active at high (Tm= 87 ˚C) 
temperature, consistent with its organism of origin (a hyperthermophile grows in 
temperatures as high as 90-95 ˚C  (Stieglitz et al., 2002)). 
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 Myo-inositol can also be 
generated by the hydrolysis of 
phosphatidylinositol lipids by a family 
of enzymes known as 
phosphatidylinositol-specific 
phospholipases (PI-PLs). This family 
of enzymes is divided into four 
classes based on where they cleave phospholipids (Figure 1-2). PLA1, originally 
discovered in snake venom, cleaves PI  at the sn-1-acyl chain position, 
generating fatty acid and 2-lyso-phospholipid (Ueda et al., 1993). PLA2 catalyzes 
the hydrolysis of PI at the sn-2-acyl chain, and releases fatty acid and 1-lyso-
phosphollipid (Dennis, 1994).  PLC and PLD are phosphodiesterases; PLC 
cleaves PI at the glycerophosphate bond to create diacylglycerol (DAG) and a 
phosphoinositide, while PLD cleaves on the other side of the glycerophosphate 
bond to create inositol and phosphatidic acid (Singer et al., 1997; Meldrum et al., 
1991). The phosphatidylinositol-specific phospholipase C branch of the PLC 
family is of the greatest interest. These enzymes are found in bacteria, protozoa, 
yeast, mold, plants, insects, and mammals. In bacteria, these enzymes are 
secreted virulence factors, while in eukaryotes they are intracellular enzymes that 
produce signaling molecules (Heinz et al., 1998; Hondal et al., 1998; Griffith et al., 
1999). PI-PLCs will be discussed at length in chapter two. 
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1.2 AF2372: a Dual Action Inositol Monophosphatase / Fructose 1,6-
Bisphosphatase 
 
Archaeoglobus fulgidus 
Of the three domains of cellular life, Archaea have evolved to survive in 
the widest variety of conditions.  Archaea typically make up about 10% of the 
total microbiota present. However in extreme conditions (high heat, low pH, high 
salinity, etc.) they dominate the microbe presence (Robertson et al., 2005). 
Though not limited to extreme conditions, archaea can thrive in them. Archaea 
have been isolated from such unlikely places as terrestrial solfataric fields, 
shallow and deep hydrothermal vents, and oil reservoirs (Takai and Yoshihiko, 
1999; Stetter et al., 1993). One such extreme environment, the seawater 
supported Thistle oil reservoir, which is approximately 3000 meters below the 
bed of the North Sea, was found to have a high concentration of 
hyperthermophilic organisms. Among 
the microbes isolated from this high 
temperature, high pressure 
environment (85˚C and 350 atm) was 
the archaeon Archaeoglobus fulgidus 
(Stetter et al., 1993). A. fulgidus 
appears as irregular spheres with 
monopolar flagella and a glycoprotein 
envelope. This organism can survive 
between 60 and 95 ˚C, with peak 
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growth at 83 ˚C. A. fulgidus can grow organoheterotrophically (using several 
different carbons sources) as well as lithoautotrophically; using hydrogen, 
thiosulfate, and carbon dioxide (Klenk et al., 1997). 
 
Osmolytes 
With such a high preferred growth temperature, protein denaturation could 
be problematic. However, hyperthermophilic organisms have evolved to 
overcome this issue with a variety of mechanisms: intrinsic thermostability, 
increased turnover, improved action of molecular chaperones, and extrinsic 
stability proved by compatible solutes (Lamosa et al., 2000). These extrinsic 
stabilizing solutes, osmolytes, protect biological macromolecules, nucleic acids 
and whole cells from damage by external stresses such as high salinity and high 
heat. Osmolytes are polar, low molecular weight compounds, which can reach 
concentrations up to 1-2 M in the cell.  These solutes are generally negatively 
charged in hyperthermophiles, and can be amino acids, amino sulfone acids, 
sugars, and betaines (Lentzen and Schwarz, 2006). Though the mechanism of 
protein protection by osmolytes is not fully explored, a proposed mechanism 
theorizes that because the peptide backbone is more exposed to osmolyte when 
the protein is in the denatured state, this raises the Gibbs free energy of the 
unfolded state, shifting the folded/unfolded equilibrium towards the folded state 
and inducing a net stabilizing effect (Faria et al., 2004).  
 Hyperthermophilic archaea tend to accumulate negatively charged 
derivatives of inositol and glycerol. Di-myo-inositol-1,1'-phosphate (DIP) and α-
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diglycerol phosphate (DGP) are two such osmolytes (Figure 1-3) which are both 
accumulated by A. fulgidus. DGP is accumulated by the organism in response to 
elevated salt concentrations, while increases in temperature cause an increase in 
DIP. Both DIP and DGP act as thermoprotectants (Lentzen and Schwarz, 2006). 
DGP in particular has been shown to exert a large thermostabilizing effect on not 
only A. fulgidus proteins, but also proteins from eukaryotes (Lamosa et al., 2000). 
 
IMPases 
Inositol monophosphatases (IMPases) are abundant enzymes that 
hydrolyze both L- and D-inositol 1-phosphate and replenish the supply of myo-
inositol for the synthesis of the cell membrane lipid phosphatidylinositol (Stieglitz 
et al., 2003). In mammalian cells these enzymes are also putative targets for 
therapeutic lithium ions, used to treat bipolar disorder (Atack et al., 1995). 
IMPases are ubiquitous in nature, in part because of widespread use of inositol 
phosphate dependent cellular signaling (Morgan et al., 2004). Several crystal 
structures of IMPases from eukaryotes, archaea, and bacteria have been 
deposited in the PDB and all show a conserved general architecture. Most 
IMPase proteins are homodimers, with each monomer ordered in an αβαβα 
motif. They require divalent cations (preferably Mg+2) for catalysis, which occurs 
via an activated water molecule used as a nucleophile (Atack et al., 1995). 
Before substrate binds in the active site (1), at least one Mg+2 ion must be 
present. Upon binding of inositol 1-phosphate (I-1-P) in the active site (2) via 
coordination of the phosphate with Mg+2 one, a second Mg+2 ion is acquired by 
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the active site.  After coordination of Mg+2 two, a third Mg+2 ion binds weakly to 
the enzyme via coordination with Asp200, and Thr38 and Asp40, situated on a   
mobile loop. Two of the Mg+2 ions then activate a water molecule (3) which 
attacks the phosphate of I-1-P, resulting in the cleavage of the phosphoester 
bond. While the product myo-inositol diffuses out of the active site and the third 
Mg+2 is released from the enzyme (4), the phosphate is still coordinated to two 
remaining Mg+2 ions.  However, Mg+2 two rapidly dissociates from the enzyme 
(5), leaving the phosphate coordinated only to one Mg+2. The phosphate then 
diffuses out of the active site, leaving a regenerated active site (1) with a single 
Mg+2 ion bound in site one (Atack et al., 1995; Johnson et al., 2001). For a 
schematic of the catalytic mechanism see Figure 1-4.  
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AF2372 
AF2372, the dual action IMPase/FBPase from A. fulgidus, is of special 
interest. This enzyme was the second member of the IMPase/FBPase family 
whose structure was solved, the first being MJ0109 from Methanococcus 
jannaschii.  AF2372 is atypical for an IMPase, in that rather than belonging to the 
biosynthetic pathway of phosphatidylinositol destined for cell membranes, it 
instead belongs to the biosynthetic pathway for the unique osmolyte, di-myo-
inositol 1,1-phosphate (DIP). Like the other IMPases, AF2372 employs a three 
metal ion assisted mechanism, and unlike the mammalian IMPases, A2372F and 
MJ0109 are not inhibited by Li+ cations (Stieglitz et al., 2002; Stec et al., 2000).  
Interestingly, AF2372 exhibits activity not only with I-1-P as substrate, but also 
shows activity towards fructose 1,6-bisphosphate (Stec et al., 2000). While 
IMPases catalyze the dephosphorylation of I-1-P, fructose-1,6-bisphosphatase 
(FBPase) enzymes dephosphorylate the 1-phosphate of fructose-1,6-
bisphosphate to yield fructose-6-phosphate. These enzymes exist as separate 
gene products in eukaryotes and some bacteria, and are specific to their 
substrates. A single enzyme with dual IMPase/FBPase activity has been reported 
in only a handful of organisms: A. fulgidus, Thermotoga maritima, Thermococcus 
kodakaraensi and M. jannaschii (Fukuda et al., 2007; Chen et al.. 1999; Sato et 
al., 2004; Stec et al., 2000; Stieglitz et al., 2002). Interestingly, while these 
enzymes have greater sequence homology to mammalian IMPases, structurally 
they resemble more closely mammalian FBPases (Chen et al., 1999; Stieglitz et 
al., 2003). However, in depth analysis shows that regions of mammalian 
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IMPases share conserved local similarity with dual IMPase/FBPases (Atack et al., 
1995).  Furthermore, AF2372 has been shown to be stabilized to thermal 
unfolding by osmolytes such as DGP and potassium glutamate (Yang Wei, 
unpublished data). 
 
1.3 S. aureus Virulence Factors and Effects on Human Health 
  
Staphylococcus aureus 
S. aureus is a Gram positive coccus that colonizes the nose and skin of a 
majority of the human population. In contrast to Gram-negative bacteria, such as 
E. coli, S. aureus can survive long periods of both dryness and high-salt content 
(Humphreys, 2012). This organism has been recognized as a major human 
pathogen since 1880, when it was proposed as the major cause of wound 
suppuration (Archer, 1998). S. aureus is known to cause a large array of human 
diseases, several of which are dependent on the propensity of S. aureus to form  
biofilms. Especially troubling is the increased mutability seen in these biofilms, 
where mutations are increased by 60-fold compared to planktonic cultures 
(Ryder et al., 2012).  Though S. aureus cells are present in a relatively large 
percentage of the human population, the bacteria typically becomes problematic 
for the host only under certain conditions, particularly upon surgery or the 
insertion of an intravascular catheter (Humphreys, 2012). As such, S. aureus is 
currently the most common cause of infections in hospital patients (Archer, 
1998). 
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S. aureus infection requires a break in the skin in some manner, either 
due to surgical incision,  superficial wound, or another route. When S. aureus 
does gain access below the dermis, infection takes place in five stages: 
colonization, local infection, systemic dissemination/sepsis, metastatic infection, 
and finally toxinosis (Archer, 1998). Upon colonization, S. aureus forms an 
abscess, from which it can spread locally (via a carbuncle, cellulitis, impetigo 
bullosa, etc.) or gain access to the blood, allowing the bacteria to spread quickly 
to multiple organs, causing toxic shock (Archer, 1998).  
 
Human Health Effects 
S. aureus is part of the normal skin flora, and is commonly found in the 
anterior nasal passages. Approximately 20% of the human population always 
carry one strain of S. aureus, while 60% of the population harbors S. aureus 
intermittently. A minority of the population (20%) are non-carriers (Kluytmans et 
al., 1997). S. aureus is a significant problem in human health, and is known to 
cause a variety of diseases, from skin and soft tissue infections to life-threatening 
endocarditis, osteomyelitis, and pneumonia. Of particular concern is the 
propensity of S. aureus to acquire antibiotic resistance, particularly to methicillin 
and other β lactams (Shukla et al., 2012). The methicillin resistance gene, mecA, 
is responsible for generating the penicillin-binding protein; the presence of mecA 
in S. aureus and has grown over the past decade. It is currently present in an 
additional 11% of the population of S. aureus (Anastasiou et al., 2008). 
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MRSA/VRSA 
One of the largest challenges to human health at present is the 
emergence of multi-drug resistance in S. aureus.  Though resistance to common 
antibiotics obviously complicates treatment, both MRSA (methicillin resistant S. 
aureus) and MSSA (methicillin susceptible S. aureus) are equally virulent. 
Antibiotic resistance to S. aureus has been prevalent since the introduction of 
antibiotics (benzylpenicillin) used to treat this infection in the 1950s (Humphreys, 
2012). Methicillin resistance (see Figure 1-5) appears to be the key resistance 
phenotype, and is due to the acquisition of the penicillin-binding protein PBP2a.  
This protein mediates cross resistance to all β-lactam antibiotics by binding them 
with low affinity. Up to 50% of MRSA strains are also resistant to macrolides, 
lincosamides, fluoroquinolones, and aminoglycosides (Archer, 1998). 
Furthermore, resistance to vancomycin is seen in S. aureus strains as well. 
Typically, S. aureus populations have acquired resistance from enterococci, 
where  such resistances are fairly common (Humphreys, 2012). These VRSA 
strains have generated altered substrates for cell wall synthesis (Cheng et al., 
2011). Most bacteria, S. aureus among them, synthesize cell walls from a 
disaccharide pentapeptide that terminates in a D-alanine-D-alanine. Vancomycin 
targets these cell wall precursors and sequesters them, inhibiting proper cell-wall 
synthesis. In VRSA, the D-alanine-D-alanine carboxy terminus of the cell wall 
precursor peptide is replaced by a D-alanine-D-lactate. The affinity of 
vancomycin for the new depsipeptide is decreased by a factor of 1000 (Weigel et 
al., 2003). 
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  Though the 
emergence of VRSA is 
troubling, of more 
pressing health concern 
is the increased 
prevalence of MRSA. The 
incidence of MRSA 
infection has greatly 
increased over the past 
decade, largely due to the 
worldwide emergence of 
community acquired 
strains of MRSA. Even in 
healthy individuals without the traditional healthcare associated risks, MRSA is 
no longer exclusively a nosocomial infection. In the USA, two MRSA strains, 
USA300 and USA400 represent the majority of community acquired infections 
(Diep et al., 2006). The USA300 strain of S. aureus produces a PI-PLC which 
has 100% sequence identity to that produced by strain Newman, which is the 
focus of much of this work (Daugherty and Low, 1993; Diep et al., 2006; Baba et 
al., 2008). 
Virulence Factors 
S. aureus produces a wide array of virulence factors, which includes both 
secreted exo-protein toxins and surface proteins which do not have a direct toxic 
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effect on the host cell, but play a role in pathogenesis. In contrast to viruses, 
disease causing staphylococci such as S. aureus are not inherently 
pathenogenic. The purpose of the virulence factors S. aureus produces is not to 
cause disease so much as to adapt the environment to suit the needs of the 
bacterium (Dunman and Projan, 2001). S. aureus toxins can be broadly classified 
into  four categories: the epidermolytic toxins (exfoliative toxins A and B), the 
enterotoxins (staphylococcal enterotoxins A-J, streptococcal pyogenic exotoxin A, 
toxic shock syndrome toxin-1), membrane damaging toxins (α, β, δ, γ hemolysin,  
Panton-Valentine leukocidin,  and other toxins) and virulence factors with 
extracellular and surface enzymatic activity (Chapes et al., 2001; Yarwood and 
Schlievert, 2001; Pancholi 2001). The exfoliative toxins (ETA and ETB) are 
extracellular proteins that are the causative mechanism behind blisters in bullous 
impetigo as well as the staphylococcal scalded-skin syndrome.  These toxins 
cause intra-epidermal cell-cell dissociation; they are glutamate-specific serine 
proteases that selectively target the extracellular region of desmoglein 1, a cell-
cell adhesion molecule (Kato et al., 2011).   
Enterotoxins are involved mostly in food poisoning, as well as toxic shock 
syndrome. These superantigens are both activators of T cells and potent 
inducers of T cell tolerance. The inappropriate hyperexpression of cytokines due 
to these toxins is a major factor of the disease conditions that arise from S. 
aureus infection (Zhang and Stewart, 2001). The membrane damaging toxins are 
the major virulence factors in animal models of infection, and α hemolysin has 
been shown to be of particular importance to virulence. These virulence factors, 
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also including γ-hemolysin, leukocidin, and Panton-Valentine leukocidin, have 
been shown to be pore forming toxins, each with specialized targets (Kamio et al., 
2001). S. aureus  also produces staphyloxanthin,  an orange-red triterpenoid 
carotenoid which functions as an antioxidant, it provides S. aureus  with 
resistance to hydrogen peroxide, superoxide radical, hydroxyl radical, 
hypochloride, and neutrophil killing (Clauditz et al., 2006). Finally, S. aureus puts 
out a variety of surface and exoproteins that have a role in virulence.  These 
proteins are the front-runners of disease states, and play a primary role in 
bacterial adherence, colonization, and internalization.  The secreted exoproteins 
in particular are used to subvert host defense mechanisms and host cellular 
signaling systems either by molecular mimicry or by digestion of target tissues. 
This category of virulence factor is highly varied and contains catalases that 
degrade hydrogen peroxide, lipases that impair neutrophil functions, and fatty 
acid modifying enzymes that allow increased survivability of S. aureus in 
abscesses. Also present are variety of extracellular proteases that impair host 
defenses, the tissue degrading hyaluronate lyase, and a penicillin binding protein, 
which is responsible for resistance to the methicillin antibiotics. S. aureus also 
contains a phosphatidylinositol-specific phospholipase C (PI-PLC) which cleaves 
GPI anchored proteins, a broad class of proteins bound to the surface of 
eukaryotic cells that play important roles as adhesion molecules, and receptors 
for intracellular cell signaling (Pancholi, 2001). 
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The S. aureus PI-PLC 
Phosphatidylinositol-specific phospholipase C (PI-PLC) is a virulence 
factor produced and secreted by many Gram positive bacteria (Griffith and Ryan, 
1999). When secreted by extracellular pathogens such as Bacillus and 
Staphylococcus strains (Rhee et al., 1989; Kyei-Poku et al., 2007; Daugherty and 
Low, 1993; Lehto and Sharom, 2002), this enzyme catalyzes the cleavage of 
glycan-phosphatidylinositol (GPI) anchored proteins. PI-PLC removal of the 
protective GPI-anchored proteins on the exterior surface of mammalian cells 
allows cellular damage to occur, and product diacylglycerol, translocating across 
the bilayer (Contreras et al., 2010), can interfere with cellular signaling 
processes.  Specifically, when S. aureus PI-PLC cleaves two complement 
regulatory proteins, decay-accelerating factor and C8 binding protein, cells 
become vulnerable to damage by activated components of the complement 
cascade. The loss of these two protective proteins leads to unregulated 
complement activation and cellular damage (Marques et al., 1989). Production of 
this protein has been found to be upregulated in MRSA strains (Buriak et al., 
2007). 
My thesis work deals with two very different enzymes; the S. 
aureus phosphatidylinositol-specific phospholipase C (PI-PLC) and the 
Archaeoglobus fulgidus inositol monophosphatase (AF2372). While both 
enzymes catalyze the cleavage of phosphorylated inositol compounds, they 
share no mechanistic, structural, or taxonomical similarities. Both S. aureus PI-
PLC and AF2372 have been studied by other means, but the majority of this 
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thesis deals with the elucidation of enzyme structure, and the biological 
questions that this information can answer. Macromolecular crystallography is a 
powerful tool: With the structural information obtained on these two enzymes (as 
well as various mutants thereof), I have investigated complex biological problems 
on a molecular scale.   
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2.1 PI-PLCs 
 Phosphatidylinositol-specific phospholipase Cs (PI-PLCs) are extremely 
abundant enzymes which catalyze the cleavage of phosphatidylinositol (PI), the 
glycophosphatidylinositol (GPI) anchors of membrane surface proteins, and 
phosphorylated PI derivatives; phosphatidylinositol-4-monophosphate (PIP) and  
phosphatidylinositol-4,5-bisphosphate (PIP2), into inositol and diacylglycerol 
(DAG) (Figure 2-1) (Heinz et al., 1998). This class of enzymes is found in many 
organisms, PI-PLCs have been isolated from bacteria, protozoa, yeast, mold, 
plants, insects and mammals. PI-PLCs are intracellular enzymes, except in 
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bacteria, where they act as excreted virulence factors (Griffith and Ryan, 1999). 
In eukaryotes, these calcium dependent enzymes are involved in receptor-
mediated signal transduction, they hydrolyze PIP2 into DAG and inositol 1,4,5-
trisphosphate, both of which are second messengers in eukaryotic signal 
transduction cascades (Essen et al., 1997; Harden and Sondek, 2006). In 
prokaryotes PI-PLCs act as virulence factors hydrolyzing the phosphodiester 
bond of PI and GPI anchored proteins in a calcium independent reaction (Heinz 
et al., 1995). The non-substrate lipid phosphatidylcholine (PC) activates bacterial 
PI-PLCs (Pu et al., 2009; Qian et al., 1998; Zhou et al., 1997B). PC is a major 
component (39%) of the plasma membrane of eukaryotes, however, many 
prokaryotes lack PC (Hauser and Poupart, 2004; Sohlenkamp et al., 2003). 
   
2.2 Role as Bacterial Virulence Factors   
Bacterial PI-PLCs are secreted, and usually find substrates in the outer 
leaflet of eukaryotic cells, a surface rich in PC, sphingomyelin and cholesterol. 
While target cells may have some PI in the extracellular leaflet, there are many 
GPI-linked proteins that are likely the primary targets of these PI-PLC 
exoproteins. Removal of the GPI-anchored proteins on the exterior surface of 
mammalian cells allows cellular damage to occur. Furthermore, the diacylglycerol 
will rapidly translocate across the bilayer where it can interfere with intracellular 
signaling processes (Contreras et al., 2010; Marques et al., 1989). GPI-PLC 
activity is unique to the bacterial PI-PLCs, eukaryotic PI-PLCs do not exhibit 
activity towards these substrates (Griffith and Ryan, 1999). However, the PI-PLC 
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produced by L. monocytogenes is a notable exception. This microorganism is an 
intracellular pathogen that secretes the PI-PLC along with a nonspecific PLC and 
listeriolysin, a cholesterol-dependent cytolysin, in endosomes within the host cell 
(Smith et al., 1995; Portnoy et al., 2002). This PI-PLC, with a role in cell-to-cell 
spread, targets PI in the inner leaflet of the host plasma membrane, an 
environment rich in PE and anionic phospholipids such as PS. It does not cleave 
GPI-anchored proteins (Gandhi et al., 1993). 
 Though bacterial PI-PLCs all target the same class of substrates, their 
roles as virulence factors take different forms. B. cereus is a known causative 
agent of food poisoning, while B. thuringiensis is an industrially used biological 
insecticide (Kyei-Poku et al., 2007; Roh et al., 2007). These two bacteria differ 
only in the production of the cry insecticidal toxins by B. thuringiensis. If the cry 
plasmid is lost, B. thuringiensis and B. cereus are essentially indistinguishable, 
and studies of a series of molecular markers in a large set of strains have 
indicated that the two organisms should really be considered as one species 
(Essen et al., 1997; Roh et al., 2007). B. thuringiensis PI-PLC in particular has 
been well studied, and is shown to damage eukaryotic cellular membranes. The 
PI-PLC plays an important role in B. cereus pathogenesis; B. cereus deficient in 
this enzyme are less able to cause disease (Callegan et al., 2002). However, the 
detailed mechanism for PI-PLC contributing to the virulence of B. cereus is not 
known (Zenewicz et al., 2005).  
PI-PLC is also secreted by Bacillus anthracis (Ba). Recently this PI-PLC 
has become an enzyme of interest due to the potential use of B. anthracis as a 
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bioterror agent. Recent studies indicate that that B. anthracis PI-PLC down-
modulates dendritic cell function. Dendritic cells respond to different pathogens 
and initiate the appropriate type of T cell response needed to control infection. 
The inhibition of T cell response seen in B. anthracis infections is thought to be 
due to PI-PLC cleavage of the GPI-anchored proteins important   to activation of 
dendritic cells (Zenewicz et al., 2005).  
Similarly, the effects of PI-PLC in S. aureus infection are known. S. aureus 
PI-PLC cleaves two crucial GPI anchored proteins from the outer surface of 
human cellular membranes; decay accelerating factor and C8 binding protein. 
These two proteins are complement regulatory proteins that protect human cells 
from damage by activated components of the complement cascade. The loss of 
these two proteins leads to unregulated complement activation and cellular 
damage (Marques et al., 1989). 
The biological effects of the PI-PLCs from S. antibioticus are relatively 
unstudied. There are two PI-PLC enzymes found in this organism, one which 
acts as a normal bacterial PI-PLC (Sab1), and a second PI-PLC (Sab2), which 
appears to act more like a eukaryotic version of the enzyme (Iwasaki et al., 1998). 
Sab2 requires Ca+2 and cannot cleave GPI anchors. Two structures of the S. 
antibioticus PI-PLC have been deposited in the PDB (3H4X and 3H4W), however, 
at present there is no published structure of the Ca+2 independent Sab1 (Jackson 
and Selby, 2012). Primary sequence shows that the two Sab PI-PLCs share 
some similarity; they share 14% identical residues, and an additional 33% similar 
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residues. The sequence of Sab1 PI-PLC is better correlated with the PI-PLC from 
B. cereus, with 25% identical residues and a further 34% of similar residues. 
The PI-PLC from L. monocytogenes contributes to virulence in a unique 
manner, since it has no activity against GPI anchored proteins (Gandhi et al., 
1993). After internalization by the host cell, a significant portion of the Listeria 
microorganisms escape the primary vacuole via activation of pore forming 
listeriolysin and phospholipid cleavage by the nonspecific phospholipase C. 
Since little PI is present in the vacuole membrane surrounding the bacterium, 
there is little use for the PI-PLC. However, once organism and exoenzymes 
diffuse into the cytoplasm, the very cationic PI-PLC will bind strongly to the 
plasma membrane where it can cleave PI to DAG activating different signaling 
pathways. Once the bacteria have replicated, they can spread to other cells by 
inducing formation of pseudopod-like structures, each containing bacteria now 
facing a membrane close to the composition of the inner leaflet of the plasma 
membrane. These pseudopods are driven via actin into neighboring cells, leaving 
the L. monocytogenes encapsulated in double membrane vacuoles (Smith et al., 
1995). The PI-PLC and the nonspecific PLC produced by the bacterium are 
important for allowing the bacterium to escape this double membrane vacuole 
and infect the new cell (Portnoy et al., 2002). Though the bacterial PI-PLCs 
attack different biological targets, in each case the enzyme must bind to target 
membranes.   
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2.3 Key Structural Features  
 Bacterial PI-PLCs are comprised of a single domain between 30 and 35 
kDa, which bears structural similarity to the catalytic domain of the much larger 
(80-85 kDa) mammalian PI-PLCs (Heinz et al., 1998). Mammalian PI-PLCs are 
divided into six classes and are organized into several distinct domains; a 
pleckstrin homology or PH domain, a domain comprised of four EF hands, a 
catalytic (βα)8 barrel domain, which is interrupted by a highly variable XY linker 
domain inserted between the two halves of the (βα)8 barrel, and a C2 domain. 
Additionally, a C-terminal coiled coil domain (CT) is necessary for 
homodimerization (Hicks et al., 2008). Differences between the families of 
mammalian PI-PLCs are subtle, with PLCδ and PLCβ showing excellent RMSD 
(1.87 Å) and overall having 41% identical residues. While the organization of the 
EF hand domains is slightly different between the two families, the C2 and 
catalytic domains show nearly identical secondary structure. The PH domain and 
XY linker are only visible in the PLCβ structure, thus no comparison can be made 
(Essen et al., 1997; Hicks et al., 2008).  
 The structure of the catalytic domain of mammalian PI-PLCs resembles 
closely the bacterial PI-PLCS, both showing the same distorted  (βα)8 barrel. The 
bacterial enzymes do not require calcium for catalysis, and though they can only 
hydrolyze PI, (not PIP or PIP2) they do so at a rate 10 times faster than 
mammalian PI-PLCs (Heinz et al., 1998). The (βα)8 barrel of mammalian PI-
PLCs is divided into an X and Y portion, corresponding to the N and C terminal 
portions of the bacterial enzyme, with a highly variable link joining the two 
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sections. While bacterial PI-PLCs do not have this XY linker domain, there is 
significant primary structural similarity to the mammalian catalytic domain, with 
14% identical residues and a further 38% similar residues (comparing Bacillus 
cereus PI-PLC to human PLCβ) (Heinz et al., 1995; Hicks et al., 2008). 
 All five published bacterial PI-PLC species show this same distorted (βα)8 
barrel. Helix notation is giving according to the Bacillus cereus PI-PLC structure 
using PDB 1PTG (figure 2-2).   The active site of all bacterial PI-PLCs resides in 
the open cleft in the center of the (βα)8 barrel, and is conserved across all  
structures. The active site contains the two catalytic histidines (His32 and His82 
in the Bacillus cereus PI-PLC structure) as well several polar and charged amino 
acids, which play a role in substrate binding (Heinz et al., 1995). Secondary 
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structural alignments show excellent (RMSD between 0.49Å and 1.7Å) 
correlation between the four related structures, with slightly inferior alignment (an 
average RMSD of 2.96 Å) between the S. antibioticus structure and all others 
(Qian et al., 1998). The structures of the Bacillus thuringiensis and Bacillus 
cereus PI-PLCs are nearly identical, they differ by only 8 residues, and they will 
often be discussed together; for the purposes of structure and function the two 
enzymes are close enough to be considered indistinguishable.   
 
 2.4 Interfacial Binding Regions  
 Helix B is a key structural feature of bacterial PI-PLCs. This helix, residues 
Pro42 through Gly48 in the Bacillus cereus PI-PLC structure, is comprised of 
hydrophobic and cationic residues, and is conserved in all structures except that 
of Sab2. Table 2-1 shows a comparison of the primary sequences of helix B from 
several structures. In addition to helix B, the Bacillus structure shows a loop of 14 
aromatic residues and nine cationic residues (See figure 2-3) situated around the 
rim of the (βα)8 barrel.   This rim loop of aromatic and cationic amino acids sits in 
a solvent exposed location, and thus seems likely to be energetically disfavored. 
The high concentration of solvent exposed aromatic and cationic residues mark 
this region as likely for insertion to the membrane. The cationic residues would  
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target anionic lipids, while the hydrophobic aromatic residues are known to 
cluster between the polar head group region and the glycerol ester region of lipid 
bilayers (Feng et al., 2002; Hendrickson et al., 1992; Wallace and Janes, 1999). 
 Previous mutagenesis studies have shown that helix B residues as well as 
various rim loop aromatic residues are critical for insertion of Bacillus PI-PLC into 
the membrane (Feng et al., 2002; Shi et al., 2009; Feng et al., 2003; Guo et al., 
2008).  The rim hydrophobic/cationic groups are well conserved between the 
Bacillus PI-PLCs and the PI-PLCs from S. aureus and L. monocytogenes The S. 
antibioticus PI-PLC while showing an equivalent number of cationic and aromatic 
rim residues, does not have them in positions conserved in the other three  
 
 
Table 2-1. Helix B primary sequences 
among bacterial PI-PLC structures. 
PI-PLC Helix B sequence 
B. cereus 42PIKQVWG48 
B. thuringiensis 42PIKQVWG48 
L. monocytogenes 54ITWTLTKP61 
S. aureus 41VKSVWAK47 
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species. The Bacillus PI-PLCs show a set of twelve rim residues which are  
conserved in the S. aureus and L. monocytogenes PI-PLCs, and a further eight 
residues which are conserved in the S. aureus PI-PLC but not the L. 
monocytogenes PI-PLC.  Of the twelve residues common to all three species, six 
of them are aromatic (Y86, F128, F176, Y200, W242, and Y248). 
 
2.5 Catalytic Mechanism and Interfacial Activation of PI-PLC 
 Bacterial PI-PLCs cleave PI or the GPI anchor of a membrane surface 
protein, in a two step reaction. Initially, phosphatidylinositol is cleaved in an 
acid/base mechanism to yield diacylglycerol (DAG) and a stable catalytic 
intermediate, cyclic inositol-1-2-phosphate (cIP). In the second, water soluble 
step, the five membered ring of cIP is opened by a molecule of water, yielding 
inositol-1-phosphate (I-1-P)(Griffith and Ryan, 1999). Previous mutagenesis has 
shown that the two residues responsible for catalysis are His32 and His82 
(Bacillus numbering) (Heinz et al., 1995). Observation of the Bacillus cereus PI- 
PLC structure with substrate mimic myo-inositol has shown several residues 
responsible for orienting the substrate for catalysis. Asp198 coordinates hydroxyl 
groups at the 3 and 4 positions, while Arg163 coordinates hydroxyls at the 4 and 
5 positions. Hydroxyl 5 is also coordinated by Lys115, and hydroxyl 2 is 
coordinated by Arg69 (Heinz et al., 1995).  
 The catalytic mechanism begins with a novel 69Arg-274Asp-32His dual 
function catalytic triad, that serves to both activate the phosphate and protonate 
the leaving group (DAG). His32 is assisted by Asp274 and acts as the general 
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base, abstracting the hydrogen from the hydroxyl at the C2 of inositol. Arg69 
activates the phosphate group by hydrogen bonding to the pro-S oxygen at the 
transition state. This hydrogen bond induces optimal alignment of the phosphate 
group and the 2-OH of inositol for nucleophilic attack, and may lower the pKa of 
the 2-OH. Additionally, Asp33 and His82 function together as a “composed 
general acid” (Kubaik et al., 1999; Kravchuck et al., 1999). The nucleophilic 
oxygen at inositol C2 then attacks the phosphate, forming a pentacovalent 
transition state, which collapses to yield DAG, which is then protonated by the 
general acid His82, and the water soluble product cIP. The hydrophobic DAG 
molecule can diffuse back into the substrate membrane; in contrast, cIP must be 
released into solution (Griffith and Ryan, 1999). If the concentration of cIP is high 
enough, that initial product can rebind in the active site and be hydrolyzed to 
inositol-1-phosphate by the enzyme. The Km for this water-soluble substrate is 
quite high (Zhou et al., 1997B), so this is not the predominant product for these 
bacterial PI-PLCs. A schematic of this binding  and catalytic mechanism is seen 
in Figure 2-4.  
 Interestingly, the S. antibioticus PI-PLC has a catalytic mechanism unique 
from the other PI-PLCs. While all other PI-PLCs cleave PI into I-1-P via a cis 1,2-
cyclic inositol phosphate intermediate, S. antibioticus PI-PLC catalyzes this 
reaction via a trans 1,6-cyclic inositol phosphate. S. antibioticus requires Ca+2 for 
catalysis, which activates the phosphate (Bai et al., 2010).  
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 While the bacterial PI-PLCs produce mostly the cyclic inositol phosphate 
product, eukaryotic PI-PLCs can produce both cyclic and acyclic forms of PI, but 
almost exclusively generate the acyclic inositol phosphate when PIP2 is the 
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substrate (Bruzik and Tsai, 1994). The eukaryotic equivalents of the catalytic 
histidines, His311 and His356, are well conserved and keep the same positions 
and orientations in the active site of the eukaryotic PI-PLCs (Heinz et al., 1998). 
Like S. antibioticus PI-PLC, the eukaryotic enzymes are Ca+2 dependent, where 
the Ca+2 is coordinated to not only the side-chains of Asn312, Asp343, Glu341 
and Glu390, but also a water molecule and the 2-OH-group of inositol 
monophosphate. Much like Arg69 in the bacterial enzyme, the Ca+2 is involved in 
lowering the pKa of the C2 hydroxyl group of inositol and stabilizing the 
pentacovalent transition state (Essen et al., 1997). 
 
2.6 Physical Properties of Lipid Bilayers Affect PI-PLC 
 The natural substrate for all PI-PLCs is either a GPI anchored protein or PI 
in a eukaryotic lipid bilayer. Except for L. monocytogenes PI-PLC, all other 
bacterial PI-PLCs attack the outer leaflet of the plasma membrane (Smith et al., 
1995; Portnoy el al. 2002). While PI is a relatively minor (8%) component of the 
plasma membrane, the outer leaflet of the plasma membrane is comprised of 
39% PC (Hauser and Poupart, 2004; Cooper, 2000). It is not surprising then, that 
PI-PLCs display the highest specific activity towards cosonicated PI/PC vesicles 
(Qian et al., 1998; Zhou et al., 1997B). Furthermore, the Bacillus PI-PLC exhibits 
higher specific activity towards small (~300 Å diameter) unilamellar vesicles over 
large (≥1000 Å) unilamellar vesicles (Pu et al., 2009; Qian et al., 1998). 
Additional studies have confirmed that PI-PLC prefers vesicles with higher radii 
of curvature (and thus smaller diameters) and have found that cholesterol inhibits 
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PI-PLCs in a dose dependent way (Ahyayauch et al., 2005). Cholesterol 
inhibition is likely related to lipid raft formation. Cholesterols and sphingolipids are 
both considered a necessary component for the formation of lipid rafts (Simons 
and Ikonen, 1997; Cemeus et al., 1993). These rafts also appear to be targets for 
bacterial invasions (Fantini et al., 2000). Overall, PI-PLC activity appears to be 
highly dependent on chain length and relative unsaturation of the bilayer 
phospholipids. PI-PLC activity was found to be highest in more fluid lipids, in 
lipids with low phase transition temperatures (Tm), in lymphocyte plasma 
membranes, and in lipid mixtures that formed rafts (Lehto and Sharom, 2002). 
 
2.7 Binding of PI-PLC to Bilayers  
PI-PLCs bind reversibly to lipid surfaces, where they catalyze substrate 
cleavage with a “scooting” mechanism, performing many turnovers per binding 
event. Kinetics provide an estimate of 40-50 turnovers per binding event 
(Volwerk et al., 1994), while recent NMR work suggests this may be significantly 
higher, with as many as 250 turnovers per binding event (Pu et al., 2010) for the 
Bacillus PI-PLCs). Binding studies of PI-PLC enzymes to lipid interfaces provides 
insights into many of their kinetic properties. B. thuringiensis PI-PLC has been 
studied most extensively in this regard. In low ionic strength conditions, this 
enzyme has a high affinity for SUVs composed of only anionic phospholipids 
such as PG, PMe, PS, etc. (Wehbi et al., 2003). However, once the ionic strength 
of the experimental buffer is similar to physiological conditions of the target cells, 
the affinity drops several orders of magnitude. Conversely, if zwitterionic PC is 
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added to the anionic lipids, tighter binding is again observed (Pu et al., 2009), 
reaching a minimum value for Kd between a Xpc of 0.8-0.9. Because PC is also 
an activating phospholipid, the increased binding suggests that part of the 
nonsubstrate activation is due to the enzyme’s higher affinity for vesicle surfaces 
that contain PC (Pu et al., 2009; Qian et al., 1998). The affinity of B. thuringiensis 
PI-PLC for vesicles appears to be dependent on the aromatic/cationic rim loop, 
including helix B, and the interfacial PC binding site; proposed to be a strip of 
tyrosines in helix G. When these helix G tyrosines are removed, binding to PC-
rich vesicles decreases. This suggested that there might be one or more discrete 
sites for a single PC head group to bind to the protein (Shi et al., 2009; Feng et 
al., 2002; Pu et al., 2010). This highly aromatized binding pocket would allow for 
a specific π-cation interaction between the Bacillus PI-PLCs and a 
phosphatidylcholine, and is likely the reason for the Bacillus enzyme’s tight 
binding towards zwitterionic lipids (Pu et al., 2009). Furthermore, the crucial 
interaction between the Bacillus enzymes and a lipid bilayer does appear to be 
dependent on this π-cation interaction. To date, the Bacillus enzymes are the 
only PI-PLCs that bind zwitterionic lipids preferentially over anionic lipids, and 
they are the only enzymes that contain a discrete PC binding pocket. Table 2-2 
summarizes various relevant biochemical data. 
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S. aureus PI-PLC likely binds to the membrane mainly via electrostatic 
interactions. Helix B in S. aureus PI-PLC (41V-K-S-V-W-A-K) is one residue 
longer than in the Bacillus structures and has two lysine residues, making it more 
positively charged then the corresponding helix in the Bacillus enzymes. The rim 
loop of S. aureus PI-PLC also contains twelve positively charged residues as well 
as thirteen solvent exposed aromatic residues. Together these cationic and 
aromatic residues would suggest that membrane binding (at least to substrate 
membranes with moderate negative charge) is driven largely by electrostatics 
and hydrophobic interactions (Goldstein et al., 2012; Shi et al., 2009).  
 It is likely that L. monocytogenes PI-PLC initially binds largely due to 
electrostatic interactions, however, strong hydrophobic interactions occur as well. 
The rim loop of this enzyme contains a total of eight aromatic residues and 18 
cationic residues. Though the energy due to desolvation of the hydrophobic 
aromatics no doubt aids in membrane binding, the high number of cationic 
residues provides the main attractive force to the negatively charged lipids 
Table 2-2.Various biochemical data on the different bacterial PI-PLCs. 
Source Substrate How does 
PC activate? 
Binding to 
Zwitterionic 
Lipids 
Binding 
to 
anionic 
Lipids 
pH 
optima 
Effect of 
addition 
of salt 
Major 
binding 
mode 
Bt/ Bc GPI/PI Discreet 
binding site 
Strong Weak 7 No effect Pi-cation 
PC_rich 
bilayers 
Sa GPI/PI Aides in 
dimer 
formation 
very weak Strong 5.5-
6.7 
Strongly 
inhibitory 
Electrostatic 
/ 
hydrophobic 
Lm PI Prevents 
aggregation 
Weak Strong 7 Activating electrostatic 
/ 
hydrophobic 
Sab1 GPI/PI no activation      
Sab2 PI      Electrostatic/ 
hydrophobic 
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bilayers. Although the S. antibioticus PI-PLC is relatively unstudied, a few of the 
key structural features can provide possible insight into its mechanism of binding. 
Though this structure does not have a helix B, it does show a rim loop comprised 
of nine cationic and nine solvent exposed aromatic residues. The binding mode 
for this protein to lipid bilayers is likely to be an electrostatic/hydrophobic 
mechanism.   
 S. aureus PI-PLC is also activated by PC for cleavage of PI in vesicles, 
yet this protein has very low affinity for PC-rich bilayers (Cheng et al., 2013). 
Additionally, the highly cationic L. monocytogenes PI-PLC has little affinity for PC 
bilayers, yet also exhibits kinetic activation by PC. S. aureus PI-PLC binding to 
anionic surfaces is dramatically reduced by the addition of salt; it is in fact more 
sensitive to salt than the Bacillus proteins (Cheng et al., 2012). L. 
monocytogenes PI-PLC binding to anionic surfaces is weakened by salt, but is 
still significant. Binding of L. monocytogenes PI-PLC to surfaces only weakens 
substantially as the PC content increases above 0.7 mole fraction (Chen 
unpublished results). For these two enzymes, the strength of vesicle binding 
does not parallel enzymatic activity.  
 
2.8  Interfacial Activation  
 PI-PLC enzymes, like most other phospholipases, display interfacial 
activation, that is, they cleave lipid substrate 5-6 times faster when substrate lipid 
is presented as a micellar aggregate than when it is in monomeric form (Griffith 
and Ryan, 1999; Lewis et al., 1993; Feng et al., 2002; Hendrickson et al., 1992). 
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The explanation for the increased rate has been suggested to result from some 
combination of several factors: (i) enhanced binding of substrate when it is 
presented in a two-dimensional matrix, (ii) an interface-induced conformational 
change that enhances catalysis, (iii) changes in the orientation of the substrate 
so that it is easier to have it adopt the necessary orientation in the active site, or 
(iv) easier release of the DAG into the matrix. For the B. thuringiensis PI-PLC, 
monitoring the effect of nonsubstrate interfaces on the hydrolysis of water-soluble 
cIP provides a way of assessing if there is a change in the enzyme versus a 
change in an interface (Wehbi et al., 2003). 
 Nonsubstrate lipids or detergents can also alter kinetic behavior. In 
detailed kinetic treatments using a fixed concentration of amphiphile (substrate 
plus another lipid or a detergent), as the mole fraction of substrate decreases, 
often the specific activity of the enzyme decreases dramatically. This is termed 
surface dilution inhibition and is often used to obtain a Km in terms of the mole 
fraction of substrate in the interface. However, many factors can contribute to this 
kinetic behavior (Cheng et al., 2013), and some PI-PLC enzymes (e.g., the 
enzyme from S. aureus) do not exhibit inhibition. Other PI-PLCs show a distinct 
increase in activity as the portion of the non-substrate amphiphile is increased 
relative to substrate. The presence of PC in vesicles with PI increases specific 
activity for B. thuringiensis PI-PLC, L. monocytogenes PI-PLC and S. aureus PI-
PLC. Yet the mechanism for this kinetic activation varies dramatically. 
Furthermore, vesicle size has an effect on PI-PLC activation as well, where WT 
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PI-PLC shows much higher activity towards small vesicles than it does towards 
larger vesicles (Qian et al., 1998; Zhou et al.1997B; Feng et al., 2002). 
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Chapter 3; Structure of the S. aureus PI-specific phospholipase C reveals 
modulation of active site access by a titratable π-cation latched loop 
 
Note: The work discussed in this chapter was a collaboration with Jiongjia 
Cheng. All protein in this chapter was produced and purified by J. Cheng, 
Additionally, all enzyme assays and FCS binding studies were done by J. Cheng. 
Crystallographic setup, structure solution and interpretation was done by R. 
Goldstein 
 
This work has been published in Biochemistry. Goldstein, R., Cheng, J., Stec, B., 
and Roberts, M.F. (2012) Structure of the S. aureus PI-specific phospholipase C 
reveals modulation of active site access by a titratable π-cation latched loop. 
Biochemistry 51, 2579–2587. 
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3.1 The S. aureus PI-PLC 
Given the interest in S. aureus virulence factors and my laboratory’s 
expertise in expressing bacterial PI-PLC enzymes, I started my thesis work on 
crystallizing this particular exoprotein. Jiongjia Cheng in the lab had measured a 
variety of kinetic and binding parameters that were difficult to explain. I was able 
to crystallize the protein and determine its structure using molecular replacement.  
Using this and other structures of the S. aureus PI-PLC, we were able to explain 
these interesting biochemical parameters. 
 
3.2 S. aureus PI-PLC Experimental Procedures 
The following section details materials and methods for the entirety of the S. 
aureus PI-PLC project, discussed in chapters 4, 5, and 6 of this thesis.  
 
General Methods 
The genomic DNA of S. aureus (strain FPR3757) was purchased from 
ATCC, and the gene coding for PI-PLC was amplified by PCR, cleaved by the 
restriction enzymes EcoR1 and Xhol (New England BioLabs, Inc.), and inserted 
in to the vector (pET21a) with a C-terminal hexahistidine tag. The sequence of 
this gene, confirmed by Genewiz, was equivalent to that reported previously 
(Daughtery and Low, 1993) For producing mutant proteins, QuikChange 
methodology with the site-directed mutagenesis kit from Stratagene and the 
complementary primer purchased from Operon were used. The sequence of the 
mutated gene was confirmed by Genewiz. The plasmids containing the two PI-
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PLC genes were transformed into E. coli BL21-Codonplus (DE3)-RIL cells. 
Overexpression of the proteins followed protocols used for the B. thuringiensis 
PI-PLC (Feng et al., 2002). The S. aureus PI-PLC proteins were purified in two 
steps: (i) lysed cell pellets were mixed with an Ni-NTA resin (Qiagen) and an 
imidazole gradient used to elute the PI-PLC; (ii) after overnight dialysis in 20 mM 
Tris, pH 8.3, the protein solution was further purified by elution from a Q-
Sepharose fast-flow anion-exchange resin. The concentration of the PI-PLC 
enzymes, greater than 95% pure as monitored by SDS-PAGE, was measured by 
the absorption at 280 nm using an extinction coefficient of 60280 M-1 cm-1 
calculated by the Web-based ProtParam software. 
 Using protein generated by Jiongjia Cheng via the above methods, initial 
crystallization conditions were determined using Qiagen JCSG core 1 and 2 
screens. Conditions were then optimized to yield diffractable crystals, as 
described below.  
  
Crystallization Conditions for all S. aureus PI-PLC crystals 
Purified PI-PLC was concentrated to 20 mg/mL before being combined, if 
applicable, with myo-inositol and other co-crystallization solutes. Lipids were 
obtained from Aventi Polar Lipids, Inc. The protein solution was then diluted to 10 
mg/mL using deionized water and incubated on ice for a minimum of 2 h before 
setting up crystallization trays. Crystallization conditions for each data set can be 
found below in Table 3-1 All PI-PLC samples were crystallized at 20 °C by vapor 
diffusion, using hanging drops of 3 µL, at a final protein concentration of 10 
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mg/mL. Crystals presented in one of two forms:  Native S. aureus PI-PLC grown 
under acidic (pH 4.6) conditions presented as large (0.5-0.7 mm) square plates 
which developed over the course of several months. Native S. aureus PI-PLC 
grown under basic (pH 7.5) conditions, and loop altering mutations 
(H258Y,N254Y/H258Y, F249W) presented as large (0.4-1.0 mm) single crystals 
which  were of suitable size to collect data after two days. Suitable crystals were 
cryoprotected using 20-40% glycerol, isopropanol, or PEG 4000, and mounted in 
nylon loops and frozen in liquid nitrogen. 
 Three data sets required additional soaking of ligand. For each of these 
data sets, suitable crystals were incubated in a cryo solution of 33-35% PEG 
4000, appropriate salts and buffers (with concentrations equal to their setup 
conditions) and indicated concentration of ligand, for 2 hours before freezing. 
 Data on suitable crystals were collected at 100 K using an in-house Rigaku 
MicroMax-07 HF high-intensity microfocus rotating Cu anode X-ray generator, 
coupled with Osmic VariMax Optics and a R-Axis IV++ image plate area detector. 
Data were indexed and reduced using HKL2000 (Otwinowski and Minor, 1997). 
The acidic-ins (3V16) structure was solved by molecular replacement in CCP4 
(CCP4, 1994) using PHASER (McCoy et al., 2007), with the B. cereus structure 
1PTG (Heinz et al., 1995) as a model. All subsequent structures were solved 
similarly using the acidic-ins structure as a model. All models were either initially 
refined using CNS, (Brunger et al., 1995) and then reanalyzed and refined with 
Refmac, (McCoy et al., 2007) (acidic- ins, basic-apo and H258Y-acidic), or 
refined using phenix.refine in PHENIX (all other data sets) (Adams et al., 2010). 
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Manual model building was done in COOT (Emsley and Cowtan, 2004) with 
maps generated in PHENIX. Ligands and ligand restraints were generated using 
Prodrg2 (Schuettelkopf and van Aalten, 2004) or ReadySet in PHENIX (Adams 
et al., 2010). Comparisons were made using SSM superposition(Krissinel and 
Henrick, 2003) in COOT and alignment in Pymol. Procheck (Laskowski et al., 
1993) was used for structure validation, and ADIT (N) for structure deposition into 
the PDB. 
 
3.3 Structure of S. aureus PI-PLC  
All forms of the S. aureus PI-PLC (wild type, acidic and basic conditions, 
and H258Y, basic +ins, and F249W, etc.) crystallized as monomers in the 
P212121 space group. Data for the acidic structure were refined to a final R value 
of 17.2% (Rfree=18.3%) at a resolution of 2.3 Å; the unit cell, with dimensions 
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a=104.16, b=43.61 and c=62.22 Å, contained myo-inositol in the active site, and 
one chloride ion. Electron density contoured to 1s for the rim loop with the model 
superimposed is shown in Figure 3-1A.  Although the acidic form of PI-PLC was 
co-crystallized with 5 mM diC6PC, no discrete density for phospholipid was 
observed in the crystal structure. However, there was a significant improvement 
in crystal stability when that short-chain phospholipid was present in the 
crystallization medium. Data for the basic pH structure were refined to a final R 
value of 18.1% (Rfree=19.2%) at a resolution of 2.43 Å; this unit cell, with 
dimensions, a=85.47, b=57.95 and c=61.74 Å, contained one sulfate ion. The 
H258Y mutant structure, refined to a final R value of 19.3% (Rfree= 20.4%) at a 
resolution of 1.9 Å, was found to contain myo-inositol and two acetate anions. 
Interestingly, H258Y, though crystallized under acidic conditions, had a unit cell 
almost identical to that of the basic structure of wild type recombinant PI-PLC. 
Table 3-2 at the end of this chapter details crystallographic data and refinement 
statistics for all crystals discussed herein.  
Similar to the other bacterial PI-PLC crystal structures (Heinz et al., 1995; 
Shi et al., 2009; Moser et al., 1997) in the database, the enzyme from S. aureus 
folds into an imperfect (βα)8-barrel. Notation of the helices, following the other 
bacterial PI-PLC structures, is shown in Figure 3-1B. The mature S. aureus PI-
PLC begins with Ser1, as noted previously (Daugherty and Low, 1993). The 
overall structure of the S. aureus PI-PLC obtained at pH 7.5 is most similar to B. 
thuringiensis (3EA2) and B. cereus PI-PLC (1PTG) structures (Heinz et al., 1995; 
Shi et al., 2009). Figure 3-1C compares the basic structure of the S. aureus 
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protein to the B. thuringiensis PI-PLC. Density for Ser1 was observed in the 
acidic structure, while density began at Asp2 in both the basic and H258Y 
structures. In two of these S. aureus PI-PLC structures, a portion of the 
uncleaved C-terminal His6 tag was visible extending from the C-terminus of the 
protein. In the acidic structure, density extended to Leu303, in the basic pH 
structure, density extended to His305, and in H258Y it extended to His308. 
Active site residues (and electrostatic maps of the active site) in all three S. 
aureus PI-PLC structures are well conserved, with all catalytic residues 
remaining relatively unchanged in both position and rotamer. Additionally, myo-
inositol binding remains the same in both the acidic and H258Y mutant S. aureus 
PI-PLC structures.  
 Two key structural features of the Bacillus enzymes are short helix B and 
a mobile rim loop, both of which have been implicated in membrane binding 
(Feng et al., 2002; Feng et al., 2003; Guo et al., 2008; Pu et al., 2010). Helix B in 
the S. aureus PI-PLC (41V-K-S-V-W-A-K) is one residue longer than in the B. 
cereus structures. It also has two lysine residues making a more positively 
charged feature. This, in conjunction with the other rim positively charged 
residues (Lys209, Lys113 Lys114, Lys121, and Arg69), forms an extended 
region of positive charge along the barrel rim and would suggest that membrane 
binding (at least to substrate membranes with moderate negative charge) is 
largely driven by electrostatics.  
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  Additionally, a bound anion is seen in each structure in a conserved 
position in a cationic pocket on the rim, composed of the side chains of His86, 
Lys42, and the backbone amides of Lys38 and Asp39. The identity of the bound 
ligand changes with each structure: the pH 7.5 structure contains a sulfate, the 
pH 4.6 structure contains a chloride, and the H258Y structure contains an 
acetate anion. However, in all monomeric S. aureus PI-PLC crystal structures 
there is an anion present in this highly electropositive pocket. The position of this 
bound anion near at the rim surface is where one might expect the head group of 
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an anionic phospholipid to bind. 
 The mobile rim loop contributes a key hydrophobic residue, Trp242 in 
Bacillus PI-PLC and Phe237 in the L. monocytogenes structure) to membrane 
binding (Heinz et al., 1995; Shi et al., 2009; Moser et al., 2002). The analogous 
residue in the basic S. aureus PI-PLC structure, Phe249, is pointed towards the 
membrane interface, slightly above the lip of the (βα)8-barrel (Figure 3-2 
suggests the membrane-binding orientation by a blue line).  
 However, in the B. cereus structure, that side chain is pointed down, along the 
axis of the (βα)8-barrel between helixes G and H, and away from the membrane 
interface (Heinz et al., 1995). Similarly, in L. monocytogenes PI-PLC the 
equivalent residue (Phe237) is again pointed away from the membrane interface, 
though in that structure it flanks helix G on the opposite side. This stresses the 
flexibility of the rim loop and the Trp/Phe side chain position in the different 
bacterial PI-PLC proteins.  
 It is this loop of the S. aureus protein that undergoes the largest change in 
structure with pH (Figures 3-2 and 3-3).  In the acidic form of PI-PLC, the π 
system of Phe249 forms a π-cation complex with protonated His258. This draws 
Phe249 down between helixes F and G and leads to a condensed conformation 
of the rim loop – the π-cation complex acts as a latch to restrain the loop close to 
the protein surface. This position for the Phe side chain is similar to that of 
Phe237 in L. monocytogenes PI-PLC, However, L. monocytogenes PI-PLC has  
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an alanine in the position corresponding to His258, thus no π-cation complex can 
be formed. Although Phe237 is pointed down between two helixes, it is shifted 
upward 3.1 Å from its S. aureus PI-PLC equivalent. Without the π-cation 
complex, the loop is held in an extended conformation in the L. monocytogenes 
PI-PLC. Additionally in the S. aureus PI-PLC, the loop is most stable in the acidic 
form, with excellent coverage of electron density (see Figure 3-1) and relatively 
low B-factors. In the basic form, the rim loop is significantly more mobile, with 
higher B-factors and less complete electron density. This trend is mirrored in the 
H258Y mutant, where the loop is again in its extended and significantly more 
mobile position. Crystal packing has no effect on the mobile loop. In the basic 
form of the structure, the closest crystallographic neighbors are about 6-8 Å 
away. The H258Y form of the structure shows one crystallographic neighbor 4.5 
Å from Asn250, though this neighbor does make contact within the structure. 
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Rather, it hydrogen bonds with Asn254, and does not affect the loop. Finally, in 
the acidic structure, one hydrogen bond is made between the backbone carbonyl 
of Ala248 and the side chain amide of neighboring Asn10. However, crystal 
packing would not have sterically hindered this conformation if the loop had 
adopted the extended position in this structure. Therefore, the difference in loop 
conformations is not an artifact of crystal packing but a conformational change in 
response to the protonation state of the protein. 
3.4 pH Dependent π-Cation  
 Aside from the mobile loop and a few aromatic residues with different 
rotamers (Tyr211, Tyr212, and Tyr255 move to accommodate Phe249, and 
Trp45 in helix B moves to accommodate the mobile loop in the acidic pH 
structure), the enzyme side chains are largely unchanged between the acidic and 
basic pH structures. The rim loop undergoing the pH-dependent movement 
consists of eleven residues (241S-V-A-S-G-G-S-A-F-N-S). It shows a maximum 
backbone displacement of 9.4 Å between the acidic and basic forms of S. aureus 
PI-PLC, as measured at the α-carbon of Ser247. At pH 4.6, the cationic nitrogen 
on His258 is positioned 3.5 Å from the π system of Phe249, which itself is 3.5 Å 
from that of Tyr212 in a face-edge interaction. The π-cation interaction holds 
Phe249, and thus the rest of the mobile loop in a position where Phe249, the 
lone hydrophobic residue in the mobile rim loop, is unable to partition into 
membranes (Figure 3-3A). At pH 7.5, His258 will be deprotonated. With the 
cation no longer present, the rim loop reverts to the more extended loop position, 
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approximately 10 Å away (Figure 3-3B), where His258 is 11.7 Å away from the π 
system of Phe249. Similarly, His258 is 4.6 Å from Tyr212.  
 Interestingly, the large pH-dependent structural change we see is 
reminiscent of what is seen in the homodimeric transferrin receptor (TFR) when 
its ligand, the human transferrin molecule (hTF) binds the apo homodimer at 
biological pH. Binding of hFT to TRF at pH 7.4 causes two dimer interface 
tryptophan residues per monomer to switch from π-π stacking interactions to 
formation of π-cation interactions. The switch in these interactions causes 
rotation of the dimer interface, which primes the homodimer for chain reaction at 
the interface when endosomal pH is encountered, resulting in the rapid release of 
the iron held by the hFT/TFR complex (Eckenroth et al., 2011). Though not 
specifically an intraprotein movement, this dimer rotation further emphasizes the 
importance of these increasingly encountered π-cation interactions. 
3.5 Abolishing the intramolecular π-cation interaction 
 To confirm that the mobile loop conformational switch is dependent on a 
π-cation interaction between Phe249 and His258, the mutant protein H258Y was 
prepared and crystallized. The H258Y mutation eliminates any possibility of a 
titratable π-cation interaction in the S. aureus PI-PLC. The crystal structure 
obtained a pH 4.6 (Figure 3-3C) shows the mobile loop in an extended position 
similar to that of the native PI-PLC structure under basic conditions. Additional 
crystal structures of the native S. aureus PI-PLC at both pH 4.6 and 7.5 with or 
without myo-inositol and other ligands show a strong trend. This enzyme will 
crystallize in one of two unit cells in a pH dependent manner in a very consistent 
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basis. At pH 4.6, the S. aureus PI-PLC crystallizes with an average unit cell of 
a=104.01 Å, b=43.57Å, and c=62.17Å; at pH 7.5 it crystallizes with an average 
unit cell of a=85.68Å, b=58.22 Å, and c=61.65 Å. This trend with pH is only 
broken by the H258Y structure. Although crystallized at pH 4.6, it has a unit cell 
consistent with the basic form of native enzyme. Thus, the determining factor 
between the two unit cells appears to be the position of the mobile loop, rather 
than pH alone. The H258Y mutation prevents the π-cation interaction and the 
mutant crystallizes with the mobile rim loop in an extended conformation. The 
H258Y structure confirms that the mobile loop conformational change is the 
result of the protonation state of His258 and the resulting π-cation interaction.  
The basic pH structure of the S. aureus PI-PLC co-crystallized with myo-
inositol appears to closely match the unliganded basic pH structure in all aspects. 
Secondary structural overlap is excellent, and though density for the very tip of 
the loop, Gly246 through Ala248, was too poor to allow for placement of these 
residues, enough of the loop is present to confirm its extended, basic like 
conformation. Furthermore, the Tyr212 and Trp45 side chains are in their basic 
conformations. As could be expected, there is one unit of sulfate located in the 
anion binding pocket, and the inositol is clearly visible; coordinated by His30, 
Arg67, Arg166, Asp206 and Tyr208.  The purpose of this structure was to 
confirm that pH alone, and no other factor controlled the loop conformation. 
Therefore, S. aureus PI-PLC was crystallized in conditions identical to those 
used for the wild type acidic pH structure (with inositol) with the exception of the 
substitution of HEPES buffer at pH 7.5 for the sodium acetate buffer at pH 4.6. 
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Though part of the mobile loop is disordered, it is confirmed to be in the basic, 
loop open configuration, supporting our finings that the effects of pH alone, via 
the resultant π–cation interaction, result in the change in conformation of the 
loop. 
The F249W structure of S. aureus PI-PLC though crystallized under acidic 
conditions, was seen to adopt the basic, or open loop pattern. Density was again 
too poor to allow Gly245 and Gly246 to be placed; however the rest of the loop, 
including the F249W mutation were visible. A chloride ion is seen occupying the 
anion binding pocket, and a unit of the cyroprotectant glycerol was seen in the 
inositol binding site. This molecule mimics the bottom half of an inositol molecule, 
and coordinates to most of the residues typically seen to bind inositol: His30, 
Arg67, Arg166, and Asp206. Additionally, an acetate ion was found at the αβ 
barrel rim, proximal to the active site and coordinating to the guanidinium head 
group of Arg166. This structure supports the information found in examination of 
the H258Y-acidic structure, in that the loop will remain in the open position 
unless the π-cation complex is intact, effectively “locking” the mobile loop. The 
mutation to Trp from Phe destroys the π-cation interaction because the larger Trp 
side chain cannot fit between the side chains of His258 and Tyr212. The side 
chain of residue 249 is still aromatic, but the larger π system is unavailable for 
complexion with the cationic nitrogen.   
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3.6 Cation-π Interactions in Protein Structure 
π-Cation interactions are well known in proteins; however, these 
interactions commonly exist in protein-protein interfaces, enzyme-drug 
interactions, helix stabilization, and protein-DNA interactions (Crowley and 
Golovin, 2005; Rutledge et al., 2010; Shi et al., 2001). π-Cation complexes with 
protonated histidine as the cation are also known (Singh et al., 2009).  Most of 
these interactions result in subtle structural changes; typically, they mediate 
ligand binding or helix stabilization (Williams et al., 2003; Hassan and Koh, 2006). 
However, a recent structure of the transferrin receptor showed a large change in 
structure in the dimer interface region upon transferrin binding whereby a 
protonated surface histidine flipped into the protein to engage in π-stacking with 
a phenylalanine and tyrosine (Eckenroth et al., 2007).  
 
3.7 Intermolecular PC/π-Cation interactions 
 What distinguishes PC (and PE) from the anionic PI substrate (or 
inhibitory phospholipids PG, PMe, and PA) is the trimethylammonium 
(ammonium) moiety that has the potential to form π-cation complexes with 
aromatic residues. π-cation complexes, the electrostatic interaction between the 
face of an electron rich π system and an adjacent cation, are common binding 
motifs in proteins and occur in both intra and intermolecular forms (Ma and 
Dougherty, 1997). These interactions, though non-covalent, can be quite strong. 
They tend to be on the order of 3-4 kcal/mol, and generally occur between 
aromatic and positively charged amino acids positioned between 3-5 Å apart 
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(Gallivan and Dougherty, 1999; Singh et al., 2009).  π-cation complexes occur at 
a frequency of about one interaction per every 77 residues, and are considered 
an essential force in generating the tertiary and quaternary structures of proteins 
(Matsumura et al., 2008). π-cation interactions are especially common in the 
interfaces of homodimers, in protein-ligand and protein-DNA binding (Rutledge et 
al., 2010; Hassan and Koh, 2006). In the case of intermolecular π-cation 
interactions, Arg-Tyr complexes appear to be most common, and were found to 
have an electrostatic interaction energy of about 3 kcal/mol, though all 
combinations of Lys and Arg with Phe, Tyr, and Trp have been reported. 
Additionally, π-cation interactions are possible with protonated His residues 
(Crowley and Golovin, 2005; Wiliams et al., 2003). π-cation interactions can also 
occur intramolecularly, and are a common feature in stabilizing α helixes (Shi et 
al., 2001). 
While π-cation interactions have been shown to be of the utmost 
importance in S. aureus PI-PLC (Goldstein et al., 2012; Cheng et al., 2012; 
Cheng et al., 2013), they have yet to be examined thoroughly in PI-PLCs from 
other species. The intermolecular π-cation interactions shown to take place 
between clusters of aromatic residues and activating PC are of particular 
importance (Cheng et al., 2013; Goldstein et al., 2012). π-cation interactions 
between PI-PLCs and PC lipids may aid in the transient binding of PI-PLCs to 
eukaryotic membranes, and while unconfirmed in PI-PLCs from other species, 
the physical potential for these interactions is present.  
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3.8 Activity of S. aureus PI-PLC 
 Given the two discrete conformations adopted by the S. aureus PI-PLC, 
two questions need to be addressed. (i) How are the two conformations related 
to enzymatic activity? (ii) Does this pH-dependent change have a physiological 
role in S. aureus infectivity? To explore the first, we measured PI-PLC activity 
toward small unilamellar vesicles composed of either pure PI or PI/PC (4:1) at pH 
5.5, 6.5, and 7.5. The enzyme binds tightly to vesicles with phosphatidylglycerol  
replacing PI and small amounts of the non-substrate PC (Cheng, et al., 2012B). 
The PI-PLC enzyme mechanism involves two histidine residues acting as a 
general base and general acid (Griffith et al., 1999; Hondal et al., 1998). If the π-
cation interaction in the S. aureus PI-PLC modulates activity, it may be difficult to 
sense since it also involves a histidine residue. However, we can examine 
activity of H258Y as a control that cannot form the intramolecular π-cation 
interaction.  As shown in Figure 3-4, a comparison of activities towards vesicles 
at pH 5.5, 6.5, and 7.5 show that the recombinant enzyme has higher activity at 
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 pH 5.5, where the π-cation interaction and inward-folded orientation of the rim 
loop occur, than H258Y. Specific activities are similar and lower for both 
enzymes as the pH increases (and presumably the π-His-cation interaction is 
broken). When 20 mol% PC is present in the vesicles, the activities are low at pH 
5.5 but increase as the pH is raised. Wild type enzyme shows higher activity at 
pH 6.5 than H258Y. If the only difference is the formation of the π-cation 
interaction, it appears that the presence of PC may alter the pKa values for the 
catalytic His residues and possibly the His in the π-cation interaction as well. 
Regardless of the presence of PC, the inward-folded rim loop position appears to 
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be associated with higher enzymatic activity at acidic pH.  Previous work has 
shown that this PI-PLC, with an acidic pH optimum, is extremely sensitive to 
added salt (Daugherty and Low, 1993). Such behavior is consistent with 
electrostatic forces dominating partitioning of the protein onto membranes and 
binding of an individual substrate in the active site. Our structural analysis 
emphasizes the cationic character of the rim and active site that would be 
responsible for such behavior (Figure 3-2). However, we can obtain insight into 
the activity at acidic pH by looking at space-filling models of the S. aureus PI-
PLC at the two pH values (Figure 3-5).  Access of substrate to the active site 
from the membrane face is apparent in both structures. However, a side view, 
that should detect an exit path for the water-soluble product cIP with the protein 
still attached to the membrane, shows access to the active site only in the acidic 
pH structure. In the basic structure, the loop is extended but active site access 
via other than the membrane interface is restricted. 
 The two conformations of Trp45 appear to be linked to restricting access to the 
active site (Figure 3-6). This suggests the one function of the π-cation latch is to 
ensure water-soluble product can diffuse from the active site and into bulk 
solution. It allows for at least some degree of processive catalysis for this 
enzyme bound to membranes under acidic conditions.  
 The shift in the PI-PLC activity profile with 20 mol% PC present in the 
bilayer suggests that the phospholipid choline moiety, among other effects, can 
compete with His258 for interaction with Phe249. At pH 5.5 both wild type and  
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H258Y exhibit low specific activities. We now have an extended loop, which may 
allow membrane partitioning of the protein, but not easy release of the water-
soluble product. Increasing the pH enhances activities above what is seen in the 
absence of PC – a result that suggests other more subtle conformational 
changes in the protein occur with PC added. The pKa values for the general 
base and general acid histidines may be shifted when PC is present. Whatever 
the discrete changes, the structure suggests that PC could compete for Phe249 
and the extended loop structure can lead to more efficient PI cleavage and 
product release. 
3.9 The π-cation latched loop and S. aureus infection  
 S. aureus is known to cause a broad range of diseases in humans, and is 
commonly found in skin infections and abscesses which can lead to toxemia and 
lethal bacteremia (Marques et al., 1989; Pancholi, 2001). Secreted S. aureus PI-
PLC may aid in colonization and replication of the microorganism by generating 
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diacylglycerol from GPI-anchored proteins. It is one of the exoproteins shown to 
be upregulated upon infection in community-associated methicillin-resistant 
Staphylococcus aureus (Buriak et al., 2007). This may be part of the response of 
S. aureus in coopting the immune response of host cells. The pH of an S. aureus 
abscess decreases to 6.6 – the pH optimum of the S. aureus PI-PLC (Daugherty 
and Low, 1993; Dye and Kapral, 1980). Our kinetic studies also show that in 
bilayers with PC as well as PI, the pH optimum for this enzyme is around this 
value.  
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Table 3-1 Crystallization conditions for all S. aureus PI-PLC data sets. 
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Table 3-2. Detailed crystallographic and refinement data for all structures 
discussed in this chapter. 
Structure  Acidic Basic H258Y Basic +Ins F249W 
PDB ID Code 3V16 3V18 3V1H N/A N/A 
Diffraction Data      
 Resolution range (Å) 39.9-2.3 48.0-2.34 34.9-1.9 30.79-2.29 
30.31-
2.30 
 No. of reflections 18035 13181 24507 14181 14504 
 No. of reflections in free set 1288 1283 2310 712 733 
 Space group P212121 P212121 P212121 P212121 P212121 
 Unit cell      
 a(Å) 104.16 85.35 87.95 85.76 85.71 
 b(Å) 43.61 58 57.22 58.02 59.52 
 c(Å) 62.22 61.72 61.14 61.58 61.78 
 Completeness 97.1 98.4 97.7 99.82 98.92 
 Rmerge 0.045 0.119 0.093 0.068 0.139 
Refinement      
 Rcrysta 0.1723 0.1873 0.1927 0.1476 0.1812 
 Rfreeb 0.1827 0.1936 0.2041 0.2124 0.2411 
 No. of residues 302 304 306 301 302 
 No. of non-hydrogen protein atoms 2414 2432 2455 2404 2407 
 No. of non-hydrogen inositol atoms 12 0 12 12 0 
 No. of H2O molecules 225 156 265 269 125 
 No. of ions 1 1 2 3 2 
 r.m.s.d. bonds (Å) 0.024 0.017 0.022 0.008 0.007 
 r.m.s.d angles (˚) 1.80 1.70 1.80 1.07 1.04 
 Ramachandran plot %      
 Most favored 89.3 88.3 90.9 98.3 97.64 
 Additionally allowed 10.7 11.4 9.1 1.69 2.36 
 Generously allowed 0 0.4 0 0 0 
 Disallowed 0 0 0 0 0 
 Average B-factor (Å2) 34.4 42.1 29.0 29.96 40.37 
a Rcryst = {S (||Fo| - |Fc||) / |Fo|}, where |Fo| and |Fc| are the observed and 
calculated structure factor amplitudes, respectively. 
b Brunger (1992). 
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Chapter 4; Competition between anion binding and dimerization modulates 
S. aureus phosphatidylinositol-specific phospholipase C enzymatic activity 
 
Note: The work discussed in this chapter was a collaboration with Jiongjia 
Cheng. All protein in this chapter was produced and purified by J. Cheng, 
Additionally, all enzyme assays and FCS binding studies were done by J. Cheng. 
Crystallographic setup, structure solution and interpretation was done by R. 
Goldstein 
 
This work has been published in The Journal of Biological Chemistry, under the 
reference: Cheng, J., Goldstein, R., Stec, B., Gershenson, A., and Roberts, M. F. 
(2012B) Competition between anion binding and dimerization modulates S. 
aureus phosphatidylinositol-specific phospholipase C enzymatic activity. J. Biol. 
Chem., 287, 40317-27. 
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4.1 The S. aureus PI-PLC Dimer 
While screening S. aureus PI-PLC crystals, I found a crystal set up in 
acidic pH conditions with an unusually large unit cell. The S. aureus PI-PLC 
crystallizes in one of two unit cells very consistently, when the mobile loop is in 
the closed/latched position (as per the wild type acidic pH structures) the enzyme 
crystallizes with a unit cell with a= 104 Å, b= 44 Å, and c= 62 Å.  When the 
mobile loop is in the open/unlatched position (as per the wild type basic pH 
structures, or any of the loop altering mutant structures) the enzyme crystallizes 
with a unit cell of a= 86 Å, b= 58 Å and c= 62 Å. While small variations in the unit 
cells do exist, these are usually due to the presence of more or less of the 
uncleaved His6 tag at the C-terminal of the enzyme, and result in changes of ± 1-
2 Å. The unique crystal I screened was found to have a unit cell of a= 133 Å, B= 
50 Å and c= 90 Å. This large unit cell indicated that either the crystal was 
twinned, or that the enzyme had crystallized as an oligomer. For this crystal both 
possibilities turned out to be true. The enzyme had crystallized as a dimer, and 
using a twinned refinement with help from Dr. Boguslaw Stec at the Burnham 
Institute, it was refined to within acceptable R-values.  
Enzymes can crystallize as higher order oligomers for two reasons, either 
due to artificial crystal packing contacts (largely dependent on the crystallization 
media, pH salinity, etc.) or due to a biologically relevant interface. With the S. 
aureus dimer structure, crystal packing contacts seemed unlikely, and so the 
possibility of a biologically relevant dimer was explored. 
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4.2 S. aureus PI-PLC dimer structure  
 The initial crystal structures of the S. aureus PI-PLC show a monomeric 
protein with significantly different, pH-dependent conformations of a rim loop near 
the active site (Goldstein et al., 2012). The structure of the basic form is very 
similar to that of the Bacillus PI-PLCs (Cheng et al., 2012; Heinz et al., 1995). 
However, in the presence of diC4PC and Mg(NO3)2 at pH 4.6, we serendipitously 
found that the protein crystallized as a complete homodimer in the asymmetric 
unit (Figure 4-1). This protein crystallizes in a variety of unit cells with very  
 
different crystal packing (Figure 4-2).  However, this particular crystal structure is 
the only one to date where the dimer is not the result of crystal contacts. This 
new crystal form was in the P21 space group, with unit cell a=43.36 Å, b=133.38 
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Å, c=50.19 Å, β=89.95˚. The dataset was twinned, and was found to have the 
twinning operator of H, -K, -L with a fraction of 45.1%. Using twinned refinement 
in Refmac we have successfully improved the R values from the untwined 
refinement (Rcryst = 0.2614, Rfree = 0.3220) to the final twinned refinement Rcryst = 
0.215 and Rfree = 0.250. No distinct density consistent with diC4PC was observed. 
Crystallization as a dimer in the presence of diC4PC, might be indicative of an 
additional control mechanism at the membrane surface.  
 In the dimer, both monomers have their mobile loops in the compact, acidic- 
like conformation with Phe249 forming an intramolecular π-cation interaction with 
His258, which pulls the mobile loop in line with the barrel rim. Each monomer 
contains one molecule of myo-inositol in the active site, and the monomers are 
oriented in a head to head fashion with respect to each other (Figure 4-1A). The 
dimer interface is formed by the direct interaction of the side chains belonging to 
helix B of each monomer (Figure 4-1B). The area of contact is quite small 
(primarily consisting of residues 38-44 and adjacent regions, including residues 
50, 250- 254, 282 and 285, with a total buried surface area of 565.7 Å2, or 4.7% 
of the total surface area), and held together primarily by hydrophobic interactions, 
with only 6 hydrogen bonds between the two monomers. Each monomer only 
gains 3.9 kcal/mol upon complex formation (as evaluated with the PISA service 
(http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html), which would suggest a very 
transient dimer in solution (Krissinel and Henrick, 2007). The main inter-
monomer contact is the alignment of Val41 from one monomer with Val44 from 
the opposite monomer to form a hydrophobic box. When viewed as a dimer, an  
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area of hydrophobicity can clearly be seen at the interface (Figure 4-1C), as well 
as along the barrel rim. Besides contributing to dimer formation, the valine box 
could also directly participate in membrane binding. Several other interactions aid 
the valine box in holding the monomers together. An ionic bond forms between 
Lys38 and Asp50 from the opposing monomer, and a hydrogen bond occurs 
between the backbone carbonyl of Thr36 and the side chain hydroxyl of Tyr285 
from the opposing monomer. This helical valine box, along with several 
hydrophobic side chains, would orient the active site towards the membrane. 
 The anion binding pocket adjacent to helix B in the S. aureus PI-PLC 
monomer structures is made up of the backbone amides of Asp38 and Lys39, as 
well as the cationic side chains of His86 and Lys42 (Goldstein et al., 2012). This 
open surface pocket is shaped to snugly fit a tetrahedral anion such as 
phosphate or sulfate. Anionic phospholipid could also localize in the vicinity of 
this cationic site. However, in the dimer, helix B of one monomer occludes the 
pocket of the other, limiting water-soluble or membrane bound anion binding. 
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Thus, in the dimer, this unoccupied positively charged region could contribute to 
electrostatic steering to anionic phospholipids, but the binding pocket is no longer 
accessible. 
 Though the secondary structures of both Bacillus and Listeria proteins are 
quite similar to that of the S. aureus PI-PLC, kinetic evidence suggests that those 
other proteins do not function as dimers. As will be shown in Figure 4-4, the 
specific activity of B. thuringiensis PI-PLC does not increase with increasing 
protein concentration (and previous work showed that the enzyme was a 
monomer in solution (Zhou et al., 1997B). The L. monocytogenes PI-PLC specific 
activity decreased with increasing protein concentration strongly suggesting it 
does not function as a dimer (Chen et al., 2009). Examining crystal structures for 
each of those would suggest that if they do form transient dimers on a membrane, 
it is not with the helix B orientation found in the crystal structure for that protein  
(Figure 4-3). Significant conformational changes in this region would be needed. 
 Though crystallographically elegant, it is unclear whether the S. aureus PI-
PLC dimer structure is functionally relevant. If the dimer is the active form of PI-
PLC, PI-PLC cleavage of PI in small unilamellar vesicles in the absence and 
presence of PC should display the following characteristics. (i) Specific activity 
should increase with increasing enzyme concentration in a saturable manner. (ii) 
If PC kinetic activation functions to enhance dimer formation, then the 
dependence of specific activity on enzyme concentration should shift to lower 
protein concentrations. (iii) If formation of the dimer and occupation of the nearby 
anion binding pocket are mutually exclusive, the enzyme should show reduced 
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sensitivity to soluble anions under conditions that favor dimerization. 
  
4.3 S. aureus dimer PI-PLC enzymatic activity 
 The pH optimum for the S. aureus PI-PLC enzymatic activity depends on 
the SUV composition (Goldstein et al., 2012).  Towards pure PI SUVs, the pH 
optimum is pH 5.5-6, while for vesicles with 0.5 XPC, the optimum is shifted to pH 
6.5-7 (Figure 4-4A). Thus, most assays were carried out at pH 6.5. Specific 
activity increases dramatically when PC is present in the bilayer (Figure 4-4B). 
Similar PC enhanced activity and a shift in the pH profile were observed with PI 
dispersed in micelles of diheptanoyl-PC versus Triton X-100 (Figure 4-4C). 
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Unlike B. thuringiensis PI-PLC, where specific activity decreases when XPC> 0.5 
(Pu et al., 2009), no surface dilution inhibition is observed for S. aureus PI-PLC 
with increasing PC content up to 0.8 XPC, either for fixed total phospholipid (as 
shown in Figure 4-4B) or fixed PI with increasing amounts of PC. Since the dimer 
structure with its occluded anion binding site was obtained in the presence of PC, 
S. aureus PI- PLC salt sensitivity might be ameliorated by PC. Indeed, the 
presence of PC rescues the loss of activity observed at moderate salt 
concentrations (Figure 4-4B), and higher XPC results in lower salt sensitivity. This 
is consistent with a transient dimer that has lost the ability to bind soluble anions 
in the anion binding pocket. That this is an interfacial phenomenon is show by 
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cIP kinetics (Figure 4-4D) which exhibit both only a small activation by diC7PC 
micelles and only about a two-fold drop in specific activity with added salt. 
 A more direct indication of a functional dimer is the observation that, in the 
absence of salt, S. aureus PI-PLC specific activity is dependent on enzyme 
concentration, particularly when the substrate is pure PI SUVs (Figure 4-5A). For 
comparison, the specific activity of B. thuringiensis PI-PLC, which is unlikely form 
the same dimer through helix B, does not depend on enzyme concentration and 
is only weakly salt dependent (Figure 4-5B). If PC is present in the bilayer, there 
is still an increase in S. aureus PI-PLC specific activity with increasing enzyme 
concentration, but this reaches an optimal value at a much lower enzyme 
concentration (Figure 4-5C). This dependence of PI-PLC specific activity on 
protein concentration strongly suggests that the optimally active form of the 
enzyme is a dimer. The presence of PC in the membrane must shift the 
equilibrium between protein monomer and oligomer to lower protein 
concentrations. 
 As a further test of this hypothesis we mutated Val44, one of the key 
components of the dimer interface in the crystal structure. This valine was 
replaced with: (i) a cysteine, a small amino acid capable of hydrogen bonding 
that is likely to destabilize the dimer interface (a large excess of DTT was present 
to prevent any disulfide formation) or (ii) a tryptophan, a large side chain with a 
propensity to partition into membranes which might be expected to strengthen 
the transient dimer interaction. For PI SUVs, the specific activity of V44C was 
lower than that of the WT enzyme and increased at most two-fold (compared to 
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five- fold for WT) over the protein concentration range examined (Figure 4-5D). In 
contrast, the specific activity of V44W was higher than wild type and appeared to 
reach a maximum value at lower enzyme concentrations. These data clearly 
indicate that the S. aureus PI-PLC functions optimally as a transient dimer on the 
SUVs. They strongly suggest that enhanced protein dimerization on the surface 
is part of the PC activation mechanism for S. aureus PI-PLC. 
 
4.4 The effect of PC on S. aureus PI-PLC vesicle binding  
  For the B. thuringiensis PI-PLC, increasing XPC up to 0.8 also increases the 
affinity of the enzyme for SUVs, and tight binding (Kd < 10 µM) sequesters the 
enzyme on the vesicles inhibiting enzyme activity (Pu et al., 2009). The S. aureus 
PI-PLC behaves quite differently. As shown in Figure 4-6A, the S. aureus PI-PLC 
binds well, with mM Kd values, to either PG or PG/PC (1:1) SUVs at acidic pH, 
but binding at pH 7.5 is much weaker, indicating that the primary interaction is 
electrostatic. At pH 6.5, where optimal activity is observed, the enzyme has high 
affinity for anionic phospholipid-rich bilayers (XPC<0.5), with fairly low affinity for 
PC-rich bilayers (Figure 4-6B). Indeed, binding to pure PC SUVs could not be 
measured. The apparent Kd for pure PG vesicles is 0.38±0.14 mM at pH 6.5, and 
this value corresponds well with the apparent Km value (0.23±0.03 mM) for 
cleavage of PI in pure PI SUVs (Figure 4-6C). For XPC= 0.5, again the apparent 
Kd determined by FCS (2.5±0.5 mM) is approximately the same as the kinetic 
apparent Km for PI/PC SUVs (1.9±0.5 mM). The S. aureus PI-PLC apparent Kd 
values increase with PC content and the enzyme binds much less tightly at high 
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PC. For these compositions, and in the absence of salt, the Km reflects the Kd for 
vesicle binding as measured by FCS. 
 Added salt reduces the affinity for PG-rich SUVs to such an extent that the 
apparent Kd for pure PG SUVs could not be measured. To explore this further we 
examined the fraction of protein bound to a large excess of vesicles (18 mM PG) 
in the absence and presence of NaCl (A, inset). Without salt, all of the protein 
partitioned onto the vesicles while increasing the ionic strength dramatically 
reduced protein binding. With ~130 mM NaCl, only ~20% of the protein was 
bound.  
 
Given the high bulk phospholipid concentration (18 mM), in the presence of salt 
the apparent Kd for PG vesicles must be very high (>50 mM). This result 
suggests that S. aureus PI-PLC binding to pure PG vesicles is almost entirely 
mediated by electrostatic interactions. However, with PC in the vesicle, the much 
higher residual activity indicates that the binding of the enzyme to the bilayer now 
has a more substantial hydrophobic component.  
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4.5 Perturbing hydrophobic interactions with the membrane  
  In the Bacillus enzymes, a number of aromatic residues are critical for tight 
binding to PC-rich membranes, including Trp242 which partitions into the bilayer 
(Feng et al., 2002; Cheng et al., 2012), and a strip of four surface Tyr residues in  
 
helix G (Heinz et al., 1995). In the S. aureus PI-PLC, Trp242 is replaced by 
Phe249 and this enzyme has only two of the four tyrosine residues (Tyr253 and 
Tyr255) in helix G. It is also unclear if Phe249 interacts with the membrane since 
it is tucked into the protein and away from the surface in the monomeric acidic S. 
aureus PI-PLC crystal structure (Goldstein et al., 2012) and in the dimer structure 
described here. To test whether these residues interact with the membrane in S. 
aureus PI-PLC, we constructed the following variants: F249W and F249I, Y253S, 
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and Y253S/Y255S. Tyr290, a single Tyr residue that is unlikely to interact with 
the membrane, was also mutated to serine as a control.  As shown in Figure 4-7, 
the activity of the control, Y290S, is similar to WT. However, both Y253S and the 
double Tyr mutant enzyme are much less active under all conditions. Increasing 
PC content has a very modest effect on PI cleavage by Y253S, while 
Y253S/Y255S is virtually insensitive to the presence of PC. In contrast, mutating 
Phe249 to a tryptophan significantly enhanced enzyme activity for XPC< 0.5 while 
the activity of F249I is equivalent to that of the WT. The pH dependence was 
varied for several of these variants, and while F249I and Y290S still behave 
essentially like WT, Y253S exhibits much lower activity regardless of pH (data 
not shown). The loss of activity and PC activation for Y253S and Y253S/Y255S 
suggest that these residues play a role in the conformational change(s) that 
activate the protein in the presence of PC. 
 Since both F249W and Y253S/Y255S have activities that are significantly 
different than WT, protein binding to PG/PC SUVs was measured by FCS (Figure 
4-7B). The Kd values for F249W are comparable to WT at XPC = 0 and 0.2 but 
significantly smaller at 0.8 XPC, indicative of enhanced interactions with the 
membrane as might be expected  when the larger tryptophan side chain replaces 
a phenyalanine that inserts into the membrane. However, this higher affinity for 
PC-rich SUVs does not translate into significantly higher activity. For comparison, 
Y253S/Y255S has similar affinities to WT up to 0.7 XPC, but much lower activity. 
For higher PC content, the fraction of mutant protein bound was small and linear 
up to 50 mM phospholipid, and the apparent Kd could not be estimated. These 
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surface tyrosine residues are important for PC-enhancement of activity; however, 
except at 0.8 XPC, the loss of activity is not a result of reduced binding. Thus, 
unlike Bacillus PI-PLC where Kd values for SUVs vary by orders of magnitude 
(from µM to >100 mM), as a function of XPC and/or enzyme mutations, the range 
of Kd for the S. aureus PI-PLC is much more limited and less easily perturbed. 
 Occupation of the anion binding pocket versus dimerization  
 Compared to WT, Y253S has little activation by PC but similar membrane 
affinity. To help explain this behavior, a 2.3 Å structure of Y253S was obtained at 
pH 4.6. This variant crystallized as a monomer in the P212121 space group, with a 
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unit cell of a=86.1 Å, b=55.96Å, and c=61.68Å. The Y253S structure refined 
down to a final Rcryst value of 0.187 (Rfree of 0.241). Statistics for the structure are 
given in Table 4-1. In the homodimer structure, the α-carbon of residue 253 is 
14.7 Å away from the active site, and, while not a direct part of the anion-binding 
pocket, Tyr253 aids in occluding the anion-binding site. When compared to the S. 
aureus monomeric PI-PLC structures  (Figure 4-8), all catalytic residues in 
Y253S appear unchanged. The structure is essentially identical to the WT 
monomeric structure at the same pH except around the mutation site. This 
mutation also has no effect on the acid form of the mobile rim loop. The 
monomer structure for Y253S, therefore, offers little explanation for the loss of 
PC activation in Y253S. However, when the native homodimer structure is used 
as a model to create an in silico Y253S homodimer, there is a significant 
perturbation in the region of the anion binding pocket, which is empty in the 
homodimer. Tyr253 aids in formation of a lid for the pocket in the opposing 
monomer of the homodimer structure (Figure 4-8B). Replacement of the Tyr side 
chain with a serine leaves an opening in the adjacent monomer, thus increasing 
anion access to the anion binding pocket in any Y253S homodimer (Figure 4-8C). 
This increased accessibility could facilitate soluble anion or interfacial anionic 
phospholipid binding to the site. Binding of ligand to the anion binding pocket in 
turn would destabilize the dimer interface by shifting helix B slightly away from 
the surface and lengthening distances between side chains that make up the 
tenuous dimer interface. This is visualized in Figure 4-9 by comparing two 
monomer structures with bound chloride overlaid on the dimer. There are slight 
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changes in the opposing helix B moieties. Helix B and the section of the adjacent 
loop move slightly to bind the ion. This slight shift would pull Val41 back from the 
dimer interface. This separation of the valines would destabilize the already small 
dimer interface. 
   
 
To further explore the role of the anion binding pocket and activity, two other 
mutant enzymes were generated: Y253W, where the ‘lid’ for the pocket is now 
considerably larger, likely preventing anion binding and favoring dimerization, 
and Y253K, where the positive charge might increase enhance anion binding 
electrostatically, although this could be balanced by the methylene chain 
occluding the pocket. As seen in the inset in Figure 4-6A, Y253W has specific 
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activity much higher than Y253S and comparable to WT. Y253K has lower 
activity than Y253W at all XPC examined. However, it is not as compromised as 
Y253S, suggesting that the bulk of the lysine alkyl chain may be blocking access 
to the anion site. 
 As a further test of how modulating the anion binding pocket can affect 
activity we also prepared H86Y and H86E. The His86 imidazole forms part of the 
anion binding pocket. H86Y will remove the side chain positive charge but will 
keep the ‘lid’ in place in the dimer. H86E should antagonize anion binding since 
we are replacing a positive charge with a negative one. As shown in Figure 4-6B, 
H86Y exhibits higher activity toward pure PI SUVs (14.1±1.0 versus 9.8±0.3 µmol 
min-1 mg-1 for WT) and activity comparable to WT with PI/PC SUVs. In contrast, 
H86E has very low activity towards pure PI SUVs (electrostatic repulsion would 
impede strong binding to SUVs), but is dramatically enhanced with PC present (a 
135-fold increase compared to the more typical 10 to 15-fold for H86Y and WT). 
Consistent with the low activity towards PI SUVs, H86E showed only a small 
increase in activity with enzyme concentration compared to the other proteins, 
reflecting its difficulty in binding to the target membrane. With XPC=0.5 SUVs, the 
relative loss of activity for H86E in the present of salt (29% residual activity) was 
also less than WT (21% residual activity). This behavior also suggests that the 
anion binding pocket is intertwined with dimer formation. 
 These results suggests a very intriguing proposal: the S. aureus PI-PLC is 
optimally active as a dimer, but an appropriate phospholipid interface and/or high 
protein concentration is needed to at least transiently stabilize this structure. 
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Soluble anions compete for the anion-binding pocket, and prevent dimer 
formation as well as weakening interfacial binding. An anionic phospholipid might 
interact with this site, but in doing so, it would also destabilize the dimer, leading 
to lower activity while aiding in binding the protein to the bilayer. The observation 
that the double mutant Y253S/Y255S behaves similarly to Y253S supports the 
importance of this single aromatic group in indirectly promoting interfacial 
dimerization. 
 
4.6 S. aureus PI-PLC activity, dimer formation and membrane PC content 
 The kinetic and structural data strongly suggest that the S. aureus PI-PLC is 
optimally active as a dimer, and that this dimer is transiently stabilized by the 
membrane surface. The small dimer interface in the crystal structure suggests 
that dimers are likely to be transient, making them difficult to observe. The S. 
aureus PI-PLC might aggregate to a small extent in solution, but obtaining 
accurate sizes for bacterial PI-PLCs in solution is difficult because they have an 
affinity for carbohydrates. At the protein concentrations required for gel filtration 
or analytical ultracentrifugation, these PI-PLCs interact with the resin or sucrose 
leading to aberrant sizes (Shi et al., 2009). Furthermore, increased ionic strength, 
which suppresses interaction of the B. thuringiensis enzyme with resins (Zhou et 
al., 1997B), would favor monomeric S. aureus PI-PLC. However, the simple 
membrane induced dimer model does not explain why S. aureus PI-PLC activity 
increases with increasing PC content despite its lower affinity for PC-rich 
membranes. The presence of PC in the vesicle also rescues activity lost by the 
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enzyme in moderate concentrations of salt (Figure 4-4), consistent with a switch 
from electrostatic to hydrophobic interactions. 
 A better understanding of the S. aureus PI-PLC might be gained by 
comparing it to the well studied PI-PLC from B. thuringiensis, which has a 
specific binding site for PC near helices F and G (Pu et al., 2010). For B. 
thuringiensis PI-PLC, apparent Kd values range from ~4 mM for anionic SUVs to 
~2 µM at XPC=0.75 with apparent Kd values of 200-30 µM from 0.2 to 0.5 XPC 
where enzyme activity is optimal (Pu et al., 2009). S. aureus PI-PLC binds more 
weakly to PC containing SUVs with apparent Kd values of 0.3 to ~50 mM for 0 to 
0.8 XPC, likely due to its lack of a PC specific binding site near the F and G 
helices (Pu et al., 2010; Goldstein et al., 2012). 
 Why then does S. aureus PI-PLC activity increase with PC content when 
the affinity for vesicles is decreasing? Incorporation of PC may dilute the surface 
concentration of the anionic phospholipids in vesicles, and that in turn could 
enhance S. aureus PI-PLC dimer formation. This mechanism is consistent with 
the observation that much lower enzyme concentrations are required to increase 
PI-PLC specific activity in the presence of PC (Figure 4-5C) even though the 
apparent Km increases as PC is increased. Alternatively, there are a number of 
aromatic residues in loops and N- terminal portions of helices around the barrel 
rim that could form transient π-cation interactions with the choline headgroup 
(Goldstein et al., 2012). This could alter the conformation of loops or side chains 
and facilitate transient protein dimerization. It should also be noted that the π-
cation latch is still observed in the dimer structure (obtained at pH 4.6), and its 
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presence is likely to aid in soluble cIP release, at least at acidic pH. However, the 
altered pH profile in the presence of PC might suggest that the zwitterionic 
phospholipid leads to alterations of pKa values for the many histidine residues in 
and around the active site. This could be the result of a conformational change or 
change in the surface charge of the membrane. Additionally, interactions with PC 
and transient dimerization could better orient the S. aureus PI-PLC relative to the 
membrane surface, facilitating enzyme activity by increasing substrate access. 
 
4.7 The anion-binding pocket; a key to inhibiting dimer formation 
 One of the unusual features of S. aureus PI-PLC is the very electropositive 
anion binding pocket just below the rim of the barrel, adjacent to helix B. Neither 
the Bacillus enzymes nor L. monocytogenes PI-PLC have such a pocket. In S. 
aureus PI-PLC the anion pocket is composed of the backbone amides of Lys38 
and Asp39, as well as the cationic side chains of Lys42 and His86. In all solved S. 
aureus PI-PLC structures (Goldstein et al., 2012; Goldstein, R., unpublished 
data) except the dimer, there is electron density for an anion in this cationic 
pocket. Anion binding leads to a shift in the pocket residues, as well as nearby 
helix B. Lys38 and Asp39 move approximately 1 Å closer to the anion, as do 
His86 and Lys42 (Figure 4-9). These shifts pull the entirety of helix B (Val41-
Ala46) down, closer to the anion binding pocket, and thus away from the dimer 
interface by approximately 1.3 Å. The shift in helix B residues upon salt binding 
to the anion binding pocket would, in turn, pull Val41 and Val44 farther away from 
the valines on the opposing monomer increasing the distance of the valine pairs 
 84 
from 4.5 Å in the dimer to 6.7 Å. This would weaken the hydrophobic interactions 
between the valine residues, destabilizing the dimer interface. The dimer 
interface itself is quite small consisting of only 14 residues. With an anion bound 
in the pocket, 10 of these residues show shifts of up to 1.5 Å, small movements, 
but enough to weaken the dimer interactions. Thus anion binding, probable at 
high salt concentrations, and dimer formation appear to be mutually exclusive. 
 
 4.8 Model of dimer regulation 
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  We hypothesize that competition between anion binding and dimer 
formation is the key regulator of the S. aureus PI-PLC activity as summarized in 
Figure 4-10. Soluble anion binding weakens protein affinity for PI-rich vesicles, 
inhibiting the S. aureus PI-PLC even at moderate salt concentrations. An anionic 
phospholipid might also bind to the pocket electrostatically, and thus aid in 
anchoring the protein to the surface. However, the presence of an anionic 
phospholipid such as PI near this site would favor the monomer and lead to low 
specific activity. High protein concentrations allow dimerization to compete with 
anionic lipid binding to the pocket leading to some dimers on the membrane, but 
activities are still low. PC then activates the S.  aureus PI-PLC, not by specific 
interactions, but by lowering the interfacial anionic lipid concentration and 
emptying the anion binding pocket, facilitating dimer formation. Occlusion of the 
pocket by the dimer interface makes the membrane-bound dimer much less 
sensitive to physiological salt concentrations. However, there is a trade-off: 
dimers have higher activity, likely because of a conformational change that 
enhances catalysis (Goldstein et al., 2012) and/or because they optimize the 
protein orientation on the membrane for catalysis, but they bind more weakly 
than monomers. On PC- rich bilayers they have lost the electrostatic interactions 
of the regulatory site. The association of an auxiliary anion binding site with the S. 
aureus PI-PLC but not with homologues from other Gram positive bacterial 
species would argue that it is related to the biology of S. aureus. Since 
abscesses are acidic (Krissinel and Henrick, 2007), the slightly more acidic 
optimum of the S. aureus PI-PLC enzymatic activity would make it more effective. 
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In a study of methicillin-resistant S. aureus, expression of the PI-PLC, as well as 
other exoproteins and cytoplasmic proteins, was significantly increased (Burlak et 
al., 2007). Although this protein has a moderate affinity for anionic surfaces in the 
absence of salt, once the enzyme is secreted into the moderate ionic strength of 
the extracellular milieu, it will not interact with other S. aureus organisms. It is 
then poised to interact with the PC or sphingomyelin-containing membranes of 
eukaryotic target cells via the valine box of the dimer. The weak interaction with 
pure PC surfaces may allow it to hone in on negatively charged regions (the 
cationic character of the anion binding pocket is still available), including target 
GPI-anchors. Clearly, this phospholipase has evolved a complex, unique way to 
control its access to the phosphatidylinositol moieties that are its substrates: (i) A 
π-cation latch allows it to work on membranes under acidic conditions and easily 
release soluble product without dissociating from the surface (Goldstein et al., 
2012). (ii) An anion binding pocket near the region that binds to the membrane 
likely modulates the location of the protein, whether it is bound to a negatively 
charged surface, one with significant zwitterionic lipid content, or in solution. (iii) 
High activity requires dimerization of the enzyme and dimerization is enhanced 
by PC content similar to that found in the external leaflet of mammalian plasma 
membranes. This interplay between protein dimerization and an anion sensing 
site could be a way of regulating other peripheral (or even integral) membrane 
enzymes. Juxtamembrane cationic regions, while favoring anionic membrane 
regions, could prohibit protein/protein interactions. However, an appropriately 
modified bilayer composition might change this balance. 
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Table 4-1: Crystallographic summary for the S. aureus PI-PLC dimer and for monomeric 
Y253S. 
protein            WT dimer Y253S 
PDB ID                 4F2B               4F2T 
Diffraction 
Data 
   
 Resolution range (Å) 66.7 – 2.16 29.89 – 2.30 
 Reflections 27485 13541 
 Reflections in free set 1534 678 
 Space Group P21 P212121 
 Unit cell   
      a (Å) 43.36 86.1 
      b (Å) 133.38 55.96 
      c (Å) 50.19 61.68 
      b (o) 89.95 90 
 Monomers in the A.U. 2 1 
 Completeness  95.4 98.4 
 Rmerge 0.063 0.063 
Refinement Rcrysta 0.215 0.187 
 Rfreeb 0.250 0.241 
 Residues 606 302 
 Non-H protein atoms 4844 2420 
 Non-H inositol atoms 24 0 
 H2O molecules 123 132 
 Ions 0 3 
 r.m.s.d. bonds (Å) 0.024 0.008 
 r.m.s.d. angles (Å) 2.1 1.2 
 Ramachandran plot (%)   
      most favored 85.8 90 
      additionally allowed 14 9.6 
      generously allowed 0.2 0.4 
      disallowed 0 0 
 Average B-factor (Å2) 42.46 44.64 
a Rcryst = {S (||Fo| - |Fc||) / |Fo|}, where |Fo| and |Fc| are the observed and calclated 
structure factor amplitudes, respectively. 
b Brunger (1992). 
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Chapter 5; Engineering a PC binding site into S. aureus PI-PLC 
 
Note: The work discussed in this chapter was a collaboration with Jiongjia 
Cheng. All protein in this chapter was produced and purified by J. Cheng, 
Additionally, all enzyme assays and FCS binding studies were done by J. Cheng. 
Crystallographic setup, structure solution and interpretation was done by R. 
Goldstein 
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5.1 Phospholipid Recognition in Bacterial PI-PLCs 
Specific phospholipid recognition is a hallmark of many proteins that transiently 
bind to membranes. Examples of defined interactions with anionic phospholipids 
include annexin V (Concha et al., 1993), lactadherin (Shao et al., 2008) and 
plasminogen (Das and Plow, 2011) that have high affinity for phosphatidylserine, 
and enzymes such as kinases, phosphatases, and phospholipases (Leonard and 
Hurley, 2011; Moravoevic et al., 2012) where specific domains distinct from the 
catalytic machinery target phosphoinositides or Ca2+/PS complexes. Less is 
known about specific binding of zwitterionic phospholipids, such as 
phosphatidylcholine (PC), to proteins. The few protein structures with a PC 
bound usually have sites with cavities that accommodate one or both the acyl 
chain with fewer headgroup interactions (Girardi et al., 2012; Harada et al., 2010; 
Wright et al., 2005). Head group specificity is usually not absolute for those PC 
complexes. A rare example with specificity for binding choline is the OpuBC 
solute receptor, where the choline moiety is surrounded by a cage of four 
tyrosine residues (Pittelkow et al., 2011). A more complete tabulation of choline 
and related ligands binding to protein follows in at the end of this chapter, in table 
5-3. The overwhelming trend in choline and phosphocholine binding proteins 
shows the cationic trimetylammonium moiety surrounded by a π-cation box, 
where 2 to 5 aromatic residues, usually tyrosines, surround the quaternary amine 
bound within 4-5 Å of the π systems of these residues.  
Bacillus thuringiensis phosphatidylinositol-specific phospholipase C (PI-
PLC), a secreted virulence factor, has a high affinity for PC (Zhou et al., 1997B; 
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Qian et al., 1997; Pu et al., 2009), and a Tyr-rich region in helix G that is critical 
for this interaction (Pu et al., 2010). A discrete binding site for one or more PC 
molecules does exist in this vicinity of the protein as probed by high resolution 
field cycling NMR studies (Pu et al., 2010). Interestingly, the structurally similar, 
secreted PI-PLC from S. aureus does not have a significant affinity for PC 
vesicles (Cheng et al., 2012). One notable difference between these two 
otherwise very similar proteins is that the S. aureus PI-PLC has only two of the 
four helix G tyrosine residues whose replacement with serine has been shown to 
reduce PC binding affinity of the B. thuringiensis PI-PLC. If this region is critical 
for specific binding of PC, the addition of the two ‘missing’ tyrosines to the S. 
aureus PI-PLC should introduce affinity for PC vesicles. To explore this, we 
generated S. aureus PI-PLC N254Y/H258Y (Goldstein et al., 2012) and 
measured both its ability to bind to PC-rich surfaces and its catalytic activity. 
Enhanced binding to PC-rich vesicles indicates that these added tyrosines are, in 
fact, critical to PC binding. That the newly created ‘site’ is similar to that of the 
well-studied B. thuringiensis PI-PLC is shown. A detailed picture of choline 
binding sites provided by crystal structures of N254Y/H258Y detects two close 
choline binding sites that would dramatically aid binding of the protein to PC-rich 
membranes. One of the sites also superimposes well with the choline  binding 
site of OpuBC (Pittelkow et al., 2011). We suggest that this particular 
arrangement of tyrosine residues on helices spaced 8-10 Å apart is a PC binding 
motif and could be used to introduce a PC-specific membrane binding module to 
other proteins. 
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5.2 Vesicle Binding and Enzymatic Activity of N254Y/H258Y.  
 If the introduction of two tyrosine residues in the helix G region enhances 
protein binding to PC interfaces, then there should be a substantial drop in 
apparent Kd compared to wild type (WT) protein. Fluorescence correlation 
spectroscopy (FCS) is an ideal technique for this since binding measurements 
can be performed with 10 nM protein, a concentration comparable to what is 
used in enzymatic assays. WT, Y253S/Y255S (removing the two Tyr in helix G 
that do align with the B. thuringiensis enzyme), and N254Y/H258Y proteins were 
fluorescently labeled on the N-terminal residue with the fluorescent dye Alexa 
Fluor 488. Apparent Kd values for PG/PC small unilamellar vesicles were 
measured as a function of the mole fraction PC, XPC (Figure 5-1A). All three 
proteins have similar affinities for PG-rich SUVs, but both WT and Y253S/Y255S 
have low affinity once XPC > 0.5. The protein with the two additional tyrosine 
residues, N254Y/H258Y, has a 50-fold lower Kd than the wildtype enzyme for XPC 
= 0.8 SUVs. At XPC < 0.2, the partitioning of the mutant enzyme is comparable to 
WT. However, as the PC content increases, the difference in binding is quite 
pronounced. N254Y/H258Y binds to pure PC SUVs with an apparent Kd of 
3.3±0.4 mM whereas the recombinant WT has virtually no binding (< 8% is 
bound with 55 mM PC) to the same SUVs.  
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Enhanced binding to PC micelles can also be measured by monitoring the 31P 
linewidth of diC7PC in the presence of the protein (Figure 5-1B). B, thuringiensis 
PI-PLC induces formation of large protein/micelle complexes right around the 
critical micelle concentration (Zhou et al., 1997B), and mutations that weaken 
association with PC reduce this change in 31P line width (Shi et al., 2009). S. 
aureus PI-PLC and the Y253S/Y255S variant had little or no effect on the diC7PC 
linewidth, consistent with poor binding to a PC interface. However, S. aureus 
N254Y/H258Y mimicked the behavior of the B. thuringiensis PI-PLC with a large 
increase in linewidth at the short-chain phospholipid CMC. The intrinsic 
fluorescence of N254Y/H258Y also increased with the addition of micellar 
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diC7PC, and this effect was not observed with the S. aureus WT protein (Figure 
5-1B, inset).   
 
5.3 Effect of Added PC Site on Enzymatic Activity 
 The addition of two tyrosines to helix G has added a site on S. aureus PI-
PLC that is capable of binding one or more PC molecules. Does this have an 
effect on enzyme activity? S. aureus PI-PLC enzymatic activity is sensitive to 
both pH and salt (Cheng et al, 2012; Goldstein et al., 2012), and PC in the 
interface alters the optimal pH for activity and ameliorates the salt sensitivity. 
This is not due to specific PC binding but rather appears to be the result of a 
competition between anion binding to a specific pocket in S. aureus PI-PLC and 
formation of a more active homodimer that occludes the anion binding site 
(Cheng et al., 2012). Like WT, N254Y/H258T specific activity increases with 
increasing enzyme concentration (data not shown) indicating the active form is 
still a dimer. At pH 6.5 in the absence of salt, specific activity shows a large 
increase with PC content for both N254Y/H258Y and WT (Figure 5-2A). If salt is 
present with pure PI SUVs, neither WT nor mutant exhibits much activity. 
However, once PC is present in the SUVs, the N254Y/H258Y enzyme exhibits 
activity close to what is seen without salt. 
 Specific activity towards PI in vesicles partially reflects how efficiently the 
protein partitions onto vesicles (Cheng et al., 2012). The tightest binding is 
observed at pH 5.5, and added salt dramatically weakens binding of the wild type 
protein to both pure PG and PG/PC (1:1) SUVs (Figure 5-2B and C).  
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With the pure PG SUVs and pH >5.5 (Figure 5-2B), the binding of both proteins 
is similarly inhibited by salt. Once PC is present in the SUVs, N254Y/H258Y 
binding is not significantly affected by salt (Figure 5-2C). The apparent Kd for WT 
and N254Y/H258Y to XPC = 0.5 SUVs, pH 6.5, in the presence of 140 mM salts 
was ~ 70 mM for WT protein but 2.6±0.6 mM for the mutant protein. WT binding 
to pure PC SUVs was too low to measure. However, in the presence of salt 
N254Y/H258Y exhibited an apparent Kd of 5.4±0.9 mM, only about 50% higher 
than the apparent Kd in the absence of salt. Vesicle binding via the added PC site 
minimizes the salt inhibition, which prevents WT protein from binding via 
electrostatic interactions.  
 
5.4 N254Y/H258Y Structures  
 
The overall structure of the double mutant follows closely that of the native 
structure in the basic conformation (Goldstein et al., 2012), with only slight 
deviations in the positioning of the mobile loop. With the introduction of N254Y 
and H258Y, S. aureus PI-PLC closely resembles the Bacillus enzymes in the 
region spanning the top halves of helixes F and G. In this region, the unliganded 
structure of the N254Y/H258 (4F2Y) mutant differs only slightly from the basic 
form of the native structure, aside from the obvious mutation, in that the side 
chains of Tyr212 and Tyr255 are rotated by 83o and 22o, respectively. These 
rotamer differences are necessary to accommodate the larger side chains of the 
mutated residues. Further evidence for the location of a specific site for a choline  
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moiety binding is provided by crystal structures of N254Y/H258Y in the presence 
of choline, of diC4PC and an unliganded structure of this mutant. 
 
N254Y/H258Y + HEPES and H258Y (Basic) 
Exploration of the PC binding site began with the structures of the 
N254Y/H258Y and H258Y mutants crystallized with HEPES buffer. Initially an  
attempt was made to crystallize the N254Y/H258Y double mutant with the short-
chain phosphatidylcholine diC7PC. Though no electron density for 
phosphocholine was found in the crystal structure, two HEPES molecules were 
bound in the helix F/G region (Figure 5-3A) with 100% occupancy.  
In contrast, when wild type S. aureus PI-PLC was crystallized under 
similar conditions, no small molecules were bound in this region. In the 
N254Y/H258Y + HEPES structure, one HEPES molecule lies in binding site one, 
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directly between helixes F and G, with the cationic nitrogen held between the π 
systems of Tyr212 and Tyr258, which are 4.5 and 4.7 Å from the HEPES cationic 
nitrogen, respectively. Likewise the cationic nitrogen of the second molecule of 
HEPES is held in binding site two, between the π systems of Trp287, Tyr290 and 
Tyr258. Tyr254 provides edge face interactions with Tyr258. In order to 
accommodate the HEPES molecule in the binding pockets, the side chain of 
Tyr212 must rotate downward from its position in the unliganded double mutant 
structure by 94o, while the side chain of Tyr258 must rotate upward 99˚. The 
rotation of Tyr212 forms the left sidewall of binding site one, while Tyr258 forms 
the right side of this binding site, as well as the left side of binding site two. 
Though crystallized in the presence of both glycerol phosphocholine and diC6PC, 
it appears both of these zwitterionic molecules were out competed by the higher 
concentration of zwitterionic HEPES.  
We have previously obtained a structure of H258Y crystallized in acidic 
conditions (Goldstein et al., 2012) but more recently examined crystals of this 
mutant protein grown in basic conditions in HEPES buffer with inositol and 
diC6PC. The basic H258Y structure has no clear indication of HEPES occupying 
the sites seen in N254Y/H258Y, although there is some electron density 
consistent with a low occupancy (<30%) ligand bound in site 2. However, the 
refinement is best fit with a small PEG molecule.  The reason for the decreased 
affinity for HEPES in the H258Y single mutant is clearly seen when examining 
the side chains of the binding pockets.  Without the mutation N254Y, the 
stabilizing edge face interaction between Tyr254 and Tyr258 is lost, this allows 
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the side chain of Tyr258 to exist in either the conformation in the absence of 
ligand (57%) or the conformation with ligand bound (43%).  More importantly, 
without the mutation of Asn254 to the significantly larger Tyr residue, the side 
chain of Tyr212 is not completely rotated down into the mutant conformation, and 
instead appears primarily in the conformation of the native structure (70%) rather 
than that of the HEPES bound mutant structure (30%). Thus, it appears that 
while the mutation of H258Y is crucial to the formation of both binding sites, 
without the mutation of N254Y, binding pocket 1 cannot be formed. Hence, in the 
H258Y structure, binding site 1 was completely unoccupied, and binding site 2 
was only partially occupied. This strongly suggests that both Tyr254 and Tyr258 
are needed for discrete PC binding. 
 
N254Y/H258Y +Choline and N254Y/H258Y +DiC4PC 
Both the choline and diC4PC occupied forms of the N254Y/H258Y 
structure were co-crystallized with 30 mM glycerol phosphocholine and 25 mM 
choline chloride. Before data collection these crystals were soaked for 2 h in a 
solution containing either 500 mM choline or 100 mM diC4PC. Statistics for the 
different crystal structures are presented in Tables 5-1 and 5-2.  
When crystals were soaked with high concentrations  (500 mM) of choline, 
two molecules of choline were seen (Figure 5-4A). The quaternary amines of 
each choline were observed to bind on either side of H258Y, with the quaternary 
amine of choline one making π-cation interactions with the aromatic side chains 
of H258Y and Tyr212, while choline 2 makes π-cation interactions similarly with  
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Trp287 and Tyr290.  In comparison with the unliganded structure, the side chains 
of Tyr211 and H258Y can be seen to rotate 77˚ and 100˚ respectively. The 
rotation of Tyr211 creates binding pocket 1, while the rotation of H258Y forms the 
right side of binding pocket 1, as well as the left side of binding pocket 2.   
  
When this method proved to be successful, crystals grown under similar 
conditions were soaked in a solution containing 100 mM diC4PC.  These data 
showed a structure with three molecules of diC4PC bound, at various 
occupancies (Figure 5-4B). One molecule of diC4PC (at 80% occupancy) is 
located in choline binding pocket two, the quaternary amine of both the choline 
and diC4PC ligands are completely superimposable, with the phosphate of the 
diC4PC making additional polar contacts to the side chain hydroxyls of Tyr290 
and Tyr258. Density for this ligand (Figure 5-3A) is very complete for the 
phosphocholine portion of the molecule, as well as part of the glycerol; the lipid 
chains appear to be disordered. No diC4PC lipids were seen occupying choline 
binding site one. However, the high concentration of lipid led to the observation 
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of two additional diC4PC molecules in the structure. One diC4PC was found at 
70% occupancy and was bound via polar contacts to the phosphate via the 
backbone carbonyls of Leu37 and Lys38, as well as to the side chain hydroxyl of 
Ser43. An additional molecule of diC4PC (80% occupancy) was observed with 
the phosphate occupying the anion binding pocket (Goldstein et al., 2012).  
Under the conditions this crystal was formed, an acetate ion would be the typical 
occupant of the pocket. However, the anion binding pocket is shaped to 
accommodate a small anion. This preference, in conjunction with the high levels 
of diC4PC in the soak, could easily outcompete the acetate ion. Both these two 
additional lipids are considered artifacts of the crystallization conditions; they are 
held by polar contacts only and do not represent additional choline or 
phosphatidylcholine binding sites. Representative maps of the electron density 
and ligand binding to N254Y/H258Y are shown in Figure 5-5. 
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WT + DiC4PC 
To confirm that the binding of the two auxiliary diC4PC units were due to 
crystallization artifact only, a crystal of the wild type S. aureus PI-PLC grown 
under basic conditions was soaked in 100 mM diC4PC for two hours before data 
collection. The structures shows a typical basic conformation of this PI-PLC with 
two molecules of diC4PC present, and one molecule of HEPES.  The diC4PC 
moieties are present in identical conformations as in the N254Y/H258Y structure, 
with one ligand bound by the acyl chains under helix B with an occupancy of 
40%, and another ligand bound via the phosphate group to the anion binding 
pocket with 60% occupancy. Though two molecules of diC4PC are seen 
crystallographically (though at quite low occupancy) the wild type S. aureus PI-
PLC shows no binding to vesicles of pure PC (see Figure 5-1A). One molecule of 
HEPES sits in choline binding site two, in they same orientation as is seen in the 
N254Y/H258Y structure, but with only about 70% occupancy. 
 
5.5 Interfacial Binding Pocket 
 The nature of this interfacial binding pocket has been explored with 
several mutagenic studies. Initial studies on the mode of binding of B. 
thuringiensis PI-PLC to membranes indicated that the protein was activated by 
PC, and that specific residues were necessary for this activation (Feng et al., 
2002; Feng et al., 2003). Based on this data, a W47A/W242A B. thuringiensis 
mutant was generated. This interfacially impaired mutant crystallized (PDB ID 
2OR2) as a dimer, with the dimer interface generated by the residues Tyr246, 
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Tyr247, Tyr248, and Tyr251 (Shao et al., 2007). To explore the relevance of this 
region, several different mutants were generated, each converting two, three, or 
four of these tyrosines to serines. All of these tyrosine mutants showed a drastic 
reduction of both PC activation and protein binding to PC vesicles (Pu et al., 
2009; Shi et al., 2009). The relation of this area, deemed the interfacial binding 
pocket, to PC binding was then confirmed by field-cycling NMR experiments, 
which concluded that the PC binding site was not only distinct from the active site, 
but was also related to the tyrosines previously indicated (Pu et al., 2010).  
The fortuitous similarity of the B. thuringiensis enzyme to the S. aureus PI-
PLC was then employed to generate a putative PC binding site. Native S. aureus 
PI-PLC shows minimal PC activation, which was previously determined to be 
related to dimer formation in that enzyme, but no binding to pure PC (Cheng et 
al., 2012). The interfacial binding pocket is incomplete in the native S. aureus 
enzyme, but does show two of the four indicated tyrosines, equivalent to Tyr246 
and Tyr248 in the Bacillus enzyme. Upon mutation of N254Y and H258Y (S. 
aureus numbering) all four tyrosines in the region of the interfacial binding pocket 
were restored. Kinetic studies on this mutant confirmed that it bound much more 
tightly to PC-rich interfaces than the native S. aureus PI-PLC. The double mutant 
had a specific PC binding site similar to that observed for Bacillus PI-PLCs. 
Additional crystallographic studies found two molecules of choline bound to the 
mutant S. aureus PI-PLC, one of which sat directly in the proposed interfacial 
binding pocket (the second sits in a site specific to the S. aureus enzyme which 
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is not present in the Bacillus enzymes) (Cheng et al., 2013). The binding of 
choline to the proposed interfacial binding pocket matches exactly the in silico 
modeling of butylphosphocholine to the B. thuringiensis PI-PLC (Figure 5-6) (Pu 
et al., 2010).  
 In this S. aureus PI-PLC mutant, it was found that the cationic choline 
moiety from PC targeted clusters of aromatic residues, in canonical π-cation box 
type arrangements (Cheng et al., 2013). These π-cation boxes consist of 2-4 
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aromatic residues, with the π systems of these residues oriented at roughly 100˚ 
to each other, approximately 6Å apart, and located close to the dimer interface. 
This arrangement is seen in a mutated (N254Y/H258Y) S. aureus PI-PLC in two 
locations, both with confirmed choline binding (Cheng et al., 2013). This S. 
aureus PI-PLC mutant was created to mimic the proposed interfacial PC binding 
pocket in the B. thuringiensis PI-PLC. When crystallized with 500 mM choline, 
the mutant S. aureus PI-PLC shows a choline binding site comprised of tyrosines 
Tyr204, Try251, Tyr247, and Try248. These residues are consistent with 
previous studies using mutagenesis and NMR data to determine the interfacial 
PC binding site in the native B. thuringiensis enzyme (Pu et al., 2010; Cheng et 
al., 2013; Shi et al., 2009). The native S. aureus PI-PLC does not show any likely 
π-cation pockets. Unsurprisingly, the B. cereus enzyme looks quite similar to the 
B. thuringiensis PI-PLC, with the exact same residues forming a π- box. The PI-
PLC from L. monocytogenes shows two such π boxes, one is comprised of Tyr92 
and Phe97, and a second comprised of Phe244 and Tyr249. Finally, S. 
antibioticus PI-PLC shows one such π box, comprised of Try275 and Tyr276. 
Though the interfacial binding pocket does allow for an activating effect by 
PC, this activation is without limit. It has been found that Bacillus PI-PLC specific 
activity decreases dramatically when the mole fraction of PC is greater than 50% 
(Qian et al., 1998; Volwerk et al., 1994). This surface dilution inhibition effect is 
seen when the concentration of substrate PI decreases below a two dimension 
Km, as measured by mol fraction of PI (Pu et al., 2009; Carman et al., 1995). 
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5.6 Confirming the PC Binding Pocket 
 We have obtained an unliganded, choline, and diC4PC ligand bound 
structures of these binding pockets, with clear differences in side chain rotamers 
(Figure 5-7C). Furthermore, in the cation bound conformation, binding pocket 1 
of the double mutant overlays exactly with the side chains of the B. thuringiensis 
PI-PLC structure (1T6M). We have generated a choline binding pocket in the S. 
aureus PI-PLC, and identified that same pocket on the Bacillus enzyme.  
  The necessity for both added tyrosine residues is also highlighted by 
examining vesicle binding data. The different enzymes (0.2 mg/ml) were 
incubated with 1 mM PG/PC (0.2 mM / 0.8 mM) SUVs in MES-HEPES, pH 7.5, 
with 140 mM salt (to ensure protein solubility), followed by centrifugation of the 
sample to separate vesicle bound from free protein (the later quantified with DCA 
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protein assay according to the Bio-Rad instruction manual (Lowry et al., 1951; 
Peterson et al., 1979). The total phospholipid concentration was chosen to be 
close to the Kd for N254Y/H258Y as measured by FCS. Under these conditions, 
no WT or N254Y protein was bound, 12.3% of H258Y and 58.6% of 
N254Y/H258Y were bound to the vesicles. This suggests that a tyrosine at 
residue 258 is particularly critical, but adding one at residue 254 enhances PC 
binding. 
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Table 5-1. Crystallographic data for S. aureus N254Y/H258Y PI-PLC crystals.  
 
Crystal N254Y/H258Y (no ligand) 
N254Y/H258Y + 
choline 
N254Y/H258Y 
+diC4PC 
    
PDB ID    
Diffraction Data   
Resolution Range (Å) 2.10-30.69Å 1.65-30.08 1.85-37.76 
No. of reflections 18210 36554 24758 
Reflections in free set 933 1840 1279 
Space group P212121 P212121 P212121 
Unit cell    
a(Å) 85.55 85.98 85.65 
b(Å) 57.78 57.58 57.47 
c(Å) 61.38 61.69 61.75 
Completeness 99.2% 97.2% 92.5 
Rmerge 9.9 5.8 8.4 
Protein molecules in A.U. 1 1 1 
Refinement   
Rcrysta 0.1781 0.1772 0.1627 
Rfreeb 0.2312 0.2136 0.2076 
No. residues 303 301 301 
No. non-hydrogen protein 
atoms 2441 2449 2465 
No. H2O molecules 138 195 239 
No. ions 2 2 2 
r.m.s.d. bonds (Å) 0.009 0.007 0.019 
r.m.s.d angles (o) 1.11 1.05 1.94 
Ramachandran plot (%)    
Most favored 98.02 98.69 98.70 
Additionally allowed 1.98 1.31 1.30 
Generously allowed 0 0 0 
Disallowed 0 0 0 
Average B-factor (Å2) 33.74 29.40 28.998 
a Rcryst = {S (||Fo| - |Fc||) / |Fo|}, where |Fo| and |Fc| are the observed and 
calculated structure factor amplitudes, respectively. 
b Brunger (1992). 
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Table 5-2. Crystallographic data for S. aureus PI-PLC with HEPES. 
Crystal N254Y/H258Y + HEPES H258Y : Basic 
WT + diC4PC + 
HEPES 
    
PDB ID 4F2Y   
Diffraction Data   
Resolution Range (Å) 2.19-30.85 1.99-37.63 1.80-29.70 
No. of reflections 15898 20933 27665 
Reflections in free set 795 1072 1397 
Space group P212121 P212121 P212121 
Unit cell    
a(Å) 86.22 85.59 85.48 
b(Å) 56.12 57.83 55.68 
c(Å) 61.71 60.78 61.57 
Completeness 99.5% 99.3% 99.28% 
Rmerge 11.7 7.6 4.4 
Protein molecules in A.U. 1 1 1 
Refinement   
Rcrysta 0.1580 0.1786 0.1590 
Rfreeb 0.2358 0.2324 0.1929 
No. residues 304 305 302 
No. non-hydrogen protein 
atoms 2437 2498 
2460 
No. H2O molecules 342 195 223 
No. ions 1 1 1 
r.m.s.d. bonds (Å) 0.02 0.20 .007 
r.m.s.d angles (o) 1.70 1.98 1.19 
Ramachandran plot (%)    
Most favored 90.1 96.49 97.74 
Additionally allowed 9.9 3.19 2.26 
Generously allowed 0 0.32 0 
Disallowed 0 0 0 
Average B-factor (Å2) 33.45 25.64 22.67 
a Rcryst = {S (||Fo| - |Fc||) / |Fo|}, where |Fo| and |Fc| are the observed and 
calculated structure factor amplitudes, respectively. 
b Brunger (1992). 
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The following table compares all proteins in the PDB as of August 2012 
which contain choline, phosphocholine, phosphatidylcholine lipid, or similar 
choline containing ligands. Included in the chart is the identity of the protein, its 
organism of origin, all PDBs associated with its identity and origin, as well as its 
state of membrane interaction and the function of the protein. Ligands are 
abbreviated as per PDB codes, and a table of their abbreviations follows. The 
binding mode of the choline ligand is also noted, with attention focused on the 
nature of the coordination of the quaternary amine of the choline or choline 
portion of the ligand. Proteins are ordered in a general sense by function, i.e. 
proteins which bind choline specifically, lipid transfer proteins, esterases, etc. 
Highlighted in red are any proteins which bind the quaternary amine of choline in 
π-cation box type arrangement: that is, the cationic quaternary amine is held 
between the π systems several (usually 2-5) aromatic residues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5-3A. Proteins which bind choline or choline like molecules. Table 5-3B 
follows, which provides ligand abbreviations.  
 110 
B
in
di
ng
 M
od
e 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
π
-
ca
tio
n 
bo
x 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
π
-
ca
tio
n 
bo
x 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 in
 π
-
ca
tio
n 
bo
x,
 h
yd
ro
xy
l h
el
d 
by
 a
 
co
or
di
na
te
d 
ph
os
ph
at
e 
vi
a 
an
 
A
sn
 a
nd
 a
 S
er
 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
π
-
ca
tio
n 
bo
x,
 A
S
P
 a
nd
 A
S
N
 
fo
rm
 p
ol
ar
 c
on
ta
ct
s 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
π
-
ca
tio
n 
bo
x 
qu
at
er
na
ry
 a
m
in
e 
 h
el
d 
by
 π
-
ca
tio
n 
bo
x 
qu
at
er
na
ry
 a
m
in
e 
 h
el
d 
by
 π
-
ca
tio
n 
bo
x 
bo
un
d 
 v
ia
 th
e 
ph
os
ph
at
e 
qu
at
er
na
ry
 a
m
in
e 
is
 h
el
d 
by
 a
 
π
-c
at
io
n 
bo
x 
Li
ga
nd
 
C
H
O
 
C
H
O
 
 
C
H
O
 
C
H
O
 
C
H
O
 
C
H
O
 
C
C
E
 
 
P
C
 
P
C
 
Fu
nc
tio
n 
ch
ol
in
e 
bi
nd
in
g 
pr
ot
ei
n 
ch
ol
in
e 
bi
nd
in
g 
pr
ot
ei
n 
ch
ol
in
e 
bi
nd
in
g 
pr
ot
ei
n 
A
B
C
 
tra
ns
po
rte
r 
ge
ne
ra
te
s 
ac
et
yl
ch
ol
in
e 
ch
ol
in
e 
bi
nd
in
g 
pr
ot
ei
n 
ac
et
yl
ch
ol
in
e 
bi
nd
in
g 
pr
ot
ei
n 
ph
os
ph
oc
ho
lin
e 
bi
nd
in
g 
pr
ot
ei
n 
ch
ol
in
e 
lip
id
 
bi
nd
in
g 
pr
ot
ei
n 
M
em
br
an
e 
In
te
ra
ct
io
ns
 
so
lu
bl
e 
 
so
lu
bl
e 
 
so
lu
bl
e 
  
m
em
br
an
e 
bo
un
d 
so
lu
bl
e 
 
so
lu
bl
e 
m
em
br
an
e 
bo
un
d 
so
lu
bl
e 
in
te
rfa
ci
al
 
 
PD
B
 ID
 
2V
04
,2
V
05
,2
V
Y
U
, 2
X
8M
, 
2X
8O
, 2
X
8P
 
1G
V
M
, 1
H
8G
, 
1H
C
X
 
3H
IA
 
 
2R
E
G
 
2F
Y
3 
3R
6U
, 3
P
P
Q
 
1U
V
6,
 2
X
Z5
 
 
1b
09
 
1H
8P
 
O
rg
an
is
m
 
S
tre
pt
oc
oc
cu
s 
pn
eu
m
on
ia
e 
S
tre
pt
oc
oc
cu
s 
pn
eu
m
on
ia
e 
S
tre
pt
oc
oc
cu
s 
pn
eu
m
on
ia
e 
S
in
or
hi
zo
bi
um
 
m
el
ilo
ti 
H
um
an
 
B
ac
ill
us
 
su
bt
ili
s 
Ly
m
na
ea
 
st
ag
na
lis
 
H
um
an
 
B
ov
in
e 
Pr
ot
ei
n 
C
ho
lin
e 
B
in
di
ng
 
Pr
ot
ei
n 
F 
C
ho
lin
e 
bi
nd
in
g 
do
m
ai
n 
fr
om
 
au
to
ly
si
n 
(C
-L
YT
A
) 
C
ho
lin
e 
bi
nd
in
g 
do
m
ai
n 
of
 S
pr
12
74
 
C
ho
lin
e 
bi
nd
in
g 
pr
ot
ei
n 
(C
ho
X)
 
C
ho
lin
e 
ac
et
yl
tr
an
sf
er
as
e 
O
pu
B
C
 
A
ce
ty
lc
ho
lin
e 
B
in
di
ng
 P
ro
te
in
 
C
-r
ea
ct
iv
e 
pr
ot
ei
n 
 PD
V-
10
9 
fib
ro
ne
ct
in
 
m
od
ul
e 
 111 
B
in
di
ng
 M
od
e 
qu
at
er
na
ry
 a
m
in
e 
is
 h
el
d 
by
 a
 
π
-c
at
io
n 
bo
x,
 p
ho
sp
ha
te
 is
 
co
or
di
na
te
d 
by
 a
n 
A
rg
 
qu
at
er
na
ry
 a
m
in
e 
is
 h
el
d 
by
 a
 
π
-c
at
io
n 
bo
x,
 p
ol
ar
 c
on
ta
ct
s 
to
 p
ho
sp
ha
te
 
qu
at
er
na
ry
 a
m
in
e 
is
 h
el
d 
by
 a
 
π
-c
at
io
n 
bo
x,
 a
ls
o 
he
ld
 b
y 
ac
yl
 c
ha
in
s,
 li
ga
nd
 is
 v
er
y 
tig
ht
ly
 b
ou
nd
 
ac
yl
 c
ha
in
s 
an
d 
ph
os
ph
at
e 
bo
un
d,
 c
ho
lin
e 
gr
ou
p 
is
 
ap
pa
re
nt
ly
 u
nc
oo
rd
in
at
ed
 
qu
at
er
na
ry
 a
m
in
e 
 h
el
d 
by
 π
-
ca
tio
n 
bo
x,
 li
pi
d 
ch
ai
ns
 a
ls
o 
bo
un
d 
qu
at
er
na
ry
 a
m
in
e 
 h
el
d 
by
 π
-
ca
tio
n 
bo
x 
qu
at
er
na
ry
 a
m
in
e 
 h
el
d 
by
 π
-
ca
tio
n 
bo
x 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
π
-
ca
tio
n 
bo
x 
m
os
tly
 b
ou
nd
 th
ro
ug
h 
ph
os
ph
at
e 
on
e 
 π
-c
at
io
n 
w
ith
 
qu
at
er
na
ry
 a
m
in
e 
Li
ga
nd
 
P
C
 
N
C
H
 
D
LP
 
P
C
, P
C
W
 
6P
L 
C
H
O
 
C
H
O
 
C
H
O
 
P
C
 
Fu
nc
tio
n 
ph
os
ph
oc
ho
lin
e 
bi
nd
in
g 
pr
ot
ei
n 
ph
os
ph
oc
ho
lin
e 
bi
nd
in
g 
pr
ot
ei
n 
P
C
 li
pi
d 
tra
ns
fe
r p
ro
te
in
 
P
I/P
C
 tr
an
sf
er
 
pr
ot
ei
n 
P
I/P
C
 tr
an
sf
er
 
pr
ot
ei
n 
pe
pt
id
og
ly
ca
na
se
 
pe
pt
id
og
ly
ca
na
se
 
es
te
ra
se
 
es
te
ra
se
 
M
em
br
an
e 
In
te
ra
ct
io
ns
 
so
lu
bl
e 
so
lu
bl
e 
in
te
rfa
ci
al
 
in
te
rfa
ci
al
 
so
lu
bl
e 
so
lu
bl
e 
so
lu
bl
e 
so
lu
bl
e 
in
te
rfa
ci
al
 
PD
B
 ID
 
2M
C
P
 
 
1D
L7
 
1L
N
1,
 1
LN
2,
 
1L
N
3 
1U
W
5,
 2
A
1L
, 
1T
27
 
3B
7Q
, 3
B
7Z
 
2W
W
5,
 
2W
W
C
, 
2W
W
D
 
1O
B
A
 
1P
0M
 
1W
R
A
, 2
B
IB
 
 
O
rg
an
is
m
 
M
ou
se
 
H
um
an
 
H
um
an
 
H
um
an
, R
at
 
Y
ea
st
 
S
tre
pt
oc
oc
cu
s 
pn
eu
m
on
ia
e 
P
ha
ge
 C
P
-1
 
H
um
an
 
S
tre
pt
oc
oc
cu
s 
pn
eu
m
on
ia
e 
Pr
ot
ei
n 
G
A
-K
ap
pa
 M
C
/P
C
60
3 
FA
B
 
Im
m
un
e 
re
sp
on
se
 
Pr
ot
ei
n 
Ph
os
ph
at
id
yl
 c
ho
lin
e 
tr
an
sf
er
 p
ro
te
in
 
Ph
os
ph
at
id
yl
in
os
ito
l 
tr
an
sf
er
 p
ro
te
in
 
Se
c1
4 
ho
m
ol
og
 
A
ut
ol
ys
is
n 
(L
yt
C
) 
En
do
ly
si
n 
B
ut
yr
yl
 
ch
ol
in
es
te
ra
se
 
Ph
os
ph
oc
ho
lin
e 
es
te
ra
se
 d
om
ai
n 
fr
om
 
C
PB
E 
 112 
B
in
di
ng
 M
od
e 
qu
at
er
na
ry
 a
m
in
e 
 h
el
d 
by
 π
-
ca
tio
n 
bo
x,
 a
dd
iti
on
al
 p
ol
ar
 
co
nt
ac
ts
 b
in
d 
m
ol
ec
ul
e 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
π
-
ca
tio
n 
bo
x,
 a
s 
w
el
l a
s 
va
rio
us
 
po
la
r c
on
ta
ct
s 
on
 th
e 
re
st
 o
f 
th
e 
m
ol
ec
ul
e 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
π
-
ca
tio
n 
bo
x 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 in
 π
-
ca
tio
n 
bo
x,
 p
ho
sp
ha
te
 
co
or
di
na
te
d 
by
 a
n 
A
sp
 a
nd
 
G
lu
 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 in
 π
-
ca
tio
n 
bo
x,
 p
ho
sp
ha
te
 
co
or
di
na
te
d 
by
 S
er
, A
sp
 a
nd
 
A
sn
 
co
or
di
na
te
d 
 b
y 
th
e 
ph
os
ph
at
e 
on
ly
 
ph
os
ph
at
e 
he
ld
 m
os
tly
, b
ut
 1
 
π
-c
at
io
n 
in
te
ra
ct
io
n 
qu
at
er
na
ry
 a
m
in
e 
 h
el
d 
by
 π
-
ca
tio
n 
bo
x,
 a
dd
iti
on
al
 p
ol
ar
 
co
nt
ac
ts
 b
in
d 
m
ol
ec
ul
e 
Li
ga
nd
 
S
C
U
, C
H
O
, 
S
C
K
, B
C
H
 
B
C
H
 
B
C
H
 
C
H
O
 
P
C
 
P
LC
 
P
C
 
C
H
O
 
Fu
nc
tio
n 
es
te
ra
se
 
es
te
ra
se
 
es
te
ra
se
 
ki
na
se
 
ki
na
se
 
io
n 
ch
an
ne
l 
io
n 
ch
an
ne
l 
tra
ns
po
rte
r 
M
em
br
an
e 
In
te
ra
ct
io
ns
 
so
lu
bl
e 
so
lu
bl
e 
so
lu
bl
e 
so
lu
bl
e 
so
lu
bl
e 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
PD
B
 ID
 
2H
A
2,
 
2H
A
3,
2H
A
6,
 
2H
A
5,
 2
H
A
7 
1P
0P
 
2C
58
, 2
C
4H
 
3C
5I
 
2C
K
Q
 
2W
LL
 
2x
6a
, 2
x6
b,
 
2x
6c
 
3P
03
 
O
rg
an
is
m
 
M
ou
se
 
H
um
an
 
To
rp
ed
o 
C
al
ifo
rn
ic
a 
P
la
sm
od
iu
m
 
kn
ow
le
si
 
H
um
an
 
B
ur
kh
ol
de
ria
 
ps
ed
om
al
le
i 
M
ag
ne
to
sp
iri
llu
m
 
m
ag
ne
to
ta
ct
ic
u
m
 
C
or
yn
eb
ac
te
riu
m
 g
lu
ta
m
ic
um
 
Pr
ot
ei
n 
A
ce
ty
lc
ho
lin
es
te
ra
s
e  Bu
tr
yl
ch
ol
in
e 
Es
te
ra
se
 
 Ac
et
yl
ch
ol
in
es
te
ra
s
e Ch
ol
in
e 
ki
na
se
 
(P
K
H
_1
34
52
0)
 
C
ho
lin
e 
ki
na
se
 
al
ph
a 
2 
  Po
ta
ss
iu
m
 c
ha
nn
el
 
Po
ta
ss
iu
m
 C
ha
nn
el
 
So
di
um
 c
ou
pl
ed
 
be
ta
in
e 
sy
m
po
rt
er
 
(B
et
P)
 
 113 
 
B
in
di
ng
 M
od
e 
he
ld
 b
y 
th
e 
lip
id
 c
ha
in
s,
 n
o 
in
te
ra
ct
io
n 
w
ith
 th
e 
ph
os
ph
oc
ho
lin
e 
lip
id
 c
ha
in
s 
ar
e 
bo
un
d,
 p
ol
ar
 
co
nt
ac
ts
 to
 th
e 
ph
os
ph
at
e 
an
d 
gl
yc
er
ol
, n
o 
in
te
ra
ct
io
ns
 
w
ith
 c
ho
lin
e 
he
ld
 b
y 
th
e 
lip
id
 c
ha
in
s,
 
ph
os
ph
at
e 
is
 v
is
ib
le
 b
ut
 n
ot
 
bo
un
d,
 c
ho
lin
e 
he
ad
 g
ro
up
 is
 
no
t o
rd
er
ed
 
he
ld
 b
y 
th
e 
lip
id
 c
ha
in
s,
 
ph
os
ph
at
e 
is
 v
is
ib
le
 b
ut
 n
ot
 
bo
un
d,
 c
ho
lin
e 
he
ad
 g
ro
up
 is
 
no
t o
rd
er
ed
 
he
ld
 b
y 
lip
id
 c
ha
in
s 
an
d 
ph
os
ph
at
e,
 c
ho
lin
e 
is
 n
ot
 
bo
un
d 
he
ld
 b
y 
ph
os
ph
at
e 
on
ly
, l
ip
id
 
ch
ai
ns
 a
re
 n
ot
 o
rd
er
ed
 
he
ld
 b
y 
ac
yl
 c
ha
in
 a
nd
 p
ol
ar
 
co
nt
ac
t t
o 
gl
yc
er
ol
, c
ho
lin
e 
is
 
no
t o
rd
er
ed
 
he
ld
 b
y 
th
e 
lip
id
 c
ha
in
s 
on
ly
, 
ch
ol
in
e 
is
 n
ot
 b
ou
nd
 
Li
ga
nd
 
P
C
 
P
LC
, G
P
C
 
P
X
4 
P
X
4 
G
P
C
 
G
P
C
 
M
C
3 
P
LC
 
Fu
nc
tio
n 
so
di
um
 
sy
m
po
rte
r 
io
n 
ch
an
ne
l 
io
n 
ch
an
ne
l 
vo
lta
ge
 
ga
te
d 
io
n 
ch
an
ne
l 
io
n 
pu
m
p 
io
n 
pu
m
p 
io
n 
ch
an
ne
l 
lip
as
e 
M
em
br
an
e 
In
te
ra
ct
io
ns
 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
in
te
rfa
ci
al
 
PD
B
 ID
 
3U
S
G
, 3
U
S
L,
 
3U
S
M
, 
3p
4w
, 3
p5
0,
 
3u
u5
, 
3u
u8
,3
uu
b,
 
3E
A
M
 
3D
D
L 
3R
V
Y
, 3
R
V
Z,
 
3R
W
0 
2Z
B
D
, 3
A
R
2 
3B
8E
 
3E
M
N
 
1E
IN
 
O
rg
an
is
m
 
A
qu
ife
x 
ae
ol
ic
us
 
G
lo
eo
ba
ct
er
 
vi
ol
ac
eu
s 
S
al
in
ib
ac
te
r 
ru
be
r 
A
rc
ob
ac
te
r 
bu
tz
le
ri 
O
ry
ct
ol
ag
us
 
cu
ni
cu
lu
s 
P
or
ci
ne
 
M
ou
se
 
Th
er
m
om
yc
es
 
la
nu
gi
no
sa
 
Pr
ot
ei
n 
Le
uT
 
Li
ga
nd
 g
at
ed
 io
n 
ch
an
ne
l 
Xa
nt
ho
rd
op
si
n 
N
av
A
B
 
SR
 c
al
ci
um
 p
um
p 
So
di
um
 P
ot
as
si
um
 
Pu
m
p 
Vo
lta
ge
 d
ep
en
de
nt
 
Io
n 
A
ni
on
 C
ha
nn
el
 
Li
pa
se
 
 114 
B
in
di
ng
 M
od
e 
he
ld
 b
y 
th
e 
lip
id
 c
ha
in
s 
on
ly
, c
ho
lin
e 
is
 n
ot
 b
ou
nd
 
he
ld
 b
y 
th
e 
lip
id
 c
ha
in
s 
on
ly
, c
ho
lin
e 
is
 n
ot
 b
ou
nd
 
ex
te
ns
iv
e 
co
or
di
na
tio
n 
to
 s
ul
fu
r, 
G
lu
 
co
or
di
na
tio
n 
to
 th
e 
ch
ol
in
e 
he
ld
 b
y 
lip
id
 c
ha
in
s 
on
ly
 
lig
an
d 
is
 h
el
d 
by
 a
cy
l c
ha
in
s,
 w
ith
 1
 
as
p 
ne
ar
 c
ho
lin
e 
he
ld
 b
y 
ch
ol
in
e 
he
ad
 g
ro
up
 w
ith
 1
 
Ty
r, 
an
d 
1 
as
p,
 e
xt
en
si
ve
 p
ol
ar
 
co
nt
ac
ts
 w
ith
 p
ho
sp
ha
te
, c
om
pl
et
e 
hy
dr
op
ho
bi
c 
in
te
ra
ct
io
n 
w
ith
 th
e 
ac
yl
 
ch
ai
n 
he
ld
 b
y 
lip
id
 c
ha
in
, p
ho
sp
ha
te
 m
ak
es
 
po
la
r c
on
ta
ct
s 
Li
ga
nd
 
P
LC
 
LP
E
 
3P
C
, 
P
C
5 
P
C
K
, 
G
P
C
 
P
LC
 
P
S
C
 
P
C
F 
Fu
nc
tio
n 
lip
as
e 
lip
as
e 
ph
os
ph
ol
ip
as
e 
ph
ot
os
yn
th
et
ic
 
re
ac
tio
n 
ce
nt
er
 
m
ito
ch
on
dr
i
al
 e
le
ct
ro
n 
tra
ns
po
rt 
el
ec
tro
n 
tra
ns
po
rt 
ch
ai
n 
el
ec
tro
n 
tra
ns
po
rt 
ch
ai
n 
M
em
br
an
e 
In
te
ra
ct
io
ns
 
in
te
rfa
ci
al
 
in
te
rfa
ci
al
 
in
te
rfa
ci
al
 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
PD
B
 ID
 
1L
P
A
 
1L
8S
 
1P
6D
, 1
P
6E
 
2H
G
9,
2H
H
 
,2
H
G
3,
 2
J8
C
, 
1M
3X
 
3H
1I
, 3
H
1J
 
1V
54
, 2
D
Y
R
, 
3A
G
2,
 3
A
G
3,
 
1V
55
, 2
E
IJ
, 
3A
B
M
, 2
A
B
K
, 
3A
G
4,
 2
E
IK
, 
2E
IL
, 3
A
B
L,
 
2D
Y
S
, 3
A
G
1,
 
2Z
X
W
, 2
E
IM
, 
2E
IN
 
1K
B
9 
O
rg
an
is
m
 
H
um
an
 
P
or
ci
ne
 
B
ac
ill
us
 c
er
us
 
R
ho
do
ba
ct
er
 
sp
ha
er
oi
de
s 
R
26
 
C
hi
ck
en
 
B
ov
in
e 
Y
ea
st
 
P r o t e i n L i p a s e - p r o c o l i p a s e C a r b o x y l i c  e s t e r  h y d r o l a s e  ( p h o s p h o l i p a s e  A 2 ) P h o s p h o l i p a s e R e a c t i o n  c e n t e r C y t o c h r o m  B C 1 C y t o c h r o m e  B C 1  c o m p l e x 
 115 
 
 
B
in
di
ng
 M
od
e 
co
or
di
na
te
d 
by
 p
ho
sp
ha
te
 
on
ly
 
he
ld
 b
y 
lip
id
 c
ha
in
s 
on
ly
 
he
ld
 b
y 
lip
id
 c
ha
in
s 
an
d 
po
la
r 
co
nt
ac
t t
o 
ph
os
ph
at
e 
he
ld
 b
y 
lip
id
 c
ha
in
, p
ho
sp
ha
te
 
m
ak
es
 p
ol
ar
 c
on
ta
ct
s 
he
ld
 b
y 
lip
id
 c
ha
in
,  
an
d 
ph
os
ph
at
e 
 p
ol
ar
 c
on
ta
ct
s,
 
G
lu
 c
oo
rd
in
at
es
 to
 th
e 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
lip
id
 c
ha
in
s 
on
ly
, P
C
 
he
ad
 g
ro
up
 is
 fa
r a
bo
ve
 th
e 
pr
ot
ei
n 
su
rfa
ce
 
lip
id
 c
ha
in
s 
an
d 
ph
os
ph
at
e 
ar
e 
bo
un
d,
 c
ho
lin
e 
gr
ou
p 
st
ic
ks
 o
ut
 a
bo
ut
 p
ro
te
in
 
su
rfa
ce
 
Li
ga
nd
 
G
P
C
 
G
P
C
 
G
P
C
 
 
O
P
C
 
D
P
V
 
O
P
C
 
P
LC
 
Fu
nc
tio
n 
A
TP
 
tra
ns
po
rt 
el
ec
tro
n 
tra
ns
po
rt 
ch
ai
n 
el
ec
tro
n 
tra
ns
po
rt 
ch
ai
n 
el
ec
tro
n 
tra
ns
po
rt 
ch
ai
n 
A
TP
 
sy
nt
ha
se
 
el
ec
tro
n 
tra
ns
po
rt 
ch
ai
n 
bi
nd
s 
ph
os
ph
ol
ip
i
ds
 
M
em
br
an
e 
In
te
ra
ct
io
ns
 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
so
lu
bl
e 
PD
B
 ID
 
1O
K
C
 
1P
84
 
1Q
LE
 
2Z
T9
 
2X
2V
 
2E
74
, 2
E
75
, 
2E
76
, 1
V
f5
, 
2D
2C
 
4D
O
S
 
O
rg
an
is
m
 
B
ov
in
e 
Y
ea
st
 
P
ar
ac
oc
cu
s 
de
ni
tri
fic
an
s 
N
os
to
c 
sp
. 
P
C
C
71
20
 
B
ac
ill
us
 
ps
eu
do
fir
m
us
 
M
as
tig
oc
la
du
s 
la
m
in
os
us
 
H
um
an
 
Pr
ot
ei
n 
M
ito
ch
on
di
ra
l 
A
D
P/
A
TP
 c
ar
rie
r 
C
yt
oc
hr
om
e 
B
C
1 
co
m
pl
ex
 
C
yt
oc
hr
om
e 
C
 
O
xi
da
se
 
C
yt
oc
hr
om
e 
B
6F
 
 A
TP
 s
yn
th
as
t r
ot
or
 
rin
g C
yt
oc
hr
om
e 
B
6F
 
 N
uc
le
ar
 li
ve
r r
ec
ep
to
r 
ho
m
ol
og
 
 116 
 
B
in
di
ng
 M
od
e 
lip
id
 c
ha
in
s 
on
ly
, P
C
 h
ea
d 
gr
ou
p 
is
 
fa
r a
bo
ve
 th
e 
pr
ot
ei
n 
su
rfa
ce
 
th
e 
lip
id
 c
ha
in
s 
an
d 
ph
os
ph
at
e 
ar
e 
bo
un
d,
 th
e 
ch
ol
in
e 
st
ic
ks
 o
ut
 a
bo
ve
 
th
e 
su
rfa
ce
 o
f t
he
 p
ro
te
in
 
he
ld
 b
y 
lip
id
 c
ha
in
, p
ho
sp
ha
te
 a
nd
 
gl
yc
er
ol
 m
ak
e 
po
la
r c
on
ta
ct
s,
 
ch
ol
in
e 
is
 a
bo
ve
 th
e 
su
rfa
ce
 o
f t
he
 
pr
ot
ei
n he
ld
 b
y 
lip
id
 c
ha
in
s 
on
ly
 
 lip
id
 c
ha
in
s 
an
d 
ph
os
ph
at
e 
ar
e 
bo
un
d,
 c
ho
lin
e 
gr
ou
p 
st
ic
ks
 o
ut
 
ab
ou
t p
ro
te
in
 s
ur
fa
ce
 
1 
P
he
 w
ith
in
 π
-c
at
io
n 
di
st
an
ce
, b
ut
 
m
os
tly
 h
el
d 
by
 li
pi
d 
ch
ai
ns
 
lip
id
 c
ha
in
s 
ar
e 
bo
un
d,
 c
ho
lin
e 
is
 
co
or
di
na
te
d 
by
 2
 G
lu
s 
he
ld
 b
y 
lip
id
 c
ha
in
, p
ho
sp
ha
te
 a
nd
 
gl
yc
er
ol
 m
ak
e 
po
la
r c
on
ta
ct
s,
 
ch
ol
in
e 
no
t  
or
de
re
d 
Li
ga
nd
 
P
LC
 
G
P
C
 
LP
C
 
LP
3 
P
42
 
P
C
F 
S
P
U
 
G
P
C
 
Fu
nc
tio
n 
lip
id
 a
nd
 
m
et
al
 
st
or
ag
e 
lip
op
ol
y 
sa
cc
ar
id
e 
bi
nd
in
g 
lip
id
 tr
an
sf
er
 
pr
ot
ei
n 
ly
so
so
m
al
 
lip
id
 tr
an
sf
er
 
pr
ot
ei
n 
lip
id
 b
in
di
ng
 
nu
cl
ea
r 
re
ce
pt
or
 
gr
ow
th
 
fa
ct
or
 
in
hi
bi
to
r 
C
al
ci
um
 
bi
nd
in
g 
pr
ot
ei
n 
G
P
C
R
 
M
em
br
an
e 
In
te
ra
ct
io
ns
 
in
te
rfa
ci
al
 
in
te
rfa
ci
al
 
m
em
br
an
e 
bo
un
d 
in
te
rfa
ci
al
 
in
te
rfa
ci
al
 
so
lu
bl
e 
so
lu
bl
e 
m
em
br
an
e 
bo
un
d 
PD
B
 ID
 
1L
S
H
 
1E
W
F,
 
1B
O
1 
1B
W
O
, 
1M
ID
 
2A
G
2 
3F
7D
 
2Y
G
N
, 
2Y
G
O
, 
2Y
G
P
,2
Y
G
Q
 
3I
F7
 
2Z
73
 
O
rg
an
is
m
 
Ic
ht
yo
m
yz
on
 
un
ic
us
pi
s 
H
um
an
 W
he
at
 
  H
um
an
 
M
ou
se
 
H
um
an
 
B
ov
in
e 
sq
ui
d 
Pr
ot
ei
n 
Li
po
vi
te
lli
n 
B
ac
te
ria
ci
da
l/p
er
m
e
ab
ili
ty
 in
cr
ea
si
ng
 
pr
ot
ei
n 
N
on
-s
pe
ci
fic
 L
ip
id
 
Tr
an
sf
er
 P
ro
te
in
 
G
M
2-
ac
tiv
at
e 
pr
ot
ei
n 
SF
-1
 
W
nt
  i
nh
ib
ito
ry
 
fa
ct
or
 1
 
C
al
m
od
ul
in
 
R
ho
do
ps
in
 
 117 
B
in
di
ng
 M
od
e 
lip
id
  c
ha
in
s 
ar
e 
he
ld
, p
ol
ar
 c
on
ta
ct
 
w
ith
  p
ho
sp
ha
te
s,
 c
ho
lin
es
 a
re
 
ab
ov
e 
th
e 
su
rfa
ce
 o
f t
he
 p
ro
te
in
 
he
ld
 b
y 
lip
id
 c
ha
in
s,
 p
ol
ar
 c
on
ta
ct
s 
an
d 
1 
π
-c
at
io
n 
on
 th
e 
qu
at
er
na
ry
 
am
in
e 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
π
-c
at
io
n 
bo
x 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
a 
π
-
ca
tio
n,
 p
ho
sp
ha
te
 b
ou
nd
 b
y 
A
rg
 
he
ld
 b
y 
lip
id
 c
ha
in
, p
ho
sp
ha
te
 
m
ak
es
 p
ol
ar
 c
on
ta
ct
s 
ch
ol
in
e 
is
 
ab
ov
e 
th
e 
su
rfa
ce
 o
f t
he
 p
ro
te
in
 
he
ld
 b
y 
ph
os
ph
at
es
 o
r l
ip
id
s,
 n
ot
 
ch
ol
in
es
 
lip
id
  c
ha
in
s 
ar
e 
he
ld
, a
nd
 p
ol
ar
 
co
nt
ac
ts
 a
re
 fo
rm
ed
 w
ith
 th
e 
ph
os
ph
at
es
 
m
os
tly
 c
oo
rd
in
at
ed
 b
y 
th
e 
ph
os
ph
at
e,
 o
ne
 π
-c
at
io
n 
in
te
ra
ct
io
n 
w
ith
 th
e 
qu
at
er
na
ry
 
am
in
e 
Li
ga
nd
 
M
C
3 
D
P
V
 
P
C
 
P
C
 
M
C
3 
C
P
L 
P
FS
 
P
C
 
Fu
nc
tio
n 
pr
ot
ea
se
 
m
em
br
an
e 
fu
si
on
 
pr
ot
ei
n 
po
re
 fo
rm
in
g 
pr
ot
ei
n 
se
lf 
as
se
m
bl
in
g 
ch
an
ne
l f
or
m
in
g 
pr
ot
ei
n 
w
at
er
 p
or
e 
fo
rm
in
g 
pr
ot
ei
n 
m
em
br
an
e 
fu
si
on
 
pr
ot
ei
n 
lip
id
 tr
an
sf
er
 
pr
ot
ei
n 
tra
ns
fe
ra
se
 
M
em
br
an
e 
In
te
ra
ct
io
ns
 
m
em
br
an
e 
bo
un
d 
in
te
rfa
ci
al
 
in
te
rfa
ci
al
 
in
te
rfa
ci
al
 
m
em
br
an
e 
bo
un
d 
m
em
br
an
e 
bo
un
d 
so
lu
bl
e 
so
lu
bl
e 
PD
B
 ID
 
2X
TV
 
3K
Y
Q
 
1O
72
 
3L
K
F 
2B
6O
 
2W
6D
 
1T
JJ
 
3U
J9
, 
3U
JC
, 
3U
JD
 
O
rg
an
is
m
 
E
. C
ol
i 
R
at
 
S
tic
ho
da
ct
yl
a 
he
lia
nt
hu
s 
S
ta
pl
oc
oc
cu
s 
A
ur
eu
s 
O
vi
s 
ar
ie
s 
N
os
to
c 
pu
nc
tif
or
m
e 
H
um
an
 
P
la
sm
od
iu
m
 
fa
lc
ip
ar
um
 
Pr
ot
ei
n 
R
ho
m
bo
id
 P
ro
te
as
e 
G
LP
G
 
SN
A
R
E 
yk
t6
 lo
gi
n 
do
m
ai
n 
Po
re
-fo
rm
in
g 
cy
to
ly
si
n 
st
ic
ho
ly
si
n 
II 
Le
uk
oc
id
en
 F
 (h
lg
b)
 
 Le
ns
 S
pe
ci
fic
  
A
qu
ap
or
in
 
B
ac
te
ria
l D
yn
am
in
 
lik
e 
pr
ot
ei
n 
G
M
2 
A
ct
iv
at
or
 
Pr
ot
ei
n 
Ph
os
ph
oe
th
an
ol
am
i
ne
 
m
et
hy
ltr
an
se
ra
se
 
 
 118 
B
in
di
ng
 M
od
e 
ac
yl
 c
ha
in
s 
on
ly
, P
C
 h
ea
d 
gr
ou
p 
is
 
fa
r a
bo
ve
 th
e 
pr
ot
ei
n 
su
rfa
ce
 
lig
an
d 
is
 b
ou
nd
 b
y 
lip
id
 c
ha
in
s 
an
d 
po
la
r c
on
ta
ct
s 
w
ith
 th
e 
ph
os
ph
at
e,
 
on
e 
po
ss
ib
le
  π
-c
at
io
n 
in
te
ra
ct
io
n 
w
ith
 th
e 
qu
at
er
na
ry
 a
m
in
e 
he
ld
 b
y 
ac
yl
 c
ha
in
s,
 
ph
os
ph
oc
ho
lin
e 
is
 a
bo
ve
 th
e 
 
su
rfa
ce
 o
f t
he
 p
ro
te
in
 
co
or
di
na
te
d 
by
 a
ce
ta
te
 
 
co
or
di
na
te
d 
by
 a
ce
ta
te
 
he
ld
 b
y 
lip
id
 c
ha
in
s 
an
d 
gl
yc
er
ol
 
gr
ou
p,
 p
ho
sp
ho
ch
ol
in
e 
st
ic
ks
 u
p 
ab
ov
e 
th
e 
pr
ot
ei
n 
he
ld
 b
y 
ac
yl
 c
ha
in
s,
 
ph
os
ph
oc
ho
lin
e 
is
 n
ot
 o
rd
er
ed
 
he
ld
 b
y 
lip
id
 c
ha
in
 a
nd
 p
ol
ar
 
co
nt
ac
ts
 to
 th
e 
gl
yc
er
ol
 
Li
ga
nd
 
6P
L,
 P
C
6 
L9
R
 
L9
R
 
A
C
H
 
A
C
H
 
P
C
F 
H
G
X
 
6P
L 
Fu
nc
tio
n 
lip
id
 b
in
di
ng
 
an
tig
en
 
pr
ot
ei
n 
an
tig
en
 
an
tig
en
? 
le
ct
in
-li
ke
 
im
m
un
e 
de
fe
ns
e 
pr
ot
ei
n 
m
ul
tid
ru
g 
re
si
st
an
ce
 
ge
ne
 
1,
2 
di
ox
yg
en
as
e 
di
ox
yg
en
as
e 
di
ox
yg
en
as
e 
M
em
br
an
e 
In
te
ra
ct
io
n
s 
so
lu
bl
e 
so
lu
bl
e 
so
lu
bl
e 
so
lu
bl
e 
so
lu
bl
e 
in
te
rfa
ci
al
 
so
lu
bl
e 
so
lu
bl
e 
PD
B
 ID
 
2F
IK
, 2
G
A
Z,
 
2H
26
, 1
ZH
N
 
3M
7O
 
3L
9R
 
2J
0H
 
3Q
5S
 
2A
ZQ
, 1
D
M
H
, 
1D
LT
, 1
D
LM
, 
1D
LQ
 
1T
M
X
, 3
N
9T
, 
1S
9A
 
3H
H
Y
,3
H
JS
, 
3I
51
, 3
H
K
P
, 
3I
4Y
, 3
H
G
I, 
3H
H
X
,3
H
JQ
, 
3I
4V
, 3
H
J8
 
O
rg
an
is
m
 
M
ou
se
 
M
ou
se
 
B
ov
in
e 
H
um
an
 
B
ac
ill
us
 
su
bt
ili
s 
 
P
se
ud
om
on
as
 
ar
vi
lla
 
N
oc
ar
di
oi
de
s 
si
m
pl
ex
 
R
ho
do
co
cc
us
 
op
ac
us
 
Pr
ot
ei
n 
C
D
1D
 a
nt
ig
en
 
M
D
-1
 ly
m
ph
oc
yt
e 
an
tig
en
 
C
D
1b
3 
L-
fic
ol
in
 
B
m
rR
 
C
at
ec
ho
l 
H
yd
ox
yq
ui
no
l 1
,2
 
di
ox
yg
en
as
e 
C
at
ec
ho
l 
 
 
 119 
Table 5-3B.  Abbreviations used for ligands in table 5-3A. 
 
3PC (3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine 
6PL 1-Palmitoyl-2-Stearoyl-Sn-Glycero-3-Phosphocholine 
ACH Acetylcholine 
BCH Butyrylthiocholine 
CCE Carbamyl-Choline 
CH
O 
Choline 
CPL Palmitoyl-Linoleoyl Phosphatidylcholine 
DLP 1,2-Dilinoleoyl-Sn-Glycero-3-Phosphocholine 
DPV N-Dodecylphosphocholine 
GPC 1,2-Diacyl-Sn-Glycero-3-Phosphocholine 
HGX 1-Heptadecanoyl-2-Tridecanoyl-3-Glycerol-Phosphonyl Choline 
L9R 1-Stearoyl-2-Oleoyl-Sn-Glycero-3-Phosphocholine 
LP3 (7r)-4,7-Dihydroxy-N,N,N-Trimethyl-10-Oxo-3,5,9-Trioxa-4-
Phosphaheptacosan-1-Aminium 4-Oxide 
LPC [1-Myristoyl-Glycerol-3-Yl]Phosphonylcholine, L-Alfa-
Lysophosphatidylcholine 
LPE 1-O-Octadecyl-Sn-Glycero-3-Phosphocholine 
MC3 1,2-Dimyristoyl-Rac-Glycero-3-Phosphocholine 
NCH P-Nitrophenyl-Phosphocholine 
OPC Dioleoyl-Phosphatidylcholine 
P42 1-Stearoyl-2-Palmitoyl-Sn-Glycero-3 
PC Phosphocholine 
PC5 1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine 
PC6 7-[(Dodecanoyloxy)Methyl]-4-Hydroxy-N,N,N-Trimethyl-9-Oxo-3,5,8-
Trioxa-4-Phosphadotriacontan-1-Aminium 4-Oxide 
PCF 1,2-Dipalmitoylphosphatidylcholine 
PCK 1,2-Distearoyl(9,10-Dibromo)-Sn-Glycero-3-Phosphocholine 
PC
W 
1,2-Dioleoyl-Sn-Glycero-3-Phosphocholine 
PFS 1-O-Octadecyl-2-Acetyl-Sn-Glycerol-3-Phosphocholine 
PLC Diundecyl Phosphatidyl Choline 
PSC 2-Linoleoyl-1-Palmitoyl-Sn-Gycerol-3-Phosphocholine 
PX4 1,2-Dimyristoyl-Sn-Glycero-3-Phosphocholine 
SCK  Succinyl Dicholine 
SCU Succinylcholine 
SPU sphingosylphosphorylcholine 
 
 
The preceding table shows one overwhelming theme; if a protein 
specifically binds choline, either as the substrate or product of a reaction, or as a 
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ligand in a transfer protein, it does so via a π-cation box type interaction with the 
quaternary amine of the choline. Proteins that bind lipids and are non-specific as 
to the head group, or proteins which are integral membrane proteins, bind ligand 
mostly via the lipid chains, or possibly via interactions with the phosphate. In 
proteins surveyed, out of 12 proteins that show choline as a ligand, all 12 bound 
choline via a π-cation box. Similarly, of the 10 proteins that contain 
phosphocholine 9 bound the quaternary amine in a π-cation box, while one did 
not. Conversely, of the 41 proteins that bound lipids with a phosphocholine or 
choline head group, 6 had π-cation boxes, while 37 did not. Overall, of the 67 
different proteins that bind choline or choline containing ligands, 43% of them 
bind the choline via a π-cation interaction. 
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Chapter 6; Conclusions for the S. aureus PI-PLC Project 
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6.1 Comparison of S. aureus PI-PLC with other Bacterial PI-PLCs 
 
Structural Overview 
 The two Bacillus PI-PLC structures (1PTG, 1T6M) and the S. aureus PI-
PLC structure (3V18) show excellent structural similarity, the general architecture 
of the structures is nearly identical with only minor differences in loops. The L. 
monocytogenes PI-PLC structure (2PLC) shows some minor variations, with 
helix B at approximately a 90˚ angle to its position in the previous three 
structures, and additional differences in β-strands between helixes E and F. 
However, the differences between the S. antibioticus PI-PLC structure (3H4X) 
and the Bacillus structures are much more striking. While the distorted (βα)8  
barrel is preserved in S. antibioticus PI-PLC, the exterior helices are shifted, with 
the greatest differences occurring between helices F and G, which are rotated an 
angle of 54˚ from similar helices in the Bacillus structures. Furthermore, helix B, 
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which has been suggested to be crucial to membrane binding, does not appear 
to exist in the S. antibioticus structure (Figure 6-1). Table 6-1 at the end of this 
chapter summarizes all structures of bacterial PI-PLCs deposited in the PDB. 
  
Interfacial Binding Region; the Rim Loop 
The ratio of cationic to aromatic residues in the rim loop varies between 
PI-PLCs depending on species, and determines whether the binding of the 
protein to the lipid bilayer is electrostatic in nature, hydrophobic, or both. In 
addition to these two structural features, which are present to a greater or lesser 
extent in all determined structures of bacterial PI-PLCs (Figure 6-2), the Bacillus 
enzymes contain an additional mode of membrane binding specific for PC. 
Mutagenesis studies (Feng et al., 2002; Feng et al., 2003) suggest a tyrosine 
strip in helix G forms an interfacial PC binding pocket. This PC binding pocket is 
consistent with the Bacillus enzymes’ significantly improved binding to these 
zwitterionic lipids. Though the complete PC binding pocket is only seen natively 
in the Bacillus proteins, there are components of it that could provide a partial 
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binding pocket in other PI-PLCs. These partial binding pockets could feasibly be 
the reasoning behind the weak binding affinity exhibited by the L. 
monocytogenes PI-PLC.  
 
6.2 S. aureus PI-PLC Mobile Loop 
  The S. aureus PI-PLC structure in particular has a further complexity than 
the other structures, wherein it exhibits a mobile loop shift dependent on pH. 
Under slightly basic conditions, the S. aureus PI-PLC structure closely follows the 
conformation of other bacterial PI-PLCs. However, when crystallized under acidic 
conditions, a section of loop consisting of 11 residues (241S-V-A-S-G-G-S-A-F-N-
S) shows signification structural perturbation.  This mobile loop shows a 
maximum backbone displacement of 9.4 Å between the acidic and basic forms of 
S. aureus PI-PLC, and its position is determined by a pH dependent π-cation 
interaction between His258 and Phe249. At pH 4.6, the cationic nitrogen on 
His258 is positioned 3.5 Å from the π-system of Phe249, which itself is 3.5 Å 
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from that of Tyr212 in a face-edge interaction. This π-cation interaction holds 
Phe249, and thus the rest of the mobile loop in a position where Phe249, the 
lone aromatic residue in the mobile loop, is unable to partition into membranes. 
At pH 7.5, His258 will be deprotonated. With the cation no longer present, the 
mobile loop reverts to the more extended loop position, ∼10 Å away, where 
His258 is 11.7 Å away from the π system of Phe249. Similarly, His258 is 4.6 Å 
from Tyr212 (Goldstein et al., 2012). See figure 6-3 for a comparison of acidic 
and basic condition loops. 
 
6.3 Surface potential 
 The surface potentials of bacterial PI-PLCs vary somewhat, dependent on 
their species of origin. The Bacillus PI-PLCs are an example of a “typical” PI-PLC 
in terms of surface potential. They have evenly distributed regions of positive and 
negative charge, with more intensely charged regions situated in the active site 
pocket, as well as around the rim of the (βα)8 barrel. The S. aureus PI-PLC 
structure shows similar surface potentials to that of the two Bacillus structures, 
however the S. aureus PI-PLC shows a generally more cationic rim loop; with an 
additional region of cationic residues directly adjacent to the active site, 
comprised of Lys133, Lys114, and Arg166. The surface potentials of the Listeria 
monocytogenes and S. antibioticus PI-PLCs, however, break the trend of the 
previous three. The surface potential of Listeria monocytogenes structure is quite 
unique. This structure shows a large (420 Å2) region of cationic charge located 
on the underside of the molecule, opposite the membrane interface. The S. 
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antibioticus structure also shows one distinctive area of intense charge, a large 
anionic patch comprised of the entirety of the active site cleft as well as much of 
the rim loop is caused by a strip of ten Glu and Asp residues bisecting the 
membrane interface side of the enzyme. The strip is abutted on two sides by 
highly cationic regions, comprised of multiple Lys or Arg residues. Electrostatic 
maps of all structures discussed can be seen in Figure 6-4.  
 
6.4 Questions Raised by S. aureus PI-PLC Biochemistry 
The PI-PLC from Staphylococcus aureus is a small but complex enzyme.  
Though only 302 amino acids in length, this PI-PLC has several structural 
features that contribute to its interesting activity. When this project began, the 
structure of S. aureus PI-PLC was unknown, however the initial biochemical 
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studies of this enzyme had raised some interesting questions.  The pH optimum 
of S. aureus PI-PLC for pure PI SUVs, ~pH 5.5, appeared to be significantly 
lower than other bacterial homologues (typically ~ pH 7). In theory, this and other 
PI-PLCs might be expected to be optimized for attacking eukaryotic membranes, 
and thus should be most active at physiological pH. The catalytic mechanism 
also uses two histidine residues as a general base and a general acid, which 
might be expected to lead to a pH optimum around 7.  Furthermore, experiments 
using mixed PI/PC vesicles showed that PC not only increased S. aureus PI-PLC 
activity, but also shifted its pH optimum from 5.5 to 6.5.  
The specific activity (S.A.) of S. aureus PI-PLC also proved to be curious. 
With no salt present in the buffer, S.A. towards substrate PI was dependent on 
enzyme concentration, implying that the enzyme was active as a higher order 
oligomer, most likely a dimer. However, in the presence of modest amounts of 
salt (140 mM), S.A. appeared to decrease to approximately 25%, and was 
unaffected by increasing the concentration of enzyme, implying that salt 
somehow precluded formation of the more active oligomeric form. Experiments 
done with mixed PI/PC vesicles showed that the addition of PC lowered the 
concentration of the enzyme needed to form the functional enzyme aggregate on 
the membrane. The mechanism behind PC rescue of dimerization (and hence 
activity) was not immediately obvious: S. aureus PI-PLC does not bind vesicles 
of pure PC, thus PC must activate this enzyme without binding to it. 
 Finally, the inability of S. aureus PI-PLC to bind PC was seen as an 
opportunity to clarify the composition of the PC binding site in the PI-PLC from B. 
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thuringiensis. A putative PC binding site at the top of helix F/G in the B. 
thuringiensis PI-PLC had previously been suggested, and the S. aureus PI-PLC 
contained some but not all the residues in that same region. If the S. aureus PI-
PLC could be mutated to create a PC binding pocket, given its amiability to 
crystallization, a structure of this mutant enzyme could indicate the location of the 
PC site on the enzyme. If this mutant S. aureus PI-PLC could bind PC, it would 
confirm the tight PC binding site in the Bacillus  PI-PLCs. 
 
6.5 pH Sensitivity and PC  
The reason for the unique pH optimum of this enzyme, pH 5.5 with 
vesicles of pure PI and pH 6.5 when XPC=0.20, was supplied by structural data 
on crystals formed at pH 4.6 and pH 7.5. Upon realizing that we had elucidated 
structures of two pH dependent isomorphs of S. aureus PI-PLC, we set about to 
determine the cause of the 10 Å shift seen in the rim loop. The structural 
changes seen between the two pH values were actually due to a pH dependent 
π-cation interaction. This was remarkable not because of its occurrence (π-
cation interactions are fairly common), but because it effected such a large 
change. π-cation interactions tend to generate small conformational changes in 
proteins. Typically, they are involved in ligand-protein binding interactions or in 
helix stabilizations. A large-scale change dependent on a pH controlled π-cation 
interaction has only been reported once previously (Eckenroth et al., 2011). With 
the cause of the loop shift determined, its effect on activity towards pure PI SUVs 
could be examined. When observing the two forms of the enzyme in space filling 
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view it can easily be seen that in the acidic form of the enzyme, Trp45 rotates to 
open up an active site channel. This channel will allow for the soluble product, 
cyclic inositol-1-phosphate, to diffuse out of the active site without the enzyme 
having to disengage from the membrane. In contrast, the basic form of this 
enzyme does not have this active site channel, forcing it to disengage from the 
membrane after each catalytic cycle.  
 The pH 6.5 optimum of S. aureus PI-PLC towards mixed PI/PC vesicles 
does make sense, biologically speaking. The PI/PC vesicles more closely mimic 
the native substrate of this enzyme, a mammalian cell membrane. Of the 
phospholipids that make up the eukaryotic membranes, PC comprises about 
40%, with another zwitterionic lipid (phosphatidylethanolamine) making up a 
further 20%, (Hauser et al., 2004) therefore a majority of the phospholipids that 
S. aureus PI-PLC will encounter in nature are zwitterionic. This enzyme is 
actively secreted as a virulence factor in S. aureus infections, which are 
commonly found to take the form of abscesses.  Upon abscess formation, local 
pH drops from 7.0 until it stabilizes at approximately 6.6 (Dye et al., 1980). Thus, 
the S. aureus PI-PLC is optimized to perform catalysis at the pH found in 
abscesses, where S. aureus infection is usually located.  
  Though the addition of at least 20% PC to the vesicle mixture does 
increase the pH optimum of this enzyme to 6.5, the mechanism by which it does 
so is not entirely clear. One possibility is the presence of PC may alter the pKa 
values for the catalytic histidine residues and possibly the pKa for the histidine in 
the intramolecular π-cation interaction as well.  However, if the quaternary amine 
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of the PC head group were competing with His258 for the π system of F249, we 
should see a shift in the pH optimum to something more like what was observed 
for the H258Y mutation in which the Phe249/His258 π-cation interaction is 
destroyed. Because this is not the case, the PC activation must, and has been 
found to be, more complex. 
 
6.6 R.S.A. Salt Dependence/Dimerization 
The specific activity of the S. aureus PI-PLC was found to be affected by 
both enzyme concentration and the presence of salt in the reaction buffer. A 
possible explanation for the increased activity of the dimer could be that the 
enzyme is performing a see-saw type catalysis. That is, in the dimeric state, 
while one monomer is performing catalysis, the other can partially disengage 
from the membrane to release product. The active monomer anchored to the 
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membrane via substrate holds the product releasing monomer in near proximity 
to the membrane, so that once soluble product is removed, it can more easily 
rebind to membrane and seek new substrate. In monomeric form, when the S. 
aureus PI-PLC disengages from the enzyme to release product, there would be  
little to keep it near the membrane surface, and it could diffuse away, thus 
lowering the enzyme specific activity  (see Figure 6-5). Thus, dimerization 
enhances processive catalysis. 
 When 140 mM salt was present in the reaction buffer, the specific activity 
of the enzyme decreased to approximately 25% of the original value, and was 
unaffected by increasing enzyme concentration. These two trends point to an 
equilibrium between a more active dimeric state and a less active monomeric 
state, where the addition of salt forces the enzyme to the monomeric state. 
Interestingly, the addition of PC to the vesicles restores high specific activity, 
negating the salt effect and tipping the equilibrium back toward the dimeric state 
(Figure 6-6). The mechanism behind this equilibrium and how salt and PC affect 
it can be explained with observation of the anion binding pocket on the protein. 
When the anion binding pocket is occupied, either by an anion of inorganic salt 
(Cl-, SO4-2, etc.) or the phosphate of a phospholipid, the dimer interface is 
perturbed, and a dimer cannot form.  However, when PC is included in the 
vesicles, the zwitterionic lipid either interacts with the bound anion, pulling it out 
of the pocket, or dilutes the anionic lipid content of the vesicle, making it less 
likely for an anion to occupy the anion binding pocket, and more likely for the 
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enzyme to dimerize.  Thus, while PC promotes dimer formation, it does so in a 
way without directly binding to the enzyme.  
In theory, the S. aureus PI-PLC could operate at peak efficiency at a 
membrane composition which contained enough anionic lipid to allow the 
  
efficient binding of the enzyme to the membrane, but enough zwitterionic lipid to 
prevent occupation of the anion binding pocket, thus creating conditions optimal 
for both binding and dimerization. 
PC affects S. aureus PI-PLC by two different mechanisms. PC causes a 
shift in the pH optimum of the enzyme. Both WT and H258Y enzymes show a 
more basic pH optimum with PC present (Figure 6-7). That the shift to a more 
basic pH is larger for H258Y, suggests that in the activated form the 
intramolecular π-cation still plays a role – again perhaps by enhancing soluble 
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product release under conditions where the protein is anchored to the 
membrane.  
 
While the mechanism of pH shift by PC is not fully understood, the 
mechanism of activation of the S. aureus PI-PLC by PC has now been 
elucidated. The presence of PC in the bilayer can alter the equilibrium between 
the less active monomer and the more active dimeric form of S. aureus PI-PLC in 
favor of the dimer form, by preventing anions from binding to the enzyme and 
preventing dimerization.  
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6.7 Dimerization of Bacterial PI-PLCs  
With the notable exception of S. aureus, all native bacterial PI-PLCs are 
likely monomeric in vivo. Though the structures for B. thuringiensis PI-PLC have 
all crystallized as dimers, this is likely the result of the mutations made to these 
proteins; the structures for 2OR2, 3EA1, 3EA2, and 3EA3 all show the site of 
mutagenesis to be directly involved in the dimer interface (Shi et al., 2009; Shao 
et al., 2007). The only exception to this is the structure of B. thuringiensis 1T6M, 
which is likely a crystallographic dimer only. PISA analysis of the 1T6M structure 
shows an overall energy gain of 2.7 kcal/mol upon complexation, and shows a 
complex formation significance score of 0.00, indicative of a dimer that is a result 
of crystal packing only (Apioyo et al., 2005; Krissinel and Hendrick, 2007). A 
model of native Bacillus PI-PLC dimerization has been proposed, wherein the 
dimer is formed after partitioning of Trp47 and Trp242 into a PC membrane. 
Upon movement of these two Trp residues into the membrane, steric hindrance 
to the proposed site of dimerization (the strip of 4 tyrosines which comprise the 
interfacial PC binding pocket) is removed, allowing for dimerization of the protein 
(Shao et al., 2007). However, the possibility that dimer formation in this case is 
driven by mutation cannot be discounted, as the dimer interface is directly formed 
by the W47A/W242A mutation. Furthermore, the occlusion of the interfacial 
binding pocket is troublesome. If dimerization of the native Bacillus PI-PLC 
precluded the binding of PC, the strong PC activation exhibited by this enzyme 
would seem unlikely. Indeed, studies on this mutant found minimal activity 
 135 
towards cIP, dramatically reduced PI cleavage, and virtually no binding to PC 
interfaces, vesicles, or micelles (Shao et al., 2007). 
While the native Bacillus enzymes are likely monomeric in vivo, native S. 
aureus PI-PLC most likely dimerize, at least transiently. A recent crystal structure 
of this enzyme shows a dimer, with interface along helix B. Kinetic evidence 
shows increased enzyme specific activity with increasing enzyme concentration, 
which strongly suggests that the optimally active form of the enzyme is a dimer. 
A mechanism for dimerization has been proposed wherein an equilibrium 
between dimerization and occupation of a highly electropositive anion binding 
pocket, (unique to S. aureus PI-PLC) which sits just  below the rim of the βα 
barrel. This anion binding pocket is occupied by anionic ligands in every S. 
aureus structure except the dimer structure, where occupation of the pocket 
would preclude dimer formation. Mutagenesis of the key interface residue Y253S, 
shows a significant decrease in activity under all conditions, and almost no 
sensitivity towards PC. It has therefore been proposed that PC activates native S. 
aureus PI-PLC, not by specific binding interactions, but by lowering the interfacial 
anionic lipid concentration and emptying the anion binding pocket, facilitating 
dimer formation (Cheng et al., 2012). Figure shows 2-10 for an overview of PC 
activation in bacterial PI-PLCs. 
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6.8 S. aureus PI-PLC as a B. thuringiensis PI-PLC mimic: how PC activation 
works in B. thuringiensis PI-PLC 
At the outset of my work, the location for a tight PC binding site in the B. 
thuringiensis PI-PLC had been proposed. The strip of four tyrosine residues on 
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top of helix G (Tyr246, Tyr247, Tyr248, Tyr251) appeared critical for this binding 
and the site was suggested to involve tyrosine π – PC choline cation interactions. 
However, which of these tyrosines and how particular tyrosine residues were 
arranged were not known. With the determination of the S. aureus PI-PLC 
structures and its affinity for different vesicles, it became clear that this enzyme 
could be used to explore what constitutes a tight PC binding site in the B. 
thuringiensis enzyme.  The S. aureus PI-PLC secondary structural elements line 
up perfectly with those of the B. thuringiensis PI-PLC with only small differences 
in loops. Most importantly, the native S. aureus enzyme has virtually no affinity 
for PC bilayers, although it has two of the helix G tyrosine residues are already in 
place. Finally, the S. aureus PI-PLC crystallizes readily, forming large crystals 
that diffract to high resolution, so that if improved binding can be engineered, an 
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atomic level structure of PC binding might be obtained. 
With the two added tyrosines, S. aureus PI-PLC N254Y/H258Y exhibits a 
dramatically enhanced affinity for PC. Furthermore, the crystallographic analyses 
showed that a PC binding site had indeed been introduced into the S. aureus PI-
PLC, and that the tyrosine residues believed to be important for binding PC did in 
fact form π-cation interactions with the water-soluble cationic choline. (Figure 6-
9).  
  Comparison of the choline bound structure of S. aureus N254Y/H258Y 
PI-PLC with the B. thuringiensis PI-PLC structure (1T6M), this particular structure 
picked because it is the only structure of B. thuringiensis deposited which has no 
mutants proximal to the proposed PC binding site, shows that the four tyrosines 
thought to be important for PC binding lie clustered around a choline residue 
(defining choline site 1). Furthermore, an additional residue (Tyr204), not 
previously known to be important to PC binding, is clearly crucial to choline 
binding. 
 The choline site 1 in the mutant S. aureus enzyme overlays exactly with 
that of the native B. thuringiensis enzyme in the absence of any PC. However, 
there is a second PC site in the S. aureus PI-PLC N254Y/H258Y that does not 
exist in the Bacillus proteins. Therefore, native B. thuringiensis PI-PLC must bind 
PC tightly by complexing the trimethylammonium moiety in choline site 1. With 
this PC site identified, the mechanism of PC activation in mutant S. aureus PI-
PLC and native B. thuringiensis PI-PLC can be proposed. 
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 The PC binding pocket(s) are located near the rim of the βα barrel of S. 
aureus PI-PLC N254Y/H258Y and could act as anchor points, binding the 
enzyme more securely to the membrane (Figure 6-10). This model is extended to 
the Bacillus enzyme by modeling a diC7PC on top of a choline docked in the 
native B. thuringiensis PI-PLC. The activating PC clearly anchors the enzyme to 
membrane (Figure 6-11).  
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6.9 Future Directions for this Project 
 The successful introduction of a zwitterionic lipid binding site in a second 
related peripheral membrane protein that initially has very low affinity for such 
lipids, suggests several other experiments. Based on the geometry of π-cation 
interactions with both choline and diC4PC, we could install a PC binding site on 
any soluble protein with two parallel helices that are approximately 10 Å apart. A 
PC binding site could even be installed as a membrane binding module on a 
fusion protein, thus, using this technology we could potentially make any protein 
bind to a eukaryotic membrane. A PC binding motif could be attached to a drug 
or marker carrying bio-capsule able to deliver its payload directly to cell 
membranes. Since most eukaryotic cells have an abundance of PC and 
shphingomyelin in their outer leaflet, this should label many different types of 
cells. Specificity could be achieved by the protein cargo. Somewhat 
nondiscriminate labeling could label different cell types with fluorophores that 
could be used to track cells and monitor turnover of cells, internalization, etc. 
 As proof of concept, the next stage of this project could be the generation 
of a PC binding site in phosphoribosyl isomerase A (PriA) from Streptomyces 
coelicolor. The structure of this dual substrate isomerase, involved in both 
histidine and tryptophan biosynthesis, was recently were solved at 1.8 Å 
resolution (Wright et al., 2007). This enzyme is an ideal test case for this 
technology, since it is a highly regular (βα)8 barrel with  parallel helices which are 
10 Å apart, and it crystallizes as a monomer. Most importantly, this enzyme is 
completely soluble, and does not interact with membranes in any way. In order to 
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generate a PC binding site in PriA, four mutations would need to be introduced: 
L35Y, A65Y, L66Y, and E69Y (Figure 6-12). This mutant should create the 
tyrosine box needed to bind the trimethylammonium group of the PC head group. 
Progress is currently being undertaken to obtain a plasmid of this enzyme. 
 
 
6.10 Bacterial PI-PLCs 
 Much progress has been made recently in the field of bacterial PI-PLCs, 
although in-depth studies have been published on only a handful of the more 
than 45 species of bacterial PI-PLC known. Bacterial PI-PLCs target PI and GPI 
anchored proteins, with a few varieties showing preference for one target only. 
While most bacterial PI-PLCs are extracellular virulence factors, attacking the 
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outer leaflet of the plasma membrane, the L. monocytogenes PI-PLC acts in an 
intracellular manner. Due to L. monocytogenes’ unique mode of infection, this PI-
PLC cleaves PI on the cytoplasmic side of the cell membrane. Furthermore, all 
bacterial PI-PLCs show kinetic activation by the nonsubstrate lipid PC, though 
the microscopic causes of this activation vary by species: the Bacillus proteins 
have distinct interfacial PC binding pockets, the S. aureus PI-PLC uses PC to 
bias towards its more active dimer conformation, and L. monocytogenes uses PC 
to prevent inactive enzyme/lipid aggregates from forming. Bacterial PI-PLCs are 
of particular interest because they perform the same catalysis as the significantly 
larger eukaryotic PI-PLCs. The catalytic domains of eukaryotic PI-PLCs share 
not only the same mechanism as the bacterial PI-PLCs, they share a structural 
motif (the distorted (βα)8 barrel) and structures of these domains are easily 
superimposable. Indeed bacterial PI-PLCs appear to have evolved for maximum 
efficiency as a virulence factor, due to their simpler structure they require less of 
a metabolic investment on the part of the organism that the eukaryotic PI-PLC. 
The bacterial enzymes target eukaryotic cells and are activated by PC, a major 
component of eukaryotic plasma membranes, and perform efficient catalysis of 
their target PI or GPI anchored proteins. 
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Table 6-1. Listing of all structures of bacterial PI-PLCs in the PDB as of 
publication time. PDB ID and mutation are noted. 
 
Organism of Origin PDB ID Mutation Oligomer State 
B. cereus 1GYM Native Monomer 
B. cereus 1PTD Native Monomer 
B. cereus 1PTG Native Monomer 
B. cereus 2PTD D198E Monomer 
B. cereus 3PTD D274S Monomer 
B. cereus 4PTD D274N Monomer 
B. cereus 5PTD H32A Monomer 
B. cereus 6PTD H32L Monomer 
B. cereus 7PTD R163K Monomer 
B. thuringiensis 1T6M R70D Crystallographic Dimer 
B. thuringiensis 2OR2 W47A/W242A Crystallographic Dimer 
B. thuringiensis 3EA1 Y247S/Y251S Crystallographic Dimer 
B. thuringiensis 3EA2 Y247S/Y251S Crystallographic Dimer 
B. thuringiensis 3EA3 Y246S/Y247S/
Y248S/Y251S 
Crystallographic Dimer 
L. monocytogenes 1AOD Native Monomer 
L. monocytogenes 2PLC Native Monomer 
S. antibioticus 3H3X Native Monomer 
S. antibioticus 3H4W Native Monomer 
S. aureus  N254Y/H258Y Monomer 
S. aureus  N254Y/H258Y Monomer 
S. aureus  N254Y/H258Y Monomer 
S. aureus 2F2B Native Dimer 
S. aureus 2F2T Y253S Monomer 
S. aureus 3V16 Native Monomer 
S. aureus 3V18 Native Monomer 
S. aureus 3V1H H258Y Monomer 
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Chapter 7; Compatible solute stabilization of AF2373, a moderately stable 
inositol monophosphatase in Archaeoglobus fulgidus 
Note: The work discussed in this chapter was collaborative project with Yang 
Wei. All protein in this chapter was produced and purified by Y. Wei. Additionally, 
all enzymatic assays and effects of solutes on the thermostability of AF2372 
were carried out by Y. Wei. Crystallizations, x-ray diffraction data collection, 
structure solution and interpretation were done by R. Goldstein 
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7.1 Introduction - AF2372 structure and function 
AF2372 is the dual action inositol monophosphatase (IMPase)/ fructose 
bisphosphatase (FBPase) from A. fulgidus, and was the second IMPase/FBPase 
to be structurally characterized.   AF2327 forms an obligate dimer with a large, 
hydrophobic interface.  Each monomer consists of an α-β-α structure organized 
in two domains of alternating layers of α-helices and β-sheets connected by 
variable length loops. An additional key feature of this enzyme is the mobile 
catalytic loop (Asp32 to Lys43) that guards the mouth of the active site and is 
stabilized in the presence of metal ions and ligands (Stieglitz et al., 2002).  
AF2372 dephosphorylates both inositol monophosphate (I-1-P) and 
fructose-1,6-bisphosphate (Stec et al., 2000). This enzyme employs a three 
divalent metal ion assisted mechanism, and in contrast the mammalian IMPases, 
the archaeal IMPases (A2372F as well as MJ0109, a similar IMPase/FBPase 
from Methanococcus jannaschi) are not inhibited by Li+ cations (Stieglitz et al., 
2002; Stec et al., 2000; Johnson et al., 2001).  AF2372 is the last step (Figure 7-
1) in the biosynthetic pathway of di-myo-inositol 1,1-phosphate (DIP), an 
osmolyte produced by A. fulgidus in response to supraoptimal temperatures and 
levels of salinity (Lamosa et al., 2000; Martins et al., 1996; Chen et al., 1998). 
Although this archaeon thrives at temperatures up to ~90oC, AF2372 is not 
sufficiently stable under these extreme conditions. It irreversibly loses significant 
secondary structure and enzymatic activity as that temperature is approached, 
with a midpoint temperature for unfolding (Tm) of 89 ˚C. However, the protein can 
be significantly protected from thermal denaturation by the addition of submolar  
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concentrations of certain osmolytes (Yang Wei, unpublished results). These 
small, charged, organic molecules are synthesized by A. fulgidus in sufficient 
concentrations to preserve almost 100% of AF2372 activity after heat treatment 
at 90 ˚C for 30 min. A. fulgidus produces two major phosphodiester osmolytes in 
response to osmotic stress and increased temperature; di-myo-inositol 1,1’-
phosphate (DIP) and α-diglycerol phosphate (DGP). DIP and DGP are both 
excellent thermoprotectants (Lentzen and Schwarz, 2006), and DGP in particular 
has been shown to exert a large thermostabilizing effect on not only A. fulgidus 
proteins, but also proteins from eukaryotes (Lamosa et al., 2000). In addition to 
the two major osmolytes, the amino acids aspartate and glutamate can also 
function as osmolytes, though greater concentrations of amino acids are needed 
to effect the same levels protection afforded by DGP and DIP. 
 The mechanism by which osmolytes provide thermoprotection is not clear. 
Several theories have been proposed: Osmolytes likely push the folded/unfolded 
equilibrium towards the folded state, though how precisely they do this is a 
matter of some debate (Aioanei et al., 2011). One proposed mechanism 
postulates that peptide backbone/osmolyte interactions raise the free energy of 
the denatured state such that it is higher than that of the folded protein, creating 
a net stabilizing effect in the presence of osmolytes (Faria et al., 2004). Alternate 
theories suggest that osmolytes can bind to the protein specifically in its 
unfolding transition state and push the equilibrium towards the folded state 
(Street et al., 2006; Garcia-Manyes et al., 2009; Yiu et al., 2000). Examination of 
the thermoprotective properties of DGP, aspartate (Asp), and glutamate (Glu) 
 148 
towards AF2372 by kinetic and crystallographic studies could serve to further 
elucidate the mechanism of osmolyte derived thermoprotection. 
7.2 AF2372 Experimental Procedures 
Note: The work discussed in this chapter was collaborative project with Yang 
Wei. All AF2372 protein was produced and purified by Y. Wei. Additionally, all 
enzymatic assays and effects of solutes on the thermostability of AF2372 were 
carried out by Y. Wei. Crystallizations, x-ray diffraction data collection, structure 
solution and interpretation were done by R. Goldstein 
 
Overexpression and Purification of IMPase wild type and mutants 
The overexpression and purification of wild type IMPase/FBPase AF2372 
was accomplished as described previously (Wang et al., 2006).  The wild type 
protein was expressed in E. coli BL21condon plu-RIL competent cells 
(Stratagene). After 20 h overexpression at 16°C, the cells were harvested and 
sonicated in 50 mM Tris, 1 mM EDTA (pH 8.0). The supernatant was heated at 
85 °C for 30 min to denature E. coli proteins, which were then pelleted by 
centrifugation. After centrifugation, the supernatant was dialyzed overnight 
against 4L of 50 mM Tris and 1 EDTA. The protein was purified by Sepharose 
QFF ion exchange column (GE Healthcare) with 0 to 0.5 M KCl gradient. The 
>90% pure protein fractions, monitored by SDS-PAGE, were collected and 
dialyzed twice against 4 L of 50 mM Tris, 1 mM EDTA, then concentrated to 
around 10 mg/ml as measured by the Lowry assay. 
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The plasmids containing the genes for IMPase mutants (R18A, R29A, 
R92Q, K164E, R11A/R18A, R92Q/K164E, R11A/R18A/R92Q/K164E) were 
constructed with the site directed mutagenesis kit (Stratagene) following the 
manufacturer protocol. The plasmids containing the designated mutants were 
confirmed by DNA sequencing (Genewiz). The overexpression and purification of 
mutant proteins was performed as per the wild type protein, with a slight the 
modification of  the E. coli protein denaturation step, where denaturation 
temperatures were dropped to 65°C for the R11A/R18A and 
R11A/R18A/R92Q/K164E mutants, and to 75°C for all other mutants. 
 
Circular Dichroism  
The CD spectra of AF2372 wild type and mutant proteins were recorded at 
25 °C in a 1 cm path length quartz cuvette, with 0.4 mg/ml protein in 10 mM 
borate buffer (pH 8.0). The Tm of wild type and mutant proteins were monitored 
by measuring the ellipticity of the proteins at 222 nm over a temperature range of 
30 to 99 °C. 
 
Thermoprotection Assays.  
The activity of wild type AF2372 was measured at 85 °C by colorimetric 
malachite green assay as reported previously (Wang et al., 2006). Typically, 0.2 
µg of protein was added to 50 µL of a solution consisting of 0.5 mM D-I-1-P, 50 
mM Tris, 1 mM EDTA and 5 mM MgCl2. This mixture was incubated at 85 °C for 
5 min and then immediately placed in an ice bath to cool to room temperature. 1 
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ml of Malachite green reagent was then added, and the absorbance at 660 nm 
was measured. The concentration of the resulting product, inorganic phosphate, 
was calculated from the standard curve using a KH2PO4 standard.  
 
Osmolyte thermoprotection assays 
9.6 µg of wild type AF2372 (the amount selected to generate 5%-20% 
substrate hydrolysis) was combined with either 0, 0.05, 0.1, 0.3 or 0.5 M solutes 
(KCl, K+-Glu, Na+-Glu, K+-Asp, Na+-Asp, proline and betaine) in a solution of 50 
mM Tris (pH 8.0), and was incubated at 90°C in PCR amplifier (GeneAMP PCR 
System 9700, PE Applied BIosystems) for 30 min. After heating, an aliquot of the 
protein/solute solution was used to measure the residual activity as compared to 
untreated wild type protein. Simultaneously, another aliquot of the designated 
solute was mixed with unheated wild type AF2372, to measure the control activity 
as previously described.  
The thermoprotecting abilities of additional dicarboxylate salts were also 
examined. Wild type AF2372 (7.6 µg) was mixed with either 0.3 M tartrate, 
succinate, methylsuccinate, maleate, fumarate or isocitrate (all sodium salts) in 
50 mM Tris (pH 8.0) and incubated at 90°C for 30 min. The residual activity was 
then measured at 85°C using 0.5 mM D-I-1-P as the substrate. 
Mutant AF2372 activity and residual activity after heating were measured 
using the same methodology with only minor changes. The activity and residual 
activity after heating of R11A/R18A and the tetra-mutant 
(R11A/R18A/R92Q/K164E) were measured at 55°C with 0.5 mM FBP as the 
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substrate.  R11A/R18A was heated at 73°C for 30 min, and 
R11A/R18A/R92Q/K164E was heated at 71°C for 30 min. The activity and 
residual activity after heating of R18A and R29A were measured at 75°C using 
0.5 mM D-I-1-P as the substrate. R18A was heated at 87°C for 26 min, and R29A 
at 85°C for 30 min. The enzymatic activity of R92Q and R92Q/K164E were 
measured at 65°C with 0.5 mM D-I-1-P as a substrate. R92Q was heated at 80°C 
for 26 min and R92Q/K164E was heated at 77°C for 25 min. 
 
DGP Thermoprotection of IMPase Activity   
The activity of wild type AF2372 toward pNPP substrate was measured by 
the addition of 2 µg of wild type IMPase/FBPase to a solution of 0.5 mM pNPP in 
50 mM Tris, 1 mM EDTA, and 5 mM MgCl2. The reaction was incubated at 85°C 
for 5 min before being cooled on ice. After returning to room temperature, 1 ml of 
3 M NaOH was added to stop the reaction. The absorbance of the solution was 
recorded at 405 nm, and was used to calculate the concentration of the resulting 
p-nitrophenylate ( ε=1.78X104M-1 cm-1). 
 
Crystallography   
Purified protein was concentrated to 10 mg/mL and combined with myo-
inositol and appropriate osmolyte solution, before being diluted to reach a final 
concentration of 4 mg/mL protein, with 100 mM myo-inositol, and either 0.025 or 
0.4 M osmolyte. After gentle mixing, the co-crystallization solution was incubated 
on ice for a minimum of 2 hours. Crystallization mixtures are listed in table 7-1 
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below. All samples were crystallized at 20˚C by vapor diffusion, using hanging 
drops of 3 µL, at a final protein concentration of 4 mg/mL. Suitable crystals were 
cryoprotected with either glycerol or isopropanol, mounted in nylon loops, and 
frozen in liquid nitrogen.  
Before setup of the AF2372/DGP mixtures in crystallization media, the 
protein was incubated with 0.20 M DGP at 87˚C for 2 min. The protein was 
allowed to cool slowly to room temperature over the course of 2 h before 
proceeding further. Heating the protein to just below its melting temperature 
allows this enzyme, extremely rigid at both 25 and 4 ˚C, to gain the flexibility 
required to allow large molecules to diffuse into its active site. In crystals set up 
without heat treatment, only small molecules were seen in the active site (PO4-3, 
SO4-2, Asp, Mg+2) while larger molecules (Glu, DGP, inositol) were unable to 
diffuse in. Gentle (relative to AF2372) heat treatment provides the enzyme with 
the flexibility needed to accommodate these larger molecules, if they have an 
affinity for the active site. 
Crystals of AF2372 with 0.025 M Glu or 0.20 M DGP, R92Q/K164E (in the 
absence and presence of 0.40 M Glu), and R29A with 0.40 M Asp were of 
sufficient size for data to be collected on the in-house diffractometer at Boston 
College; a Rigaku MicroMax-07 HF high intensity microfocus rotating Cu anode 
X-ray generator, coupled with Osmic VariMax Optics and a R- Axis IV++ image 
plate area detector, at 100K. Data for the crystals of AF2372 with 0.40 M Glu 
were collected at Argonne National Laboratory on the 23ID-D beam line. In all 
cases, data were indexed and reduced using HKL2000 (Otwinowski and Minor, 
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1997). Structures were solved by molecular replacement and refined in PHENIX 
(Adams et al., 2010), using the published structure of AF2372, 1LBV (Stieglitz et 
al,. 2002), to solve the initial structure (WT + 0.40 Glu) and that structure to solve 
subsequent structures, manual model building was done using COOT (Emsley 
and Cowtan, 2004). Ligands were generated in sketcher from CCP4 (CCP4, 
1994) and ligand restraints were generated using Ready.Set in PHENIX (Adams 
et al., 2010). Structural comparisons were made using SSM superposition 
(Krissinel and Henrick, 2003)) in COOT and alignment in Pymol. Procheck 
(Laskowski et al., 1993) was used for structure validation, and Adit (Yang et al., 
2004) for deposition into the PDB. 
 
7.3 Osmolyte induced thermoprotection 
Effect of known osmoytes 
DGP and DIP are the two major osmolytes produced by A. fulgidus, 
although Glu and Asp are also accumulated in these cells, and could contribute 
to osmotic balance and thermoprotection of proteins. To determine if DGP, Asp, 
Glu and other common osmolytes had any thermoprotective effect on AF2372, 
the residual activity of the protein after heat treatment in the presences of each of 
the solutes at various concentrations was measured (Figure 7-2).  After heating 
for 30 minutes at 90°C, the activity (assayed at 85°C) of the heat-treated protein 
was found to be 25% of that of the untreated protein.  
Protein that was heated in the presence of osmolyte showed that 
enzymatic activity was protected by the solutes, with the extent of protection  
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dependent on the identity and concentration of the osmolyte (Figure 7-2). It 
quickly became apparent that proline and betaine, common osmolytes found in 
many bacteria (Whatmore et al., 1990), showed little thermoprotecting effect at 
low and moderate concentrations. In concentrations less than 0.5 M, these two 
solutes preserved 50% of AF2372 enzymatic activity, when compared to the 
untreated protein. KCl showed similar low levels of protection (although KCl was 
slightly more effective than the two zwitterionic solutes). Better thermoprotection 
was provided by K+-Glu, Na+-Glu, K+-Asp and Na+-Asp; results showed the 
identity of the associated cation to be irrelevant, and both dicarboxylates 
exhibited almost identical protection profiles. Concentrations of these 
dicarboxylate osmolytes as low as 0.05 M increased AF2372 residual activity 
from 25-30% to 40-50%. When concentrations of these two osmolytes were 
increased to 0.5 M, the activity of heated protein was nearly completely 
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preserved (at least 92% of relative activity compared to the untreated protein, 
where residual activity was 25%). 
DGP, another an anionic osmolyte, is specifically synthesized and 
accumulated by A. fulgidus in response to salt and heat stress (Lentzen and 
Schwarz, 2006). This phosphodiester was found to be an efficient inhibitor of 
AF2372 enzymatic activity. As little as 0.4 mM DGP with 1 mM substrate I-1-P 
reduced AF2372 to 70% of its original activity. Increasing the concentration of 
DGP to 10 mM left only 5% residual AF2372 activity. 
DGP is of particular interest because of its effectiveness in protecting 
AF2372 from thermal denaturation, even after heating at 90oC for 30 min (Figure  
7-3). The addition of only 10 mM DGP can preserve 85% of enzyme activity. 
These measurements indicate that DGP is 30 times more efficient a 
thermoprotectant than the dicarboxylate osmolytes, with 0.010 M DGP as 
effective as 0.30 M Glu. When concentrations of DGP are increased to 0.10 M, 
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AF2372 is completely protected from thermal denaturation.  
One might suppose that DGP mimics DIP, the osmolyte to whose 
biosynthetic pathway AF2372 belongs. DIP also thermoprotects AF2372, (Longo 
et al., 2009) preserving 11% of enzymatic activity when heated to 95 ˚C for 15 
min, at concentrations of 0.1 M (differences in assays and methodology [heating 
temperature; these experiments had a baseline of 3% residual activity vs. 25% 
when the protein is heated to 90 ˚C] skew these numbers, potassium glutamate 
was also tested in the high temperature assay, 
and was found to be less effective than DIP). 
DIP is structurally similar to I-1-P, (an AF2372 
substrate, and product of the DIPP 
dephosphorylation reaction) and thus its 
thermoprotection is likely derived from binding 
to the active site, though DIP binds more 
weakly than DGP. DGP can be thought of as a 
simplified version of DIP, one where each of the 
inositol rings is cut in half (Figure 7-4 shows a comparison of these molecules).  
DGP is a competitive inhibitor of AF2372, and with its smaller structure, is likely 
to bind in the active site much tighter than DIP, where the second inositol ring 
would likely prove to be sterically hindering. With its ability to bind tightly to the 
active site of AF2372, DGP is a more potent inhibitor than DIP, and the weakly 
inhibiting  (~90% activity remains with 0.01 M Glu) dicarboxylate osmolytes.  
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Thermoprotection by dicarboxylate solutes 
To determine if the mechanism of Glu and Asp thermoprotection of 
AF2372 was dependent on the presence of two carboxylate groups, the 
protective effects of several other dicarboxylates were tested (Figure 7-5).   
 
Tartrate, succinate, methyl-succinate, maleate, fumarate and the tricarboxylate 
isocitrate were examined at 0.3 M. Interestingly, all the dicarboxylate molecules 
showed significant thermoprotection, while the tricarboxylate isocitrate did not 
(Figure 7-6).  
In contrast to DGP, the addition of isocitrate and the dicarboxylates led to 
significantly less inhibition of the enzyme activity. The addition of 0.13 M of  
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isocitrate decreased AF2372 enzymatic activity by 30%, while addition of 0.02 M 
of any of the dicarboxylate solutes to assays decreased activity by ~20%. That 
there is some inhibition suggests that these molecules may also bind weakly to 
the active site of AF2372. As shown in Figure 7-6, the dicarboxylate solutes do 
provide adequate thermoprotection of AF2372 at higher concentrations. If DGP 
protects AF2372 from thermal denaturation by binding to the active site, either 
the binding of the dicarboxylates is weaker or they lead to thermoprotection by a 
different mechanism. Monitoring specific solute binding at high solute 
concentrations (needed for weak binding) is non-trivial for this system. These 
solutes have no chromophores, and the enzyme lacks any tryptophans, making 
use of intrinsic fluorescence difficult. The addition of extrinsic chromophores is a 
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possibility, however, this could alter the thermal behavior of the protein. In order 
to determine if there are specific interactions of the protein with osmolytes, other 
methods must be used. 
 
7.4 AF2372 Structures with osmolytes 
 AF2372 crystallizes readily, and structures of the protein in the absence 
and presence of thermoprotective solutes might provide insights as to the 
existence of specific binding sites for these solutes. Eight different structures of 
AF2372 were solved to examine if there were specific binding sites on the protein 
for osmolytes on the protein. These structures include the native AF2372 protein 
co-crystallized with 0.025 M and 0.40 M potassium glutamate, with 0.025 M and 
0.40 M sodium aspartate, and with 0.20 M DGP. Structures of the R92Q/K164E 
mutant protein were obtained in the absence and presence of 0.40 M glutamate. 
The structure for the R29A mutant co-crystallized with 0.40 M aspartate was also 
obtained.  
 All eight structures were crystallized in the P32 space group, with roughly 
the same unit cell; b=89.7 Å and c=101.9 Å. Data for the wild type structure co-
crystallized with 0.025 M Glu were collected to 2.7 Å and refined to a final R 
value of 0.191 (Rfree=0.238).  For the native protein co-crystallized with 0.40 M 
Glu, data were collected to 2.0 Å and refined to a final R value of 0.162 
(Rfree=0.172). For the native structure co-crystallized with 0.025 M Asp, data were 
collected to 2.30 Å and refined to a final R value of 0.169 (Rfree=0.197). Data for 
native AF2372 co-crystallized with 0.40 M Asp were collected to 2.7 Å and 
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refined to a final R value of 0.181 (Rfree=0.225). Data for the native structure co-
crystallized with 0.20 M DGP were collected at 2.69 Å and refined to a final R 
value of 0.174 (Rfree=0.213). Data for the R92Q/K164E mutant structure in the 
absence of osmolytes were collected at 2.7 Å and refined to a final R value of 
0.198 (Rfree=0.247). Data for R92Q/K164E mutant structure co-crystallized with 
0.40 M Glu were collected to 2.5 Å and refined to a final R value of 0.159 
(Rfree=0.201). Finally, data for the R29A mutant structure co-crystallized with 0.40 
M Asp were collected to 2.6 Å and refined to a final R value of 0.173 
(Rfree=0.222). Additional crystallographic information is presented in Table 7-2. 
 
Non-osmolyte ligands in all AF2372  
 All eight AF2372 structures (five with native protein, two with R92Q/K164E 
as well as the R29A mutant) contain ions in both active sites. All structures 
contain at least one magnesium ion, and at least one tetrahedral anion, (usually 
a sulfate) in conserved sites (Stieglitz et al., 2002). A full list of bound ligands is 
given in Table 7-3. The higher occupancy anion binding site corresponds to the 
phosphate site of I-1-P, while the lower occupancy anion binding site 
corresponds with aspartate binding site 5. 
Table 7-3. Non-osmolyte ligands found in the active sites of each structure of 
AF2372. 
Ions WT 
+0.4 M 
Glu 
WT 
+0.025
M Glu 
WT 
+0.4 M 
Asp 
WT 
+0.025
M Asp 
WT 
+0.2 M 
DGP 
R92Q/K
164E 
R92Q/K
164E + 
0.4 Glu 
R29A 
+0.4 M 
Asp 
Mg+2 2 2 1 2 3 2 2 3 
SO4-2 2 2 1 1 - 1 2 2 
Other 1 
glycerol 
- - 1 Ins 1 HPO4-
2 
1 
isoprop
anol; 1 
glycerol 
1 
glycerol 
- 
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Displacement of the phosphate ions (more reasonable ligands for the IMPase in 
cells) by sulfate ions is likely due to the high concentrations (>0.20 M) of sulfate 
in the crystallization media. Phosphate rather than sulfate is seen in the 0.20 M 
DGP structure due high levels of phosphate left from the synthesis of DGP. 
 
Structure of AF2372 with 0.40 M Glu  
The structure of AF2372 crystallized with 0.40 M Glu contains eight total 
glutamate ligands, four per monomer, each in positions conserved between the 
two monomers (Figure 7-7). All glutamate ligands form ionic bonds directly to 
cationic residues, as well as forming extensive hydrogen bonding networks with 
solvent molecules.  Two glutamates in each monomer might be suggested to 
provide thermoprotection, based on their extensive involvement in the hydrogen 
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bonding network located in the dimer interface.  
The two Glu sites that are well coordinated by protein residues, Glu1 and 
Glu2, are expected to have a high affinity for Glu molecules. Glu1 (yellow) is 
situated in a cationic pocket between Arg11 and Arg18 and creates an ionic bond 
between the guanidinium group of Arg18 and the α-carboxylate of the ligand. 
Both Glu1 carboxylates also hydrogen bond to the hydroxyl group of Tyr118, 
while the α-amino group hydrogen bonds to the backbone carbonyl of Arg11. 
Additionally, the γ-carboxylate of Glu1 forms a hydrogen bond with the 
guanidinium group of Arg11. Figure 7-8A shows an expanded view of the Glu1 
binding site.  
 
Glu2 (blue) is also highly coordinated by protein residues. It sits in a 
pocket of cationic residues at the top of dimer interface, a region adjacent to the 
active site mouth. Each Glu2 forms ionic bonds with both monomers, Glu2 in 
chain A forms an ionic bonds with residues from chain A: a direct interaction with 
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to Arg92, and water mediated bonds with Lys43 and Asp32.  Glu2 from chain A 
also forms hydrogen bonds with residues from chain B: a direct interaction with 
the side chain nitrogens of Asn151, Arg165 and Lys164 (Figure 7-8B). 
  
 The other two Glu sites per monomer sit in the dimer interface, and all four 
are connected through a highly complex hydrogen bonding network (Figure 7-9). 
Glu4 (red) in each monomer is anchored to Arg18, with the α-carboxylate of Glu4 
binding to the guanidinium of Arg18, as well as forming a water mediated 
hydrogen bond to the hydroxyl of Tyr97. Additionally, the α-carboxylate of Glu4 
shows a water mediated hydrogen bond to Try118, and two additional 
interactions with Ala121 and Thr122.  Glu4 also forms a water mediated 
hydrogen bond to Glu3 (green). Glu3, in turn, is involved in a water mediated 
hydrogen bond to the backbone carbonyl of Ala121. The α-carboxylate of Glu3 
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also forms an ionic bond with the guanidinium head group of Arg29 as well as a 
hydrogen bond with the hydroxyl group of Tyr97. Finally, the Glu3 ligands in each 
monomer also form a hydrogen bond with each other, with the γ-carboxylates 
forming a hydrogen bond with the α-carboxylate from the opposing monomer 
bound Glu3. 
 
Structure of AF2372 with 0.025 M Glu  
The structure of AF2372 in the presence a much lower concentration of 
Glu contains only four glutamates, two per monomer, as well as one molecule of 
PEG, introduced from crystallization media. In each monomer of AF2372, the 
glutamates occupy the sites of Glu1 and Glu2 that are seen in the 0.40 M Glu 
structure. Interactions with the protein are essentially the same, prompting the 
decision to name these two sites the high affinity osmolyte sites. Glutamates do 
not populate sites 3 and 4, indicating that these are lower affinity sites, and their 
occupation is likely concentration dependent. 
 
Structure of AF2372 with 0.40 M Aspartate 
The structure of the AF2372 with 0.40 M aspartate appears much the 
same as that of the structure with 0.40 M glutamate, though a few small changes 
in osmolyte behavior arise. This structure contains 5 aspartates per monomer: 
Three aspartates occupy the sites of Glu1, Glu2, and Glu3 as observed in the 
higher concentration glutamate structure. There is no Asp present in the 
equivalent of site of Glu4. This is likely because of the shorter length of an 
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aspartate molecule making it more difficult to hydrogen bond to both Arg18 and 
Thr122., residues separated by 8.3 Å. While glutamate is of sufficient length to 
hydrogen bond to both residues, without the additional methylene group, 
aspartate cannot bridge the gap, resulting in decreased binding to this site. 
Finally, there are two additional aspartate binding sites, which are not seen in the 
glutamate structures (Figure 7-10). Aspartates 5 and 6 bind in the active site of 
AF372, with Asp5 binding at the mouth of the active site. Asp5 coordinates to the 
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α-carboxylate of Asp2, and the γ-carboxylates of Asp6. Asp5 also hydrogen 
bonds with the hydroxyl group of Tyr156, the guanidinium groups of Arg165 and 
Arg167, and an active site phosphate. Asp6 binds in the inositol binding site, 
mimicking one half of that molecule and hydrogen bonding to the guanidinium 
group of Arg191, the α-carboxylate of Ala172, and the sulfate in the active site 
(corresponding to the phosphate of I-1-P). 
The structure would strongly suggest that Asp should inhibit the enzyme 
activity more than Glu. Its smaller size (compared to Glu) would allow it to diffuse 
into the active site with relative ease. Since Asp is seen in the active site of 
AF2372 while Glu is not, one might expect to see better thermoprotection from 
Asp. However, the two amino acids have about the same thermoprotective 
effects. Even though Asp is small enough to diffuse into the active site, it is 
possible that aspartates in these sites (5 and 6) are artifacts due to the very high 
concentration of asp in the crystallization media. If specific binding of osmolytes 
is important for thermoprotection, then it appears that aspartates in Glu binding 
sites 1, 2, and 3 are the sites responsible for enhanced stability to heat. 
 
Structure of AF2372 with 0.025 M Aspartate 
 The structure of AF2372 with a much lower concentration of Asp contains 
only three glutamates monomer, as well as one molecule of inositol per 
monomer. In each monomer of AF2372, the aspartates occupy the sites of Glu1 
and Glu2 and Glu3 as in the 0.40 M Asp structure. Interactions with the protein 
 167 
are essentially the same, indicating that these three sites are the high affinity Asp 
sites, with sites 5 and 6 being concentration dependent. 
 
Structure of AF2372 with 0.20 M DGP 
 DGP was  found to be the most inhibitory solute of those tested, and as 
such we expected to observe DGP bound in or very near the active site of 
AF2372. This is indeed the case as seen in Figure 7-11. 
Each monomer in the AF2372 structure binds two molecules of DGP, one 
in the active site, and one in the position of Glu2. The active site DGP sits with 
one of the glycerol arms in the inositol binding site, making hydrogen bonds to 
Asp200, Asp85, and an inorganic phosphate moiety in the active site. The other 
glycerol arm hydrogen bonds to Arg165 and Arg167, and makes a hydrogen 
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bond with the backbone amide of Phe88. The DIP phosphate group sits at the 
end of Tyr156, and hydrogen bonds to the hydroxyl group of this residue, as well 
as to the side chains of Arg167 and Arg191. This location corresponds to binding 
site of the second phosphate in fructose bisphosphate. The second DGP sits in 
the location of Glu2, and shows slightly lower occupancy (80%) under these 
crystallization conditions. The phosphate moiety of this DGP is strongly anchored 
by Arg92, Lys43, and Lys164. Lys164 also hydrogen bonds to one of the glycerol 
arms of DGP. Thus, the strongly cationic binding site 2 is able to bind a variety of  
anions. 
 
AF2372 and Glu-site Mutants – thermostability and osmolyte thermoprotection 
  The structural observations indicated that dicarboxylate osmolyte 
molecules Glu and Asp bind in specific locations of AF2372 that have clusters of 
cationic residues. These sites were therefore targeted for mutation (Figure 7-12), 
to attempt to correlate specific osmolyte binding sites to thermoprotective effects. 
Single mutants (R18A, R29A, R92Q, and K164E), double mutants (R11A/R18A 
and R92Q/K164E), and a tetra mutant (R11A/R18A/R92Q/K164E) were 
generated to remove or perturb the different Glu binding sites.  
The thermal denaturation temperature, Tm, was measured for each 
mutant, with surprising results. As can be seen in Table 7-4, all but one of the 
mutants (K164E) showed a significant drop (4o to 21o) in denaturation 
temperature when compared to the wild type enzyme. Oddly, the K164E mutant 
was more thermostable than native AF2372. 
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Mutants R11A/R18A and R11A/R18A/R92Q/K164E have especially low 
Tm values (~70°C). In contrast to these dramatic changes, previous experiments 
to replace several hydrophobic residues with alanine (L57A, V142A, and L148A), 
in an attempt to reduce hydrophobic interactions and thus lower the Tm, had only 
small effects (Yang Wei, unpublished results). The L57A mutation had a slight 
effect on Tm (a drop of 5˚), while V142A and L148A had no effect on Tm. These 
results indicate that replacing surface clusters of cationic residues in AF2372 can 
destabilize the enzyme significantly, more so than removing interior hydrophobic  
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interactions. 
 
 
 
 
 
 
 
 
The enhanced thermostability of K164E is likely due to a probable salt  
bridge forming between the two monomers of AF2372 upon mutation of Lys164 
to a glutamate. As seen in Figure 7-8B, Lys164 from one monomer lies very 
close to Arg92 of the opposing monomer. Upon mutation of Lys164 to Glu 
without a change of Arg92, a salt bridge could easily form. Indeed, the decreased 
Tm for K164E/R92Q (a drop of 24o in comparison with the K164E mutant) 
confirms this interaction. 
Because of the decreased Tm of the Glu site mutant enzymes, the 
temperature at which activity assays were conducted was decreased, as well as 
the incubation temperature for thermal unfolding. With the exception of the more  
stable K164E mutant, the assay temperature of each of the other mutants was 
tuned to the temperature where it showed 25% residual activity upon heat 
treatment in the absence of solutes.  When mutant proteins were heated in the 
presence of 0.10 M Glu or Asp, at least 50% of the enzyme activity was 
Table 7-4. Melting temperature  (Tm) of wild type and 
mutant AF. Mutants with solved structure are bolded. 
AF2372  Tm (°C) Glu site effected 
WT 89 NA 
R18A 85 1 
R29A 82 3 
R92Q 75 2 
K164E     ~95 2 
R11A/R18A 69 1 
R92Q/K164E 71 2 
R11A/R18A/R92Q/K164E 68 1 and 2 
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preserved. Additionally, when heated around or above the Tm with 0.50 M of 
solutes, nearly 100% of enzyme activity was preserved (Figure 7-13).  One or 
more of the different Glu sites observed with AF2372 and 0.40 M Glu are 
abolished in these mutant enzymes, yet Glu thermoprotection still occurs. There 
are several possible interpretations of these results: (i) Glu sites are either not 
really abolished or new ones arise, (ii) Glu and Asp can weakly bind nearer to the 
active site and stabilize the protein to thermal denaturation, or (iii) specific 
osmolyte binding sites are incidental and do not correlate with osmolyte 
thermoprotection of enzyme activity. 
 
Structural Differences Between AF2372 and Glu Site 2 and 3 Mutant Proteins 
The changes in Tm for the mutant proteins provided motivation for 
determining crystal structures of two mutants: R29A and R92Q/K164E. R29A 
shows a small drop in Tm while R92Q/K164E shows a larger decrease compared 
to native AF2372. The overall structure of native AF2372 overlays quite well with 
that of the published structures of this enzyme (1LBV). The five native AF2372 
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structures with compatible solutes (0.025 and 0.400 M each of Asp and Glu, 
0.200 M DGP) also align very well, showing excellent overlap of all secondary 
structural elements. The R92Q/K164E structures in the absence and presence of 
Glu show good alignment with each other. However, when compared with the 
native AF2372 structure there are subtle yet significant changes (Figure 8-14A). 
Specifically, the mobile catalytic loop (Asp32 to Lys43) and the helix that 
precedes it (Ser23 to Lys31) is pulled away from the dimer interface by 
approximately 1 Å. Additionally, the region from Ala128 to Glu141 is pulled back 
from the dimer interface by approximately 1 Å. On opposing monomers these two 
areas are directly opposite one another, widening the interface by 2 Å overall. Of 
even greater significance is the perturbation of the mobile loop and the helix 
directly preceding it seen in this mutation. Stabilization of this mobile element 
either by binding of an osmolyte to site two, or by mutation to create a salt bridge 
in this region (as per the K164E single mutant) has a beneficial impact on 
thermostability of this enzyme.   
 Shifts in less crucial regions are seen in the R29A mutant (Figure 8-14B). 
In this mutant, the helix which precedes the catalytic loop (Ser23 to Lys31) is 
affected, and the region pulls away from the dimer interface by 1.5 Å, while the 
catalytic loop remains unperturbed. These shifts appear to affect the hydrogen 
bonding network that stabilizes dimer formation. However, R29A has a Tm only 7o 
lower than native AF2372 while R92Q/K164E is significantly destabilized.  This 
may be due to the fact that although the hydrogen bonding network in the dimer 
interface is perturbed in both mutants, in the R29A mutant the catalytic loop 
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 remains unaffected. This indicates that the hydrogen bonding network in the 
dimer interface is important to thermostability of this protein. It may also suggest 
that it is the stabilization of the catalytic loop which provides a critical 
thermoprotective effect.  
 
Structure of R29A with 0.40 M Aspartate  
The R29A protein was created to abolish the Glu3 site in AF2372. The 
protein was crystallized in the presence of high concentrations of Asp (0.40 M) 
which we originally assumed would occupy Glu sites. Interestingly, R29A has 4 
aspartates per monomer, giving 8 aspartates overall for the homodimer. The two 
tight binding osmolyte sites in the AF2372 +0.40 M Glu structures (sites 1 and 2) 
are occupied by aspartates. The ‘weak’ Glu sites 3 and 4 do not contain Asp. 
Additionally, the active site Asp sites (5 and 6) are occupied, as in the + 0.40 M 
Asp wild type AF2372 structure.  
 
Structure of R92Q/K164E with 0.40 M Glu  
The R92Q/K164E mutant was designed to abolish binding site 2. Indeed, 
the R92Q/K164E with 0.40 M Glu structure shows two glutamates per monomer, 
corresponding to glutamate sites 1 and 4. As expected, Glu1 is unaffected by the 
distal mutation and binds the dicarboxylate normally. The mutation to binding site 
2 had the desired effect – the loss of Glu2 in this site. Site 4 does bind glutamate, 
but in a slightly different conformation than in the other structures, while site 3 is 
devoid of any osmolytes. The loss of Glu3 presumably reflects a perturbation of 
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the hydrogen bonding network with this mutation. A comparison between this 
mutant and wild type AF2372 is presented in Figure 7-15. The mutation to 
binding site two perturbs the long helix leading into this location (Glu3 to Ser23). 
This large helix provides the binding scaffolding for osmolyte sites 1, 3 and 4. 
With the mutation, this helix is slightly displaced, and the movement alters the 
binding pockets, resulting in decreased binding in site 3, and a somewhat altered 
mode of binding in site 4. 
 
 
Hydrogen Bonding in the Dimer Interface (PISA analysis) 
Clearly, an extensive hydrogen bonding network exists between the two 
monomers of AF2372. This network stabilizes the dimer interface, and extends at 
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least 5 Å up along the sides of the interface to R29. It is likely that the dimer 
interface osmolytes seen in the higher concentration structures reinforce this 
network, acting as stitches between the two monomers. Further evidence of this 
phenomenon can be seen in the mutations made to this region. The R29A 
mutation reduces Tm by 7 ˚C, a surprising drop considering that Arg29 is at least 
5 Å from the dimer interface, and is not close to any other obviously critical 
regions of the enzyme. The slight differences seen in orientation of secondary 
structure elements between the R29A mutation and native protein point to a 
widening of the dimer interface by ~3 Å. The rationale for the structural change is 
the loss of a key residue in the hydrogen bonding network. With the loss of the 
cationic guanidinium group and the inherent length of the arginine residue, a 
presumably crucial anchor point for this hydrogen bonding network has been 
eliminated. Without this anchor point the dimer interface beings to relax, widening 
slightly, and causing a lower Tm for this mutant.  
The hydrogen bonding network is comprised of residues Arg29, Asn89, 
Arg92, Glu93, Tyr97, Arg135, and Ser183. These seven residues form the 
anchor points of a heavily water mediated hydrogen bonding network between 
the two monomers. Addition of osmolytes into this network can further stabilize 
the dimer interface, and thus provide one mode of thermoprotection. Osmolytes 
in site 2 generate hydrogen bonds to Lys164, Asn151, and Arg165, Lys43, 
Asp32, and R92. Osmolytes in site 3 generate hydrogen bonds to Tyr97 and 
Arg29. Deletion of any of these hydrogen bonding partners, can, and has shown, 
to have an impact on dimer stability (Tm). 
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7.5 AF2372 Thermoprotection  
AF2372 thermoprotection via DGP  
 The mechanism of thermoprotection by DGP is better understood, and 
completely different from that that of the dicarboxylates. DGP inhibits AF2372 
enzymatic activity strongly, indicating a high affinity for the active site of the 
enzyme. The AF2372 structure with DGP confirms this inhibition. Two molecules 
of DGP bind in the active site, with one of the glycerol arms of DPG occupying 
the substrate binding pocket (mimicking a molecule of I-1-P). Indeed, DGP is so 
potent a thermoprotectant that 0.01 M DGP has similar thermoprotecting effects 
as 0.3 M Glu or Asp.  
 Recent studies (Micaelo et al., 2008) elucidated the mechanism of 
thermostabilization of the rubredoxin protein from Desulfovibrio gigas. In this 
mesophillic, protein addition of 0.1 M DGP induced a 4-fold increase in half-life 
for thermal denaturation at 90 ˚C (Blochl et al., 1995). Molecular dynamics 
studies have since concluded that the thermostabilization of rubredoxin is likely 
due to DGP restraining a mobile loop from large scale motions. Stabilization of 
this loop confers protection to the hydrophobic core of the protein (Micaelo et al., 
2008). 
 While the rubredoxin and AF2372 are structurally dissimilar, they do share 
a common feature: a catalytically crucial mobile loop. In AF2372, this mobile loop 
is responsible for binding a third metal ion which is essential for creating a 
nucleophilic water that attacks the phosphorus of I-1-P (Stieglitz et al., 2002). It is 
therefore possible that DGP provides thermoprotection in the same manner, 
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stabilizing the catalytically important loop. Structural data support this theory, with 
a phosphate from the DGP bound in the Glu2 site and hydrogen bonding to 
Lys43. Thus, DGP could confer thermoprotection by binding to and constraining  
 
the mobile loop, protecting the active site and hydrophobic core of the protein. 
Additionally, the structure of the K164E/R92Q mutation supports this theory. This 
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mutation perturbs the catalytic loop and the helix preceding it (Leu26 to Val30) 
and the Tm of this mutant drops by 18 ˚C. However, when this area is stabilized, 
as in the K164E single mutant (where a putative salt bridge forms between 
K164E and Arg92 stabilizes the area directly adjacent to the mobile loop), the Tm 
of the enzyme actually increases dramatically. Additionally, the binding of an 
osmolyte to this area further stabilizes the catalytic loop, Glu Asp and DGP all 
coordinate to Lys43, which is directly adjacent to the catalytic loop. Stabilization 
of this loop by any means clearly improves thermostability of this enzyme (Fig 7-
16).  
   
Dicarboxylates act as thermoprotectants of AF2372 activity  
 It seems likely that the crucial moiety involved in thermoprotection with 
the non-phosphodiester molecules (i.e. not DGP or DIP) is the presence of a 
dicarboxylate moiety. While the glutamates and aspartates in the structures 
discussed above have been observed to bind in specific binding sites and 
interact strongly with the extensive hydrogen bonding network of this enzyme, 
how this relates to thermoprotection is still unclear. If the binding of dicarboxylate 
osmolytes were directly related to thermoprotection, then the mutations designed 
to destroy these binding sites should have in turn, affected thermoprotection. 
However, a decrease in thermoprotective effect was not seen with the binding 
site mutants.  
While these mutations were successful, in that mutated binding pockets 
no longer bound dicarboxylates (confirmed crystallographically in the 
R92Q/K164E and R29A mutants), assays of these mutants showed 
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thermoprotection curves consistent with wild type AF2372. However, while the 
thermoprotective effects of osmolytes were not nullified by destroying their 
specific binding sites, the Tm of each of these mutants (with notable exception of 
K164E single mutant) was significantly decreased. While these dicarboxylate 
binding pockets may not be crucial for thermoprotection, we have clearly 
identified areas of the enzyme that are key to its inherent thermostability. This is 
of particular interest, as attempts previously made to decrease the thermostability 
of this enzyme, by mutation of the hydrophobic dimer interface, proved to be 
ineffective.  
Though at the moment the exact mechanisms of dicarboxylate osmolytes 
thermoprotection remains unclear, one factor affecting our investigations may be 
the temperature at which the crystallography is taking place. Modest heat 
treatment of the enzyme does aid in allowing larger substrate and osmolyte entry 
to the active site. However before setup of crystal trays, the enzyme is brought 
back to room temperature and then crystallized at 20 ˚C. Additionally, data 
collection is performed at 100 K. While these procedures are standard for 
crystallography, and are critical to obtaining high resolution structures, they may 
be limiting the use of crystallography as a tool for determining the nature of 
dicarboxylate thermoprotection.  It is possible that at higher temperatures the 
dicarboxylates are interacting with AF2372 in a way which is not visible at 100 K. 
As the enzyme mixtures cools, the osmolytes could be populating the most 
stable conformation, and thus relaxing into coincidental binding pockets. Though 
crystallography at 87 ˚C is not feasible, structural information at this temperature 
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may elucidate the nature of the dicarboxylate thermoprotection. One possible 
interaction that we may not be observing at lower temperatures is the 
stabilization of the catalytic loop. The two tight binding glutamate sites (1 and 2) 
both sit adjacent to catalytic loop, at high temperatures these residues could 
restrict loop movements and thus aid in thermoprotection.  
  
7.6 Conclusions and Future work 
Both the dicarboxylate osmolytes and DGP provide thermoprotection to 
AF2372, although the mechanism of protection by the dicarboxylate osmolytes is 
unclear. DGP is present in the active site, and protects the molecule specifically 
via stabilization of the active site and catalytic loop, which in turn protects the 
hydrophobic core of the protein. The dicarboxylate osmolytes, specifically Asp 
and Glu, bind to discrete site on the enzyme and also provide thermoprotection. 
However, their thermoprotective ability does not appear to involve this direct 
binding.  The dicarboxylate binding sites however, do correlate with 
thermostabilization of the protein, as mutation at any one of these sites perturbs 
the Tm of the protein. 
 
 
Future directions for this project 
 There is still one very large unanswered question in the AF2372 project: 
How precisely do dicarboxylate solutes such as glutamate and aspartate effect 
thermoprotection. It is possible that though we have seen some binding site for 
these osmolytes crystallographically, there are weaker but more crucial binding 
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sites that were not visualized in the crystals. These sites may not be observable 
at the lower temperatures required for crystallography. One major area that must 
be explored is the catalytic loop. Already known to be crucial to catalysis, the 
effect of modifying the catalytic loop mobility on the ability of dicarboxylate 
osmolytes and DGP to serve as AF2372 thermoprotectants must also be 
explored via mutagenesis. For instance, Asp38 appears to provide a key 
stabilizing interaction for this catalytic loop, it hydrogen bonds with Arg197. 
Mutation of this Arg197 to Ala, Asp38 to Ala, as well as mutation of Thr40, 
another hydrogen bonding residue, to Ala, could prove interesting, as could 
truncation of the loop altogether. While it would be expected that these mutants 
should be catalytically impaired, if not inactive, it is their thermostability which 
should be most interesting. If these mutants do not derive thermoprotection from 
DGP, or the dicarboxylate osmolytes, then it would appear that our assumption 
that osmolytes protect AF2372 by stabilizing this loop would be correct.  
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Table 7-1. Crystallographic conditions for AF2372 structures. 
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Table 7-2. Crystallographic diffraction and refinement data for AF2372 structures. 
 
Protein WT 
AF2372 
R29Q / 
K164E 
R29A 
Solute Glu 
0.025 
M  
Glu 
0.400 
M 
Asp 
0.025 
M 
Asp 
0.400 
M 
DGP  
0.20 M  
- Glu 
0.40 M 
Asp 
0.40M 
Diffraction Data         
 Resolution range 
(Å) 
31.13-
2.70 
44.75-
2.00 
44.70-
2.30 
42.73-
2.70 
33.97-
2.69 
36.48-
2.70 
33.65-
2.50 
42.65-
2.60 
 No. of reflections 24763 62169 40753 25139 25201 24448 31585 28144 
 No. of reflections in 
the free set 
1730 3149 2065 1252 1286 1260 1594 1416 
 Space group P32 P32 P32 P32 P32 P32 P32 P32 
 a (Å) 89.2 89.51 89.40 89.62 89.6 90.32 89.9 89.53 
 c (Å) 102.04 103.14 102.71 102.38 101.92 101.41 100.93 102.14 
 Completeness 99.42 99.98 99.95 99.51 99.81 96.48 99.77 99.95 
 Rmerge 0.107 0.081 0.108 0.112 0.100 0.100 0.100 0.109 
Refinement         
 Rcrysta 0.1914 0.1617 0.1689 0.1809 0.1743 0.1981 0.1591 0.1730 
 Rfreeb 0.2377 0.1715 0.1966 0.2250 0.2134 0.2467 0.2013 0.2215 
 No. of non-
hydrogen protein 
atoms 
3954 4031 3940 3944 4003 3954 4007 3989 
 No. of non-
hydrogen osmolyte 
atoms 
47 80 54 90 60 0 40 72 
 No. H2O molecules 77 378 273 159 83 76 197 92 
 No. ions 8 8 6 4 10 6 8 10 
 r.m.s.d. bonds (Å) 0.015 0.01 0.008 0.008 0.023 0.018 0.009 0.009 
 r.m.s.d  angle (o) 1.6 1.2 1.09 1.08 1.2 1.23 1.11 1.2 
 Ramachandran plot          
    % Favored 88.2 97.67 97.80 98.01 96.3 95.43 97.46 97.06 
    % Allowed 11.8 2.33 2.20 1.99 3.5 4.37 2.54 2.94 
    % Outliers 0 0 0 0 0.2 0.2 0 0 
 Average B factor 62.73 27.74 36.25 35.66 55.19 58.17 42.23 42.45 
 
a Rcryst = {S (||Fo| - |Fc||) / |Fo|}, where |Fo| and |Fc| are the observed and calclated 
structure factor amplitudes, respectively. 
b Brunger (1992). 
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Chapter 8; Conclusions 
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8.1 Protein Crystallography 
 Macromolecular crystallography is a powerful tool, with far reaching 
applications to all areas of science.  The first protein structures were published 
by Kendrew and Perutz in 1958 (Figure 8-1), for which they subsequently won 
the Nobel prize in chemistry in 1962, (Kendrew et al., 1958; Perutz et al., 1960), 
since that time the field has had an impact on every aspect of industrial, 
medicinal, and academic chemistry. At the time of writing this thesis, the protein 
data bank (Berman et al., 2000) holds 86,344 structures, comprised of protein, 
DNA, RNA, and various complexes thereof. Determining the three dimensional 
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structures of proteins has allowed for examination of the molecules of biological 
processes at Å scale resolution. These structures have provided invaluable 
information in fields as varied as basic biochemistry, where the structure of the 
ribosome was elucidated (for which Ramakrishnan, Steitz, and Yonath won the 
2009 Nobel prize in chemistry), to considerations of health and disease, where 
drug targets are determined, and proteins responsible for various disease states 
are studied. Additionally, crystallography has been used for biotechnology and 
nanotechnology applications as well, from antifreeze proteins being used in ice 
cream (Venkatesh and Dayananda, 2008) to green fluorescent protein tagging 
(Tsien, 1998) technology that also won a Nobel prize in 2008. The 
pharmaceutical industry in particular employs crystallography as a foundation for 
structure based drug design. In this approach, the atomic resolution structure of a 
target protein is used to search for novel ligand binding sites that can mediate its 
biological activity (Shoichet et al., 2002). Target proteins could be anything from 
superoxide dismutase, which is involved in Lou Gehrig’s disease (Pasinelli and 
Brown, 2006) to HIV-1 protease, an enzyme crucial to the lifecycle of HIV and a 
major target for AIDS therapy (Chen et al., 1994). 
 
8.2 Structure provides fundamental insight   
That structure determines function is one of the fundamental tenants of 
biology. Protein crystallography is such a powerful tool because it allows for the 
examination of the structure of proteins, DNA and RNA on an atomic scale, 
allowing for the determination of function, and atomic level mechanism of that 
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function. It is through crystallography that fundamental questions on the three 
enzymes studied have been answered.  
 
AF2372 – explorations of thermostability and solute thermoprotection 
The structure of AF2372, the thermostable IMPase/FBPase from 
Archaeoglobus fulgidus, had previously been solved (Stieglitz et al., 2002) and 
compared to other members of the IMPase superfamily (Stieglitz et al., 2003; 
Stec et al. 2000). However, the thermostability of AF2372, and how various 
osmolytes could protect it from thermal denaturation, had not yet been explored. 
Anionic solutes had been observed to protect the protein from thermal 
denaturation (Hongying Yang, Dissertation, Boston College), but no mechanism 
for this protection had been proposed. Most importantly, the manner in which 
these osmolytes provide protection was unclear.  
For the portion of my thesis research, I solved the structures of AF2372 
and two mutants that showed significantly altered thermostability in the presence 
of several different osmolytes. Although the mechanism of thermoprotection is 
still not completely clear, these structures significantly increased our 
understanding of protein stability and osmolyte thermoprotection. The A. fulgidus 
osmolyte DGP was found to bind in the active site of AF2372. In so doing, it likely 
stabilizes a mobile loop critical for catalysis. Structures of AF2372 co-crystallized 
with dicarboxylate osmolytes, (in this case the amino acids glutamate and 
aspartate) were also studied. These solutes had well-defined binding sites on 
AF2372 in regions critical to overall thermostability of the protein. Removal of 
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these dicarboxylate binding sites did not directly affect thermoprotection abilities 
of Asp or Glu, indicating that interactions of the protein with solutes that 
contributes to thermoprotection are more transient in nature. 
 
S. aureus PI-PLC – complex regulation of an exoprotein 
Although structures of several bacterial secreted phosphatidylinositol-
specific phospholipase C enzymes exist, the structure of the S. aureus PI-PLC 
had not been determined. Obtaining the structure of this enzyme became a 
priority in an attempt to explain several interesting biochemical phenomena seen 
with this enzyme:  (1) the pH optima of this PI-PLC was significantly lower than 
other PI-PLCs (particularly for PI-rich particles); (2) the dependence of specific 
activity on enzyme concentration suggested the protein was optimally active as a 
dimer or higher order aggregate, but not when moderate concentrations of salt 
were present; and (3) phosphatidylcholine added to vesicles enhanced enzyme 
activity dramatically (and rescued enzyme activity lost in the presence of 
moderate salt), although the enzyme had very little affinity for PC vesicles.  
All of the unusual biological features of this particular PI-PLC were 
explained by a combination of structural analysis, and supporting binding and 
activity assays. The explanation for the atypical pH optimum towards PI was 
provided by the solution of the structure of S. aureus PI-PLC both below (pH 4.6) 
and above (pH 7.5) its pH optimum. These structures showed a large loop 
movement controlled by a titratable intramolecular phenylalanine π - histidine 
cation. A structure of what is most likely the biologically active dimer was then 
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solved, and structures of appropriate mutations were generated to confirm how 
the dimer is destabilized by occupation of a nearby anion binding pocket. These 
structures were used to propose an equilibrium between a dimer where the anion 
pocket is occluded, and a monomer liganded with either a soluble anion (in which 
case it binds poorly to membranes) or stabilized by anionic substrate or other 
phospholipids. This structural model provided a means for PC to enhance activity 
without enhancing vesicle binding by diluting surface anion concentrations and 
shifting the equilibrium towards dimer. 
 
B. thuringiensis PI-PLC – defining a high affinity PC site 
Finally, the structure of S. aureus PI-PLC made this enzyme an ideal 
choice for continuing investigations on another bacterial PI-PLC, which has been 
an ongoing project in the Roberts lab. The B. thuringiensis PI-PLC, closely 
related to the S. aureus PI-PLC, has a specific high affinity PC lipid binding site. 
The existence of this binding site, and a general area on the protein where it 
might be located, were suggested by NMR and mutagenesis experiments (Pu et 
al., 2010). However, there was no direct evidence for a discrete PC site. 
Unfortunately, the B. thuringiensis PI-PLC is difficult to crystallize, and previous 
attempts to obtain a co-crystal structure of this enzyme with an activating PC had 
proved unsuccessful. Fortuitously, the S. aureus PI-PLC will crystallize readily, 
and mutations generated to create a PC binding pocket (based on the putative 
pocket in the B. thuringiensis PI-PLC) allowed us to co-crystallize not only 
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choline molecules, but a PC monomer with the S. aureus PI-PLC PC_binding 
mutant. 
 
8.3 Inositol – critical in all domains of life 
 The two types of enzymes that form the basis of my thesis are from not 
only different organisms, but also different domains of life altogether: one is from 
a bacterium, the other from an archaeon. Though the A. fulgidus IMPase/FBPase 
(AF2372) and S. aureus PI-PLC are extremely different enzymes, both act upon 
phosphorylated inositol substrates. AF2372 hydrolyzes inositol phosphates, and 
S. aureus PI-PLC catalyzes the cleavage of phosphatidylinositol. Myo-inositol is 
a ubiquitous compound with a plethora of important phosphorylated derivatives 
involved in a wide variety of cellular structures and events (Lu et al., 2012; 
Michell 2011, Fischer et al., 2002).  
Inositol is bound to these two vastly different enzymes in much the same 
way. AF2372 binds inositol by several polar interactions with the ring hydroxyls 
The 2 hydroxyl of inositol coordinates to the amine of Ala172, as well as the side 
chain carbonyl of Asp85. Hydroxyl 3 coordinates the hydroxyl group of Tyr155, 
the amine of Ala172, and the side chain carbonyl of Glu175. Hydroxyl 4 makes a 
water mediated hydrogen bond with the guanidinium group of Arg167, and 
hydroxyl 5 coordinates with the guanidinium group of Arg191. 
In S. aureus PI-PLC, the inositol again binds via hydroxyl groups. Hydroxyl 
1 binds to the hydroxyl group of Tyr208, and makes a water mediated hydrogen 
bond with the side chain amine of Lys113. Hydroxyl 3 binds to the guanidinium 
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group of Arg67, the catalytic residue His30, and along with Hydroxyl 2, makes a 
water mediated hydrogen bond to the side chain carbonyl Asp31. Hydroxyl 4 
coordinates both the hydroxyl group of Ser241 and the side chain carbonyl of 
Asp206, which also coordinates to hydroxyl 5. Hydroxyl 5 makes an additional 
hydrogen bond with the guanidinium group of Arg166, which in turn coordinate 
the hydroxyl 6 of inositol. 
While these binding pockets are structurally different, they do have some 
strong similarities. Both AF2372 and the S. aureus PI-PLC bind inositol with one 
tyrosine, two arginines, and at least one aspartate. Aside from the inclusion of 
the catalytic histidine in the PI-PLC binding pocket, and the backbone amide in 
that of AF2372, the binding interactions are markedly similar.  Though the PI-
PLC binds inositol more tightly than AF2372, this too makes sense. The S. 
aureus PI-PLC is specialized for one substrate, phosphatidylinositol, while 
AF2372 is more promiscuous, binding fructose bisphosphate as well as inositol 
monophosphate. 
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